<?xml version="1.0" encoding="UTF-8"?>
<projectSnippetsTree>
 <snippetsTree>
  <snippets file="dict8/PMC3004943/results/search/testTrace/results.xml">
   <result pre="units, but virtually no data are available about observations of" exact="infection" post="spreading for a very large number of immobile units."/>
   <result pre="confluent astroglial monolayer in a Petri dish and induce productive" exact="infection" post="in a limited number of cells with a genetically"/>
   <result pre="the statistics of the dynamics and spatial aspects of spreading" exact="infection" post="could be crucial in its containment [1]–[4]. Appropriate predictions"/>
   <result pre="remained limited. In general, there are two major types of" exact="infection" post="spreading: i) the position of the infected units does"/>
   <result pre="in cells in a tissue exposed to viral or bacterial" exact="infection" post="[14] or trees in a forest [15] ii) the"/>
   <result pre="trees in a forest [15] ii) the organisms carrying the" exact="infection" post="are moving around and thus are acquiring new sets"/>
   <result pre="more complex plaques. Finally, a standard paradigm used to explain" exact="infection" post="spreading through a percolation-like process involves a forest in"/>
   <result pre="study in detail the outbreak dynamics and the patterns of" exact="infection" post="spreading in a system containing tens of thousand of"/>
   <result pre="making video recordings and high resolution photos (i.e., tracking the" exact="infection" post="by both GFP expression and making preparations with various"/>
   <result pre="restricted release of infectious viral particles whereas the spread of" exact="infection" post="among interconnected cells is not compromised [24]. Figure 1"/>
   <result pre="well as in Materials and Methods. First, we initiated productive" exact="infection" post="provoking GFP expression in a limited number of cells"/>
   <result pre="h (A), 30 h (B) and 42 hours (C) after" exact="infection" post="with the BDG-PRV virus. In the bottom row (D)"/>
   <result pre="scaling behaviour at 42 hours and the spreading of the" exact="infection" post="before that are well characterized by the model. A"/>
   <result pre="exponential drop. Model time was scaled to fit to the" exact="infection" post="spreading rate of high titer experiments. Figure 5 Determination"/>
   <result pre="static configurations, we have also investigated the dynamics of the" exact="infection" post="spreading in our tissue cultures (Fig. 7 and supplementary"/>
   <result pre="all of them had been exposed to a uniformly distributed" exact="infection" post="for a short (as compared to the experiments' time"/>
   <result pre="representative microscopic field. Formation of cell clusters with more advanced" exact="infection" post="can be seen in image series F) and Video"/>
   <result pre="have determined the rate by which cells acquire a &quot;primary&quot;" exact="infection" post="(directly related to the initial exposure), and also the"/>
   <result pre="(Fig. 8). Figure 8 Visualization of the spreading of the" exact="infection" post="around a single infected seed. The upper picture (A)"/>
   <result pre="seed. The upper picture (A) demonstrates the progression of the" exact="infection" post="around a single infected cell (see Videos S4, S5,"/>
   <result pre="isolated cell (playing the role of a seed for the" exact="infection" post="spreading) to become infected. Fitted is a log-normal function"/>
   <result pre="from an algebraic (non-linear) distribution, ii) a secondary wave of" exact="infection" post="was represented by the gradual introduction of new infectious"/>
   <result pre="model can be seen in supplementary Video S7. Discussion Our" exact="infection" post="spreading experiments have been possible because the viral particles"/>
   <result pre="infect their surroundings and to initiate a focal spread of" exact="infection" post="over time. Compromised (but viable) as well as dying"/>
   <result pre="from a large distance to the place of the original" exact="infection" post="[26]–[31]. Detailed documentation of the spreading of viral infection"/>
   <result pre="original infection [26]–[31]. Detailed documentation of the spreading of viral" exact="infection" post="in a layer of many thousands of cells has"/>
   <result pre="of infection. We observed such convection current-induced disturbance of the" exact="infection" post="spread in the case of some cell types used"/>
   <result pre="of the PRV virus versus astrocytes system, however, neither the" exact="infection" post="of all of the neighbours nor the secondary infection"/>
   <result pre="the infection of all of the neighbours nor the secondary" exact="infection" post="of the medium played a dominant role and, in"/>
   <result pre="astrocytes did not lead to convection current-induced disturbance of the" exact="infection" post="spread and, in line with simulation data, the growth"/>
   <result pre="the growth of newly formed clusters after 18 hours of" exact="infection" post="did not have a relevant impact on the percolation-type"/>
   <result pre="physical parameters are known to affect the cells' susceptibility to" exact="infection" post="and/or lead to inhomogeneous spreading of infection in both"/>
   <result pre="cells' susceptibility to infection and/or lead to inhomogeneous spreading of" exact="infection" post="in both in vivo and cell cultures. Variability in"/>
   <result pre="in a highly variable number of contacts (through which the" exact="infection" post="can take place) between them. The non-linear term (power"/>
   <result pre="However, the plaques themselves have a complex geometry since the" exact="infection" post="rate of a cell is highly varying from cell"/>
   <result pre="very wide variety of experimental situations being dominated by the" exact="infection" post="taking place at spatially scattered points and spreading to"/>
   <result pre="cannot be ignored. In principle, even the network aspects of" exact="infection" post="spreading could be studied in a similar setup with"/>
   <result pre="pattern were infected with PRV viruses, as it follows. Viral" exact="infection" post="We aimed to choose a virus strain for the"/>
   <result pre="Therefore, GFP was expressed at a very early stage of" exact="infection" post="in the compromised cells that made possible to precisely"/>
   <result pre="cells that made possible to precisely follow the spread of" exact="infection" post="over time. The detailed explanation of the mechanisms underlying"/>
   <result pre="and stored at −80°C. Aliquots were thawed immediately prior to" exact="infection" post="of astrocyte cultures. During preliminary experiments, the appropriate virus"/>
   <result pre="medium, for 1 h, at room temperature. The multiplicity of" exact="infection" post="(MOI) was ∼0,17 or 0,017 PFU/cell, respectively. Removal of"/>
   <result pre="coverslip (duplicates). The data indicate that ∼24 hrs after the" exact="infection" post="astrocytes began to release infective viral particles to the"/>
   <result pre="13000*10000 pixels (8,5*6,5 mm) containing approx. 100–150 000 astrocytes. Virus" exact="infection" post="of single cells monitored by GFP expression develops in"/>
   <result pre="expression level of infected cells and the sensitivity of the" exact="detection" post="system an intensity threshold has to be declared in"/>
   <result pre="all infected cells even in a very early state of" exact="infection" post="appearing brighter than the background noise. As a result"/>
   <result pre="and white image. (See Fig. 3) Real time monitoring of" exact="infection" post="spreading Dynamics of virus propagation was monitored in astroglial"/>
   <result pre="increasing or decreasing the threshold in the range of early" exact="infection" post="results only in a time shift of virus spreading."/>
   <result pre="tagged manually one by one on the basis of visual" exact="detection" post="resulting in the xy position of infected cells in"/>
   <result pre="and S6. Simulations, modeling The model we designed to simulate" exact="infection" post="spreading is based on the combination of the well"/>
   <result pre="models [1–2.] or, in other words, it is a simple" exact="infection" post="spreading model in an inhomogeneous environment with a simple"/>
   <result pre="individual cells. Our goal was to reproduce the dynamics of" exact="infection" post="spreading and the structure and shape of the resulting"/>
   <result pre="are two stages when infected cells appear because of the" exact="infection" post="from the surrounding medium. At the beginning of the"/>
   <result pre="of the experiment the whole system is exposed to the" exact="infection" post="uniformly, thus, infected cells appear randomly in time and"/>
   <result pre="cells became infected due to the initial exposure to the" exact="infection" post="was approximated from Fig. 8B: the frequency with which"/>
   <result pre="with a lognormal distribution. This is the dominant mechanism for" exact="infection" post="from the medium. At later stages cells (primarily during"/>
   <result pre="but relatively low titer, leading to a second stage of" exact="infection" post="beginning at around 18 hours (See also the increase"/>
   <result pre="images Number of particles appearing during the first stage of" exact="infection" post="500 Approximated from Fig. 8 Number of particles appearing"/>
   <result pre="one depends on several factors and is modelled with allowing" exact="infection" post="between two trees with a given probability p. In"/>
   <result pre="p is smaller than a given, lattice dependent pc, the" exact="infection" post="cannot spread, above this critical probability a finite proportion"/>
   <result pre="GFP expressing infected cells, 48 hours after the onset of" exact="infection" post="with &quot;high&quot; virus titer. High resolution file can be"/>
   <result pre="and clusters developed in the model (D,E,F). Time elapsed after" exact="infection" post="was 18 h (A,D), 30 h (B,E) and 42"/>
   <result pre="of a simplified model. The clusters generated with seeds of" exact="infection" post="appearing at a rate corresponding to the experiment, but"/>
   <result pre="appearing at a rate corresponding to the experiment, but the" exact="infection" post="spreading according to the p=0.7 simple percolation rule leads"/>
   <result pre="Immun66134213489529051 23StaufferDAharonyA1991Introduction to Percolation Theory.LondonTaylor and Francis 24CardJPRinamanLLynnRBLeeBHMeadeRPet al.1993Pseudorabies virus" exact="infection" post="of the rat central nervous system: ultrastructural characterization of"/>
   <result pre="infected with herpes simplex virus.J Gen Virol522672786270236 30PriceRWRubensteinRKhanA1982Herpes simplex virus" exact="infection" post="of isolated autonomic neurons in culture: viral replication and"/>
   <result pre="peripheral blood mononuclear cells to equine herpes virus type 1" exact="infection" post="upon mitogen stimulation: a role of the cell cycle"/>
   <result pre="and neurochemical characterization of neural circuitry.Mol Brain Res10910511812531520 44BoldogkőiZSíkADénesÁReichartAToldiJet al.2004Novel" exact="tracing" post="paradigms-genetically engineered herpesviruses as tools for mapping functional circuits"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="dict8/PMC3561042/results/search/testTrace/results.xml">
   <result pre="groups are defined by each of their members having acquired" exact="infection" post="through a specific behavior. However, risk group definitions say"/>
   <result pre="infectious disease, the mean number of secondary infections per primary" exact="infection" post="in a completely susceptible population [4] (for notations see"/>
   <result pre="time between the primary and secondary infections, typically termed the" exact="infection" post="generation time (T; several other definitions are used in"/>
   <result pre="months or years. Here we show how transmission variability and" exact="infection" post="generation time can be estimated by combining viral genomic"/>
   <result pre="the same population. First, we used inferred HCV incidence and" exact="prevalence" post="by subtype from previous studies [25]. Next, we used"/>
   <result pre="chronically infected with HCV. The majority of patients with HCV" exact="infection" post="develop persistent or chronic infection (60–92%) whilst a minority"/>
   <result pre="majority of patients with HCV infection develop persistent or chronic" exact="infection" post="(60–92%) whilst a minority clears HCV-RNA (8–40%); viral clearance"/>
   <result pre="clearance is much faster within the first 2 years of" exact="infection" post="and slower thereafter (≪1% per year), while increased rates"/>
   <result pre="younger age, female gender, lack of HIV co-infection, chronic HBV" exact="infection" post="and genetic variation in IL28B [29]–[42]. HCV phylodynamic analysis"/>
   <result pre="while for subtype 1b and 4a infections the source of" exact="infection" post="was usually unknown. These distributions are consistent with previous"/>
   <result pre="rapid spread. HCV is hyperendemic in IDUs worldwide with anti-HCV" exact="prevalence" post="of 15–90% [45]; IDUs may share syringes, needles and"/>
   <result pre="tracking of secondary infections is very difficult and date of" exact="infection" post="is in most cases unknown. Some workers have suggested"/>
   <result pre="the duration of infectiousness (∼12.5 years). The probability of secondary" exact="infection" post="per contact is expected to be higher during the"/>
   <result pre="when viral load is 10 times greater than later in" exact="infection" post="[55], [56]. Also, in the first year patients are"/>
   <result pre="Estimated distributions of the number of secondary infections per primary" exact="infection" post="for each HCV subtype. Figure 5 Cumulative proportion of"/>
   <result pre="for each HCV subtype. Figure 5 Cumulative proportion of onward" exact="infection" post="versus the infected population ranked by the number of"/>
   <result pre="the rate of coalescence (Ne), viral generation time (T), and" exact="prevalence" post="(N) and thus is independent of phylogenetic topology. It"/>
   <result pre="Athens University Medical School. Estimation of chronic HCV incidence and" exact="prevalence" post="through time The overall and genotype-specific incidence of chronic"/>
   <result pre="through time The overall and genotype-specific incidence of chronic HCV" exact="infection" post="has been estimated in previous studies using back-calculation [24],"/>
   <result pre="infected individuals was obtained from 943 Greek patients enrolled in" exact="treatment" post="studies [24], [25]. Enrolment took place between 1995 and"/>
   <result pre="2000; patients were adults (18–70 years old) with a histological" exact="diagnosis" post="of chronic hepatitis. Injecting drug use, transfusion, other and"/>
   <result pre="of the patients, respectively. The distribution of the dates of" exact="infection" post="within each transmission group was determined using data from"/>
   <result pre="was determined using data from 456 Greek patients enrolled in" exact="treatment" post="studies with known dates of infection. We extended the"/>
   <result pre="to obtain an estimate of the overall genotype-specific incidence and" exact="prevalence" post="during 1940–1990. HCV sequence data Correct sampling is crucial"/>
   <result pre="recorded for each sample: patient's age, sex, transmission group and" exact="treatment" post="history (Table S1). Samples were excluded where the patient"/>
   <result pre="exponential phase as 1990, to reflect the introduction of anti-HCV" exact="screening" post="after the virus' discovery in 1989. The start of"/>
   <result pre="et al. (1999) Prevalence and clinical outcome of hepatitis C" exact="infection" post="in children who underwent cardiac surgery before the implementation"/>
   <result pre="Straley-EasonKD, et al. (2000) 45-year follow-up of hepatitis C virus" exact="infection" post="in healthy young adults. Ann Intern Med132: 105–111.10644270 35SantantonioT,"/>
   <result pre="Infect Dis43: 1154–1159.17029134 36Kenny-WalshE (1999) Clinical outcomes after hepatitis C" exact="infection" post="from contaminated anti-D immune globulin. Irish Hepatology Research Group."/>
   <result pre="1899–1905.1280771 41AlterMJ, Kruszon-MoranD, NainanOV, McQuillanGM, GaoF, et al. (1999) The" exact="prevalence" post="of hepatitis C virus infection in the United States,"/>
   <result pre="GaoF, et al. (1999) The prevalence of hepatitis C virus" exact="infection" post="in the United States, 1988 through 1994. N Engl"/>
   <result pre="PougetER, Des JarlaisDC, Lelutiu-WeinbergerC (2008) Meta-regression of hepatitis C virus" exact="infection" post="in relation to time since onset of illicit drug"/>
   <result pre="OrphanouE, LallaTH, LitaA, GarifallosA (2001) Prevalence of hepatitis C virus" exact="infection" post="in a cohort of pregnant women in northern Greece"/>
   <result pre="HadjipaschaliE, HatzakisA (2001) Prevalence, risk factors and evaluation of a" exact="screening" post="strategy for chronic hepatitis C and B virus infections"/>
   <result pre="721–728.12086089 52GoritsasC, PlerouI, AgaliotisS, SpinthakiR, MimidisK, et al. (2000) HCV" exact="infection" post="in the general population of a Greek island: prevalence"/>
   <result pre="HCV infection in the general population of a Greek island:" exact="prevalence" post="and risk factors. Hepato-Gastroenterology47: 782–785.10919032 53CornbergM, RazaviHA, AlbertiA, BernasconiE,"/>
   <result pre="EvansJ, ShiboskiS, LumP, et al. (2009) Acute hepatitis C virus" exact="infection" post="in young adult injection drug users: a prospective study"/>
   <result pre="2617–2626.18809775 60ChungH, UedaT, KudoM (2010) Changing trends in hepatitis C" exact="infection" post="over the past 50 years in Japan. Intervirology53: 39–43.20068339"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="dict8/PMC6695746/results/search/testTrace/results.xml">
   <result pre="Residuals were auto-correlated, thus an ARIMA model was used. After" exact="testing" post="for different models, an AR(4) model was retained. The"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="dict8/PMC6964091/results/search/testTrace/results.xml">
   <result pre="changing. Additionally, complicit are health system weaknesses which hamper early" exact="detection" post="and prompt effective response. Reforms in the WHO health"/>
   <result pre="notifiable disease. A more sensitive surveillance system led to the" exact="detection" post="of the index case in 2017 after 39 years of"/>
   <result pre="of the last recorded case [22]. Surveillance for the early" exact="detection" post="of viral spillovers and advanced genetic characterization for determination"/>
   <result pre="creating awareness and providing tools for surveillance led to the" exact="detection" post="of more suspected monkey pox cases in 21 states."/>
   <result pre="to its containment, largely credited to strengthened surveillance and laboratory" exact="diagnosis" post="support. There are several worrying trends. First, there is"/>
   <result pre="joint monitoring and evaluation of strategies for prevention, preparedness, early" exact="detection" post="and response to cross-borders events. Moving forward, countries need"/>
   <result pre="21.ShoemakerTRBalinandiSTumusiimeAet al.Impact of enhanced virus haemorrhagic fever surveillance on outbreak" exact="detection" post="and response in UgandaLancet Infect Dis20181837337510.1016/S1473-3099(18)30164-629582758 22.Ike-Obioha J. How"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="dict8/PMC7098263/results/search/testTrace/results.xml">
   <result pre="the Democratic Republic of Congo (DRC) by the late 1950s," exact="tracing" post="the most recent common ancestor of all HIV-1 group"/>
   <result pre="and trade.7,8 Other studies indicate that differences in the worldwide" exact="prevalence" post="of HIV-1 strains might be also shaped by subtype"/>
   <result pre="were circulating in Brazil for about 20-30 years before their" exact="detection" post="by the public health surveillance system. Those studies revealed"/>
   <result pre="from slow dissemination of ancient viral introductions combined with delayed" exact="detection" post="by the public health system. Phylodynamics analyses also helped"/>
   <result pre="this field have used databases compiled by national services for" exact="screening" post="of drug-resistance mutations (genotyping), which generate HIV partial genome"/>
   <result pre="serostatus were found, underscoring the importance of acute phase of" exact="infection" post="in the HIV transmission dynamics. Despite the high HIV"/>
   <result pre="during acute phase, Volz et al.24 revealed that time since" exact="infection" post="is the main explanatory variable driving clustering in a"/>
   <result pre="is limited without an approach that includes intensification of HIV" exact="testing" post="and also points out the importance of pre-exposure prophylaxis"/>
   <result pre="example, African countries has more than 60% of the HIV" exact="infection" post="cases in the world, but less than 30% of"/>
   <result pre="constant introduction of new viral lineages. In the concept of" exact="treatment" post="as prevention (TasP), both studies provided valuable data for"/>
   <result pre="in rural Cambodia, 2014-2015Clin Infect Dis201866111733174129211835 17VinkenLFransenKCuypersLAlexievIBalottaCDebaisieuxLEarlier initiation of antiretroviral" exact="treatment" post="coincides with an initial control of the HIV-1 sub-subtype"/>
   <result pre="methods for infectious disease outbreaksVirus Evol201622vew031vew03128058111 26RatmannOvan SighemABezemerDGavryushkinaAJurriaansSWensingASources of HIV" exact="infection" post="among men having sex with men and implications for"/>
   <result pre="case studyLancet HIV201635e231e23827126490 28de OliveiraTKharsanyABMGräfTCawoodCKhanyileDGroblerATransmission networks and risk of HIV" exact="infection" post="in KwaZulu-Natal, South Africa a community-wide phylogenetic studyLancet HIV201741e41e5027914874"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="dict8/PMC7102705/results/search/testTrace/results.xml">
   <result pre="an urgent need for innovative approaches and tools for early" exact="detection" post="and rapid confirmation of ZIKV-linked microcephaly and early warning"/>
   <result pre="guide decision making policies and strategies including pre- and ante-natal" exact="counseling" post="and strict abortion measures. We also need new methods"/>
   <result pre="epidemics analyzed over time and space; studies on the incidence," exact="prevalence" post="and fatality rates in affected countries; and studies focusing"/>
   <result pre="epidemics From its discovery in Uganda in 1947 and its" exact="isolation" post="in Nigeria in 2005 and 2007 and Senegal in"/>
   <result pre="1 Characteristics Zika Dengue References Discovery year 1947 UgandaZika virus" exact="isolation" post="in monkey and human in 1952 and 1954 in"/>
   <result pre="– NA 22,000 deaths mainly among children Diagnostic methods Syndromic" exact="screening" post="in most cases.Travel and work history exposure to wildlife"/>
   <result pre="in most cases.Travel and work history exposure to wildlife PrognosisDifferential" exact="diagnosis" post="by detecting of viral RNA by PCR/RT-PCR and proteins"/>
   <result pre="the virus in infected patient's blood by ELISA or Serum" exact="neutralization test." post="Syndromic screening in most cases.Travel and work history exposure"/>
   <result pre="infected patient's blood by ELISA or Serum neutralization test. Syndromic" exact="screening" post="in most cases.Travel and work history exposure to wildlife"/>
   <result pre="in most cases.Travel and work history exposure to wildlife prognosisDifferential" exact="diagnosis" post="by detecting of viral RNA by PCR/RT-PCR and proteins"/>
   <result pre="the virus in infected patient's blood by ELISA or Serum" exact="neutralization test" post="[14], [24] Preventive and control options – No vaccine"/>
   <result pre="hygiene and sanitation– Intensive care with the very few antiviral" exact="treatment" post="options including anti-inflammatory drugs and oral rehydration therapy– Integration"/>
   <result pre="education and risk communication (3) Scaling up Zika and dengue" exact="screening" post="for effective treatment and care (4) Partnership and cooperation"/>
   <result pre="communication (3) Scaling up Zika and dengue screening for effective" exact="treatment" post="and care (4) Partnership and cooperation among stakeholders in"/>
   <result pre="disease outbreaks. Currently, only palliative treatments including anti-inflammatory and antiviral" exact="treatment" post="options are readily available for patient management. Enhancing community-based"/>
   <result pre="and containment (e.g., patient isolation) and management approaches. The differential" exact="diagnosis" post="of ZIKV and DENV mosquito-borne illnesses by health workers"/>
   <result pre="system preparedness and emergency response, lack or inadequacies in early" exact="detection" post="and diagnostics, lack of surveillance indicators and benchmarks, lack"/>
   <result pre="and diagnostics, lack of surveillance indicators and benchmarks, lack of" exact="tracing" post="and tracking and lack of effective risk communication and"/>
   <result pre="co-infections and health complications requires rapid global response for effective" exact="treatment" post="or vaccines; revamping innovative socio-cultural, health education and communication"/>
   <result pre="is between 4 and 7 days [21]. Blood-fed Zika mosquito" exact="screening" post="and monitoring of emerging viral diseases, especially in maternal"/>
   <result pre="transmission dynamics of ZIKV and DENV to plan for future" exact="infection" post="resurgence, especially in vulnerable regions. Because most African countries"/>
   <result pre="outreach, prompt identification and case management, surveillance and preparedness systems," exact="contact tracing," post="laboratory diagnosis, community mobilization, recovery systems for survivors, safe"/>
   <result pre="infected individuals were able to silently and unknowingly spread the" exact="infection" post="for years [32]. In contrast, Ebola and HIV infections"/>
   <result pre="manner [25]. Apart from that, Ebola virus requires more sophisticated" exact="isolation" post="measures to contain the disease [21], [29] than does"/>
   <result pre="of limited resources or urbanized settings is necessary for effective" exact="treatment" post="and vaccine accessibility and availability to the most hard-to-reach"/>
   <result pre="delivery of palliative antiretroviral drugs to affected communities, tracking and" exact="tracing" post="of suspected cases and sexual partners, monitoring of risk"/>
   <result pre="to pregnant womenBMJ352January2016i30610.1136/bmj.i30626783242 4Oliveira MeloA.S.MalingerG.XimenesR.SzejnfeldP.O.Alves SampaioS.Bispo de FilippisA.M.Zika virus intrauterine" exact="infection" post="causes fetal brain abnormality and microcephaly: tip of the"/>
   <result pre="– United States, 2016Morb Mortal Wkly Rep65January (2)20163033 16KorhonenE.M.HuhtamoE.SmuraT.Kallio-KokkoH.RaassinaM.VapalahtiO.Zika virus" exact="infection" post="in a traveller returning from the Maldives, June 2015Euro"/>
   <result pre="(1)2016162026876061 34GoorhuisA.von EijeK.J.DoumaR.A.RijnbergN.van VugtM.StijnisC.Zika virus and the risk of imported" exact="infection" post="in returned travelers: implications for clinical careTravel Med Infect"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="dict8/PMC7119083/results/search/testTrace/results.xml">
   <result pre="symptoms who may not seek hospital care. 4 Diagnosis and" exact="treatment" post="Infection is confirmed by positive test to SARS-CoV-2 by"/>
   <result pre="is confirmed by positive test to SARS-CoV-2 by real-time RT-PCR," exact="isolation" post="in cell culture of SARS-CoV-2 from clinical specimens, or"/>
   <result pre="may be used (https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-criteria.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus%2F2019-ncov%2Fclinical-criteria.html). Based on current best evidence, supportive" exact="treatment" post="and organ support remain the focus of ICU care."/>
   <result pre="mechanisms of COVID-19 transmission makes it difficult to develop evidence-based" exact="infection" post="control protocols to prevent transmission to healthcare workers (HCW)"/>
   <result pre="cases should ideally be isolated in a negative pressure airborne" exact="infection" post="isolation room (AIIR) with sufficient air changes (&amp;gt; 12/h)"/>
   <result pre="should ideally be isolated in a negative pressure airborne infection" exact="isolation" post="room (AIIR) with sufficient air changes (&amp;gt; 12/h) and"/>
   <result pre="sanitary staff, often forgotten, should also receive appropriate PPE and" exact="infection" post="control training, particularly as there may be a risk"/>
   <result pre="be preferable as BVM was previously associated with SARS-CoV nosocomial" exact="infection" post="[31]. Pre-oxygenation under these conditions using a well-sealed BVM"/>
   <result pre="days. Anyone who develops symptoms that could suggest a coronavirus" exact="infection" post="are encouraged to call a single emergency number and"/>
   <result pre="ECMO when indicated, and are therefore well prepared for the" exact="treatment" post="of severe contagious viral infections. 9 Conclusion Should community"/>
   <result pre="occur globally, the management of critically ill patients with COVID-19" exact="infection" post="will be challenging. The lack of specific treatment is"/>
   <result pre="with COVID-19 infection will be challenging. The lack of specific" exact="treatment" post="is compounded by uncertainties about its mode of transmission"/>
   <result pre="to healthcare workers: a systematic reviewPLoS One742012e73579 19ChengV.C.ChanJ.F.ToK.K.YuenK.Y.Clinical management and" exact="infection" post="control of SARS: lessons learnedAntiviral Res1002201340741923994190 20JiangS.HuangL.ChenX.WangJ.WuW.YinS.Ventilation of wards"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="dict8/PMC7120695/results/search/testTrace/results.xml">
   <result pre="developed and articulated in the infectious diseases field for food-borne" exact="infection" post="risk assessments, as per relevant guidelines of the World"/>
   <result pre="individual (often an experimental animal) and their subsequent probability of" exact="infection" post="or death. Usually the probability of becoming infected increases"/>
   <result pre="trend to some extent linearised by expressing the probability of" exact="infection" post="or death as a probit transformation (33) plotted against"/>
   <result pre="(γ) gamma (the reciprocal of the number of days between" exact="infection" post="of a case and their recovery [assuming they are"/>
   <result pre="meaning that proportion of the population that is (s)usceptible to" exact="infection" post="and I, that part that is (i)nfected and (i)nfectious"/>
   <result pre="this instance cases are assumed to become susceptible again after" exact="infection" post="wanes) and solved explicitly as in Eq. 3, taking"/>
   <result pre="of the population that is infectious being able to transmit" exact="infection" post="(dotted line, Fig. 2a) to that part that is"/>
   <result pre="a similar description except that the level of susceptibility to" exact="infection" post="within the population and the effects of public health"/>
   <result pre="size) that might need to be immunised to control an" exact="infection" post="(V, i.e. that proportion that is required to bring"/>
   <result pre="the many problems that are not amenable to such explicit" exact="treatment" post="one must turn to the numerical solution of these"/>
   <result pre="that case; whilst the former is the time between the" exact="infection" post="of a primary case and the infection of each"/>
   <result pre="time between the infection of a primary case and the" exact="infection" post="of each of its secondary cases (36, 37). In"/>
   <result pre="discussed above (5). Thus, there could be a period between" exact="infection" post="and the first non-specific symptoms (often referred to as"/>
   <result pre="impact on the control of the onward spread of an" exact="infection" post="than if applied later. In which case it is"/>
   <result pre="the secretions, as opposed to simply ameliorating the course of" exact="infection" post="and reducing the probability of hospitalisation and death (41)"/>
   <result pre="there is usually a period between the initial acquiring of" exact="infection" post="by a case to the onset of symptoms (incubation"/>
   <result pre="contacts. Thus, diseases that can be asymptomatic at points during" exact="infection" post="or relatively mild overall, or chronic or recurring such"/>
   <result pre="might also be infectious (Fig. 5). Fig. 5. Timelines of" exact="infection" post="for two different viral diseases, given roughly to scale."/>
   <result pre="problematic. For example, quite often the point in time when" exact="infection" post="occurs (necessary for the estimation of generation interval and"/>
   <result pre="on the natural history of the disease, and possibly the" exact="prevalence" post="of the disease in the rest of the community,"/>
   <result pre="responsible for them. Smallpox was also a disease for which" exact="contact tracing" post="and quarantine was an important part of controlling outbreaks"/>
   <result pre="for them. Smallpox was also a disease for which contact" exact="tracing" post="and quarantine was an important part of controlling outbreaks"/>
   <result pre="Smallpox was also a disease for which contact tracing and" exact="quarantine" post="was an important part of controlling outbreaks and so"/>
   <result pre="(such as for influenza) so as to potentially &quot;mask&quot; unique" exact="infection" post="events. This problem can sometimes be overcome to some"/>
   <result pre="(11), or volunteer challenge studies (38) where the time of" exact="infection" post="is known. Further Improvement of Descriptions of Disease Natural"/>
   <result pre="approach could also be simplistically extended to the concept of" exact="isolation" post="or quarantine, to estimate what proportion of infected cases"/>
   <result pre="critical vaccination coverage if a simplistic view of case finding," exact="contact tracing" post="and efficient quarantine is assumed (5). Model realism, and"/>
   <result pre="vaccination coverage if a simplistic view of case finding, contact" exact="tracing" post="and efficient quarantine is assumed (5). Model realism, and"/>
   <result pre="a simplistic view of case finding, contact tracing and efficient" exact="quarantine" post="is assumed (5). Model realism, and therefore complexity, can,"/>
   <result pre="mass vaccination of some proportion of the population, case finding/reporting," exact="contact tracing," post="targeted vaccination, and so forth. The equations exemplified earlier"/>
   <result pre="strategies. The derivation and use of such WAIFW (who acquires" exact="infection" post="from whom) and similar matrices is beyond the scope"/>
   <result pre="the disease was correctly identified and subjected to appropriate local" exact="infection" post="controls (15, 30). Such contexts as described above clearly"/>
   <result pre="the connections (dotted lines in the figure) and probabilities of" exact="infection" post="between geographic units parameterised by the extent to which"/>
   <result pre="measured or indeed can never be measured (e.g. time of" exact="infection" post="for some diseases). Reasonable assumptions about such parameters can"/>
   <result pre="Great BritainProc Natl Acad Sci USA2006103126371264210.1073/pnas.051087310316894173 21CauchemezSBoellePYDonnellyCAFergusonNMThomasGLeungGMHedleyAJAndersonRMValleronAJReal-time estimates in early" exact="detection" post="of SARSEmerg Infect Dis20061211011310.3201/eid1201.05059316494726 22FergusonNMCummingsDAFraserCCajkaJCCooleyPCBurkeDSStrategies for mitigating an influenza"/>
   <result pre="the spread of airborne infectious diseasesTrends Microbiol1999737237710.1016/S0966-842X(99)01546-210470046 38CarratFVerguEFergusonNMLemaitreMCauchemezSLeachSValleronAJTime lines of" exact="infection" post="and disease in human influenza: a review of volunteer"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="dict8/PMC7144339/results/search/testTrace/results.xml">
   <result pre="and Aedes albopictus [5]. Four dengue serotypes capable of causing" exact="infection" post="have been identified so far (DENV-1, DENV-2, DENV-3 and"/>
   <result pre="people infected each year [5]. Since there is no specific" exact="treatment" post="for dengue fever, it is now considered to be"/>
   <result pre="Health and Population, Government of Nepal. The risk of dengue" exact="infection" post="and outbreak in Nepal is increasing year by year"/>
   <result pre="systems continue to be the major challenges in the early" exact="detection" post="and diagnosis of dengue [2]. It is likely that"/>
   <result pre="to be the major challenges in the early detection and" exact="diagnosis" post="of dengue [2]. It is likely that the official"/>
   <result pre="situation, the MoHP of the GoN has recently declared &quot;free" exact="testing" post="and supportive medication for all dengue suspected patients&quot; [18,19]"/>
   <result pre="epidemiological factors. Special attention should be paid to initial disease" exact="prevalence" post="and spatial patterns, basic reproduction number of vector and"/>
   <result pre="10.1128/cmr.11.3.480 8PandeyBD, RaiSK, MoritaK, et al.First case of dengue virus" exact="infection" post="in Nepal. Nepal Med Coll J. 2004;6(2):157–159.16295753 9AcharyaBK, CaoC,"/>
   <result pre="11]. Available from: https://dohs.gov.np/wp-content/uploads/2018/04/Annual_Report_2073-74.pdf 14GuptaBP, AdhikariA, RauniyarR, et al.Dengue virus" exact="infection" post="in a French traveller to the hilly region of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="dict8/PMC7180007/results/search/testTrace/results.xml">
   <result pre="Photo: Chinese patients with COVID-19 are provided with mental health" exact="counseling" post="during the COVID-19 epidemic in Wuhan, Hubei, China (from"/>
   <result pre="is given to the physical health that includes therapies and" exact="treatment" post="to pneumonic symptoms. Hence, ignoring the profound importance of"/>
   <result pre="to psychopathology and mental dysfunction when exposed to the viral" exact="infection" post="or at-least living in the regions under threat. People"/>
   <result pre="should communicate the affected population about their progress regarding developing" exact="treatment" post="and prevention strategies and improving facilities. Regions under secondary"/>
   <result pre="regions and areas other than the originating region of COVID-19" exact="infection" post="will be considered as the regions under secondary threat."/>
   <result pre="secondary threat. In these regions, the stress and fear of" exact="infection" post="along with other above-mentioned factors will likely generate moderate"/>
   <result pre="major behavioral and psychological abnormalities (S10-S12). The overall impact of" exact="infection" post="on mental health will be associated with the rate"/>
   <result pre="problems majorly in health care workers (S22), however, the COVID-19" exact="infection" post="may cause such abnormalities in the general public as"/>
   <result pre="be implemented here. Furthermore, the people should be provided with" exact="counseling" post="and guidance at specified public centers, equipped with psychologists,"/>
   <result pre="provided with pharmacological therapies and psychiatric assistance where needed. Psychological" exact="counseling" post="based therapies The alleviation of acute distress and preventing"/>
   <result pre="selected, which focuses on interpersonal relationships (S27). Pharmacological therapies Pharmacological" exact="treatment" post="of depression, anxiety, and related disorders is an alternate"/>
   <result pre="generally preferred. In such therapies antidepressants are the first-line pharmacological" exact="treatment" post="options such as serotonin-noradrenaline reuptake inhibitors (SNRIs) and selective"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="dict8/PMC7182292/results/search/testTrace/results.xml">
   <result pre="Brazil, in addition to the prevalent Asian/American genotype. CONCLUSIONS: The" exact="detection" post="of Asian II genotype of DENV-2 in mosquito pools"/>
   <result pre="multiplex-nested RT-PCR5. PCR products from serum samples, mosquitoes, or viral" exact="isolation" post="were purified using the PCR Clean-Up System kit (Promega"/>
   <result pre="in forest-collected mosquitoes raises important questions about the source of" exact="infection" post="in mosquitoes and the presence of viruses in other"/>
   <result pre="NogueiraRMRNunesMMoraes FigueiredoLTDuplex reverse transcription-PCR followed by nested PCR assays for" exact="detection" post="and identification of Brazilian alphaviruses and flavivirusesJ Clin Micro201543269670210.1128/JCM.43.2.696-702.2005"/>
   <result pre="Virus Serotypes in Children, BrazilEmerg Infect Dis201723111511810.3201/eid2301.16081727983492 10de ThoisyBLacosteVGermainAMuñoz-JordánJColónCMauffreyJFet al.Dengue" exact="infection" post="in neotropical forest mammalsVector Borne Zoonotic Dis20099215717010.1089/vbz.2007.028018945183 11TerzianACBZiniNSacchetoLRochaRFParraMCPDel SartoJLet"/>
   <result pre="Borne Zoonotic Dis20099215717010.1089/vbz.2007.028018945183 11TerzianACBZiniNSacchetoLRochaRFParraMCPDel SartoJLet al.Evidence of natural Zika virus" exact="infection" post="in neotropical non-human primates in BrazilScientific reports201881160341603410.1038/s41598-018-34423-630375482"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="dict8/PMC7197577/results/search/testTrace/results.xml">
   <result pre="the prior SARS epidemic, multiple human brain specimens demonstrated direct" exact="infection" post="of neuronal cells within the cerebral cortex and hypothalamus.16"/>
   <result pre="acute illness and in the elderly population.17 Given the higher" exact="prevalence" post="of neurological sequelae reported with prior coronavirus-related pandemics, COVID-19"/>
   <result pre="TakiyamaY, NakanoI[An adult case of acute cerebellitis after influenza A" exact="infection" post="with a cerebellar corical lesion on MRI]. Rinsho Shinkeigaku."/>
   <result pre="online: February 27 2020 (doi:10.1002/jmv.25728). 16.GuJ, GongE, ZhangBet al..Multiple organ" exact="infection" post="and the pathogenesis of SARS. J Exp Med. 2005;202(3):415-424.16043521"/>
   <result pre="nervous system manifestations in pediatric patients with influenza A H1N1" exact="infection" post="during the 2009 pandemic. Pediatr Neurol. 2014;51(3):370-376.25160541 19.FrobertE, SarretC,"/>
   <result pre="25.KumarA, ZarychanskiR, PintoRet al..Critically ill patients with 2009 influenza A(H1N1)" exact="infection" post="in Canada. JAMA. 2009;302(17):1872-1879.19822627 26.ArcherBN, TimothyGA, CohenCet al..Introduction of"/>
   <result pre="the initial cases of 2009 pandemic influenza A (H1N1) virus" exact="infection" post="in China. N Engl J Med. 2009;361(26):2507-2517.20007555 29.LibsterR, BugnaJ,"/>
   <result pre="with death or hospitalization due to pandemic 2009 influenza A(H1N1)" exact="infection" post="in California. JAMA. 2009;302(17):1896-1902.19887665 31.KediaS, StroudB, ParsonsJet al..Pediatric neurological"/>
   <result pre="characteristics of confirmed cases of Middle East respiratory syndrome coronavirus" exact="infection" post="in the Makkah region of Saudi Arabia, March to"/>
   <result pre="syndrome. Acta Neurol Taiwan. 2005;14(3):113-119. 16252612 44.LeungCW, ChiuWKClinical picture, diagnosis," exact="treatment" post="and outcome of severe acute respiratory syndrome (SARS) in"/>
   <result pre="March 19, 2020 (doi:10.1001/jama.2020.4326). 54.WanS, XiangY, FangWet al..Clinical features and" exact="treatment" post="of COVID-19 patients in Northeast Chongqing. J Med Virol."/>
   <result pre="WangSet al..Clinical characteristics of laboratory confirmed positive cases of SARS-CoV-2" exact="infection" post="in Wuhan, China: a retrospective single center analysis. Travel"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="dict8/PMC7202122/results/search/testTrace/results.xml">
   <result pre="supply, cost, and often slow turnaround time of available assays," exact="testing" post="every patient who presents with symptoms or with recent"/>
   <result pre="used sparingly in hospitalized, symptomatic patients given the risk of" exact="infection" post="transmission posed to staff and subsequent patients.2 There is"/>
   <result pre="who performed ultrasound scan self on days 1–9 after COVID-19" exact="diagnosis" post="Butterfly iQ Not reported Small bilateral pleural effusions with"/>
   <result pre="predictive value of 96% and outperformed chest radiography for the" exact="detection" post="of viral pneumonia in symptomatic patients.5 The avian influenza"/>
   <result pre="A (H7N9) epidemics of 2013–2014 and 2016 saw large regional" exact="infection" post="in China with a documented 1222 infections and a"/>
   <result pre="devices may serve as an invaluable tool for the rapid" exact="diagnosis" post="and day-to-day monitoring of suspected COVID-19 patients. In addition,"/>
   <result pre="be preferred over chest radiography or computed tomography in the" exact="diagnosis" post="and monitoring of COVID-19 patients due to its ease"/>
   <result pre="possible pneumonia and alternative causes of dyspnea while awaiting confirmatory" exact="testing" post="or in areas where molecular assays are unavailable. After"/>
   <result pre="trajectory of a seemingly unpredictable disease course and guide suitable" exact="treatment" post="options and timing of interventions. For example, detection of"/>
   <result pre="guide suitable treatment options and timing of interventions. For example," exact="detection" post="of a new consolidation with dynamic air bronchograms may"/>
   <result pre="and Health Care (CPAM). A rapid advice guideline for the" exact="diagnosis" post="and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia"/>
   <result pre="Care (CPAM). A rapid advice guideline for the diagnosis and" exact="treatment" post="of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version).Mil"/>
   <result pre="respiratory failure.Crit Ultrasound J. 2014;6:6.24949191 5.Yu-Kun ZhangJLJian-pingYYingZJunCLung ultrasonography for the" exact="diagnosis" post="of 11 patients with acute respiratory distress syndrome due"/>
   <result pre="infection.AJR Am J Roentgenol. 2009;193:1488–1493.19933638 12.collab: World Health Organization. Human" exact="infection" post="with avian influenza A (H7N9) virus – China.2017Available at:"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="dict8/PMC7203543/results/search/testTrace/results.xml">
   <result pre="often assigned to certain hospitals designated for HIV care), strict" exact="quarantine" post="enforcement and transportation lockdown in many regions across China"/>
   <result pre="hospital admissions were needed. For PLWH in care, maintaining HIV" exact="treatment" post="and achieving viral suppression were also challenging during the"/>
   <result pre="to other household members. This risk was heightened as the" exact="quarantine" post="measures took place during the Spring Festival (i.e., Chinese"/>
   <result pre="show that some PLWH chose to discontinue their medicine during" exact="quarantine" post="due to the need to conceal their HIV status"/>
   <result pre="the scale of impact by COVID-19. China’s massive and strict" exact="quarantine" post="efforts have achieved much success to contain the COVID-19"/>
   <result pre="Public Health201818118 6.ZhangNBussellSWangGZhuXYangXHuangTQianYTaoXKangDWangNDisparities in HIV care along the path from" exact="infection" post="to viral suppression: a cross-sectional study of HIV/AIDS patient"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="dict8/PMC7229974/results/search/testTrace/results.xml">
   <result pre="globalize world, it immediately became well clear that this fearsome" exact="infection" post="could not be confined to China only, but soon"/>
   <result pre="the country with the highest number of cases of SARS-CoV-2" exact="infection" post="after USA and this has generated an unprecedented health"/>
   <result pre="meta-analysis performed in 2015 identified 32 studies of SARS coronavirus" exact="infection" post="and severe influenza. These studies involved 699 treated patients"/>
   <result pre="was transfused at a median of 21.5 days after first" exact="detection" post="of viral shedding, led to the discontinuation of the"/>
   <result pre="COVID-19 patients in China and considering the efficacy of this" exact="treatment" post="in previous severe viral epidemics and the absence of"/>
   <result pre="issues regarding convalescent plasma, including donors’ selection (i.e., age, gender," exact="diagnosis" post="of SARS-Cov-2 infection and of recovery, anti-SARS-CoV-2 antibody titer"/>
   <result pre="plasma, including donors’ selection (i.e., age, gender, diagnosis of SARS-Cov-2" exact="infection" post="and of recovery, anti-SARS-CoV-2 antibody titer required for plasma"/>
   <result pre="frequency of donations, infectious disease markers and pathogen inactivation) and" exact="treatment" post="and disease characteristics (i.e., dose and timing of convalescent"/>
   <result pre="above and related to convalescent plasma collection, biologic validation and" exact="treatment" post="modalities. Meanwhile, the data arising from previous coronaviruses epidemics"/>
   <result pre="Health Organization. Coronavirus disease (COVID-19) outbreak. https://www.who.int/emergencies/diseases/novel-coronavirus-2019[accessed 2020-5-4]. 3ZhaiP.DingY.WuX.LongJ.ZhongY.LiY.The epidemiology," exact="diagnosis" post="and treatment of COVID-19Int J Antimicrob AgentsMar 282020105955 4ChenL.XiongJ.BaoL.ShiY.Convalescent"/>
   <result pre="Coronavirus disease (COVID-19) outbreak. https://www.who.int/emergencies/diseases/novel-coronavirus-2019[accessed 2020-5-4]. 3ZhaiP.DingY.WuX.LongJ.ZhongY.LiY.The epidemiology, diagnosis and" exact="treatment" post="of COVID-19Int J Antimicrob AgentsMar 282020105955 4ChenL.XiongJ.BaoL.ShiY.Convalescent plasma as"/>
   <result pre="The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the" exact="treatment" post="of severe acute respiratory infections of viral etiology: a"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="dict8/PMC7241517/results/search/testTrace/results.xml">
   <result pre="for underappreciated illnesses that manifest as a consequence of mass" exact="infection" post="[5]. As such, in the face of rapidly evolving"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="dict8/PMC7245250/results/search/testTrace/results.xml">
   <result pre="been reported as the predisposing factors in KD. As the" exact="prevalence" post="of KD in Asian countries are more than western"/>
   <result pre="presentation in the children and the fact that delays in" exact="diagnosis" post="and referral contributes significantly to the mortality in KD"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="dict8/PMC7256497/results/search/testTrace/results.xml">
   <result pre="by decreasing the workload of the healthcare systems and facilitating" exact="detection" post="of the new cases. In COVID-19 outbreak, the symptoms"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="dict8/PMC7257617/results/search/testTrace/results.xml">
   <result pre="feature of first-contact measles epidemics. As regards West Nile virus" exact="infection" post="[5], severe fever with thrombocytopenia syndrome [6] and Plasmodium"/>
   <result pre="view of these overall considerations, we can speculate that SARS-CoV-2" exact="infection" post="may not have spread in a fully susceptible population."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="dict8/PMC7265527/results/search/testTrace/results.xml">
   <result pre="than oseltamivir, reducing the duration of infectiousness. Hence, early baloxavir" exact="treatment" post="may indirectly prevent transmission. Here, we estimate impacts of"/>
   <result pre="Here, we estimate impacts of ramping up and accelerating baloxavir" exact="treatment" post="on population-level incidence using a new model that links"/>
   <result pre="would almost double the impact. Consequently, scaling up early baloxavir" exact="treatment" post="would substantially reduce influenza morbidity and mortality every year."/>
   <result pre="epidemics, suggesting that both the scaling up and acceleration of" exact="treatment" post="would avert substantial influenza morbidity and mortality every year."/>
   <result pre="little or no virus is produced. Consequently, as predicted, baloxavir" exact="treatment" post="of infected patients almost totally inhibits virus production rapidly,"/>
   <result pre="shortening the period of virus shedding. In fact, because baloxavir" exact="treatment" post="rapidly inhibits virus replication, virus shedding is shortened by"/>
   <result pre="virus shedding is shortened by 2–3 days. Consequently, widespread baloxavir" exact="treatment" post="is predicted to substantially reduce population-level incidence, analogous to"/>
   <result pre="to vaccines9. Here, we estimate the impact of increasing baloxavir" exact="treatment" post="coverage and varying times of treatment on population-level incidence"/>
   <result pre="impact of increasing baloxavir treatment coverage and varying times of" exact="treatment" post="on population-level incidence using both clinical results and a"/>
   <result pre="transmission. Our results indicate that scaling up and accelerating baloxavir" exact="treatment" post="would substantially reduce influenza morbidity and mortality every year."/>
   <result pre="and mortality every year. Results and discussion Impact of antiviral" exact="treatment" post="on the cell-to-cell proliferation of influenza Our within-host model"/>
   <result pre="measured the viral loads of 1014 influenza virus-infected patients after" exact="treatment" post="with oseltamivir, baloxavir, or a placebo (Table 1). Our"/>
   <result pre="in the time between symptom onset and the initiation of" exact="treatment" post="for patients in the clinical trial accounts for most"/>
   <result pre="used the fitted model to predict the effectiveness of drug" exact="treatment" post="scenarios beyond those tested in the clinical trial, including"/>
   <result pre="R0 in 2018–2019 season 1.10 1.08 1.13 Baseline distribution of" exact="treatment" post="initiation time, G0–48 (hours after symptom onset, truncated at"/>
   <result pre="symptom onset, truncated at 48 h) G(4.0, 6.3) Accelerated distribution of" exact="treatment" post="initiation times, G0–24 (hours after symptom onset, truncated at"/>
   <result pre="symptom onset, truncated at 24 h) G(4.0, 6.3)/2 Delayed distribution of" exact="treatment" post="initiation times, G24–48 (hours after symptom onset, compressed to"/>
   <result pre="to 24–48 h window) G(4.0, 6.3)/2 + 24 Distribution of time lag between" exact="infection" post="and symptom onset, L (hours) 24aL(0.37,0.41) aFor estimates derived"/>
   <result pre="seasonal influenza incidence data12. Parameters for distributions of time between" exact="infection" post="and symptom onset (lognormal) and from symptom onset to"/>
   <result pre="infection and symptom onset (lognormal) and from symptom onset to" exact="treatment" post="(gamma) were estimated by the interior-point algorithm fitting of"/>
   <result pre="to the time of the first dose. Impact of baloxavir" exact="treatment" post="on the transmission dynamics of influenza We incorporated this"/>
   <result pre="a case at any given time depends on viral load," exact="treatment" post="status, and baseline transmission rates estimated from influenza surveillance"/>
   <result pre="and infectiousness (Fig. 2). Unless otherwise specified, each course of" exact="treatment" post="is initiated within the first 48 h of symptom onset,"/>
   <result pre="within the first 48 h of symptom onset, with the exact" exact="treatment" post="times following the distribution reported in the recent clinical"/>
   <result pre="the recent clinical trial8 (Table 1). A day after initiating" exact="treatment" post="with baloxavir or oseltamivir, the model projects that infectiousness"/>
   <result pre="infectious for ~4 or 5 days. Fig. 2 Early antiviral" exact="treatment" post="reduces the infectiousness of influenza virus. Reduction of infectiousness"/>
   <result pre="reduces the infectiousness of influenza virus. Reduction of infectiousness by" exact="treatment" post="with a baloxavir or b oseltamivir compared with treatment"/>
   <result pre="by treatment with a baloxavir or b oseltamivir compared with" exact="treatment" post="with placebo. Patients were assumed to be treated within"/>
   <result pre="the reduction in the number of overall infections at other" exact="treatment" post="levels, ranging from 10% to 50% (Fig. 3a). As"/>
   <result pre="50% (Fig. 3a). As the percent of cases receiving antiviral" exact="treatment" post="is increased, the estimated herd effect increases as reflected"/>
   <result pre="as reflected by a proportional decline in expected incidence. Baloxavir" exact="treatment" post="is predicted to reduce the overall burden of influenza"/>
   <result pre="to reduce the overall burden of influenza more than oseltamivir" exact="treatment" post="across all treatment rates. If half of all cases"/>
   <result pre="overall burden of influenza more than oseltamivir treatment across all" exact="treatment" post="rates. If half of all cases are treated, baloxavir"/>
   <result pre="the outset of the epidemic (Supplementary Table 2). For example," exact="treatment" post="of 30% of cases with baloxavir would reduce R0"/>
   <result pre="influenza season compared with typical model simulations without any antiviral" exact="treatment" post="(black) or with 30% of cases receiving baloxavir (blue)"/>
   <result pre="in simulated intervention scenarios ranging from no cases receiving antiviral" exact="treatment" post="to 50% of cases treated. The heights of the"/>
   <result pre="the 2017–2018 influenza season, we consider the population-level impacts of" exact="treatment" post="initiation time within the 48 h period after symptom onset."/>
   <result pre="48 h period after symptom onset. Both the efficacy of baloxavir" exact="treatment" post="and the increased benefit of baloxavir relative to oseltamivir"/>
   <result pre="24 h period (Fig. 4a). For a single infected individual, baloxavir" exact="treatment" post="administered within the first 24 h period is expected to"/>
   <result pre="to achieve nearly double the reduction in infectiousness (87%) than" exact="treatment" post="administered within the second 24 h period. On a population"/>
   <result pre="within the second 24 h period. On a population level, baloxavir" exact="treatment" post="within the first 24 h after symptoms onset results in"/>
   <result pre="results in a significantly greater reduction in total incidence than" exact="treatment" post="within the second 24 h window following symptom onset (Fig."/>
   <result pre="symptom onset (Fig. 4b). At the 30% and 50% case" exact="treatment" post="rates, the early baloxavir treatment scenario is expected to"/>
   <result pre="the 30% and 50% case treatment rates, the early baloxavir" exact="treatment" post="scenario is expected to avert 3.8 and 5.3 million"/>
   <result pre="avert 3.8 and 5.3 million infections more than the delayed" exact="treatment" post="scenario, respectively. We also evaluated the distribution of treatment"/>
   <result pre="delayed treatment scenario, respectively. We also evaluated the distribution of" exact="treatment" post="times reported in the baloxavir clinical trial:8 approximately equal"/>
   <result pre="reduce transmission to almost the same extent as accelerating all" exact="treatment" post="to within 24 h of symptom onset (Fig. 4b). We"/>
   <result pre="of symptom onset (Fig. 4b). We restrict our analysis to" exact="treatment" post="initiated within the initial 48 h window, given that later"/>
   <result pre="treatment initiated within the initial 48 h window, given that later" exact="treatment" post="will only negligibly impact incidence and that treatment within"/>
   <result pre="that later treatment will only negligibly impact incidence and that" exact="treatment" post="within 48 h is clearly indicated17,18. In addition, treatment within"/>
   <result pre="and that treatment within 48 h is clearly indicated17,18. In addition," exact="treatment" post="within 48 h is increasingly feasible with the expansion of"/>
   <result pre="in Fig. 2 for untreated and treated cases. The 0–48 h" exact="treatment" post="window assumes treatment times follow the distribution reported in"/>
   <result pre="for untreated and treated cases. The 0–48 h treatment window assumes" exact="treatment" post="times follow the distribution reported in the recent clinical"/>
   <result pre="the recent clinical trial8 (Table 1); the 0–24 and 24–48 h" exact="treatment" post="windows use compressed versions of the 48 h empirical distribution."/>
   <result pre="and interquartile ranges, respectively, across 100 stochastic simulations for each" exact="treatment" post="window. b Total infections averted by treating the indicated"/>
   <result pre="and 48 h, and within 48 h of symptom onset. For each" exact="treatment" post="window, we compress the empirical 48-hour distribution of antiviral"/>
   <result pre="of antiviral administration times. c The number of courses of" exact="treatment" post="per DALY averted resulting from treating the indicated percent"/>
   <result pre="interquartile ranges across n = 1000 independent pairs of simulations (baseline vs." exact="treatment" post="scenarios) of the fitted 2017–2018 model. Finally, we estimate"/>
   <result pre="mortality and morbidity averted by scaling up baloxavir or oseltamivir" exact="treatment" post="(Fig. 4c). Specifically, we calculate the reduction in Disability-Adjusted"/>
   <result pre="the duration of illness by at least 23 h. As the" exact="treatment" post="rate increases, the number of courses of treatment required"/>
   <result pre="As the treatment rate increases, the number of courses of" exact="treatment" post="required to avert one DALY decreases with baloxavir treatment"/>
   <result pre="of treatment required to avert one DALY decreases with baloxavir" exact="treatment" post="to a greater extent than with oseltamivir treatment (Fig."/>
   <result pre="with baloxavir treatment to a greater extent than with oseltamivir" exact="treatment" post="(Fig. 4c). For example, when only 20% of cases"/>
   <result pre="20% of cases are treated, every 10.6 courses of baloxavir" exact="treatment" post="is expected to avert one DALY, whereas 18.6 courses"/>
   <result pre="expected to avert one DALY, whereas 18.6 courses of oseltamivir" exact="treatment" post="are needed to avert one DALY. Hence, each course"/>
   <result pre="avert one DALY. Hence, each course of baloxavir or oseltamivir" exact="treatment" post="is expected to prevent the loss of ~5 weeks"/>
   <result pre="weeks of healthy life, respectively. Proactive case identification and antiviral" exact="treatment" post="can significantly mitigate the burden of seasonal influenza in"/>
   <result pre="attainable scenario in which only 20% of cases receive baloxavir" exact="treatment" post="within 48 h of symptom onset, the estimated herd effect"/>
   <result pre="the United States, potentially saving ~4200 lives. With a higher" exact="treatment" post="rate (50%), the expected number of cases averted increases"/>
   <result pre="~10,200 lives. Our results indicate that optimal reduction of overall" exact="infection" post="occurs when a significant number of infected cases are"/>
   <result pre="within 24 h after symptom onset. Consequently, efforts to accelerate the" exact="diagnosis" post="and treatment of influenza infections with antivirals such as"/>
   <result pre="after symptom onset. Consequently, efforts to accelerate the diagnosis and" exact="treatment" post="of influenza infections with antivirals such as baloxavir, including"/>
   <result pre="of telehealth and increase public awareness of antivirals. Thus, antiviral" exact="treatment" post="of 20–30% of infected patients may be attainable in"/>
   <result pre="resulting in higher mortality rates24. The relative benefits of mass" exact="treatment" post="with oseltamivir and baloxavir that we have estimated for"/>
   <result pre="higher R0 values characteristic of rapidly spreading pandemic viruses, baloxavir" exact="treatment" post="is predicted to yield a higher herd effect than"/>
   <result pre="with the proportion of cases averted inversely related to the" exact="treatment" post="rate, speed of treatment, and transmission rate of the"/>
   <result pre="of antiviral-based mitigation of pandemics. The critical importance of mass" exact="treatment" post="by effective antivirals is exemplified by the global pandemic"/>
   <result pre="campaigns. We assume that the efficacy and timing of antiviral" exact="treatment" post="estimated from a clinical trial8 applies to the population"/>
   <result pre="have not considered that viral kinetics and the efficacy of" exact="treatment" post="may substantially vary across age groups and risk groups,"/>
   <result pre="viruses, which may alter the population-level benefits of ramping up" exact="treatment" post="rates. In recent clinical trials, baloxavir-resistant viruses emerged in"/>
   <result pre="indicate that both the scaling up and acceleration of baloxavir" exact="treatment" post="would avert substantial influenza morbidity and mortality every year."/>
   <result pre="substantial influenza morbidity and mortality every year. Even modest baloxavir" exact="treatment" post="rates can potentially spare millions of people from influenza"/>
   <result pre="replication to clinical trial data to estimate the impact of" exact="treatment" post="on the infectiousness of patients (2) fitting a between-host"/>
   <result pre="model to project the impacts of expanding and accelerating antiviral" exact="treatment" post="during emerging epidemics. Within-host model of influenza A replication"/>
   <result pre="ϵ denote the viral replication rate, viral death rate, cell" exact="infection" post="rate, growth rate of the immune response, and the"/>
   <result pre="estimate all model parameters. We assumed that the time from" exact="infection" post="to symptom onset follows a lognormal distribution, L, and"/>
   <result pre="lognormal distribution, L, and the time from symptom onset to" exact="treatment" post="follows a gamma distribution truncated at 48 h, G0–48 (ref."/>
   <result pre="where V(t) denotes the virus load at time t since" exact="infection" post="(Supplementary Section 2). To estimate total reduction in infectiousness"/>
   <result pre="the area between the infectiousness curves estimated for placebo and" exact="treatment" post="throughout the entire period of viremia. Between-host influenza transmission"/>
   <result pre="influenza tests12,13. We then incorporated viral replication dynamics and antiviral" exact="treatment" post="into a stochastic agent-based version of the fitted SEYR"/>
   <result pre="symptomatic states with continuously changing infectiousness from the moment of" exact="infection" post="that is governed by our within-host model. Exposed individuals"/>
   <result pre="average infectious periods of 9, 4, and 7 days, as" exact="infection" post="for untreated, baloxavir-treated, and oseltamivir-treated cases, respectively (assuming treatment"/>
   <result pre="as infection for untreated, baloxavir-treated, and oseltamivir-treated cases, respectively (assuming" exact="treatment" post="times follow G0–48). The force of infection (the probability"/>
   <result pre="cases, respectively (assuming treatment times follow G0–48). The force of" exact="infection" post="(the probability that a susceptible individual becomes exposed) is"/>
   <result pre="conduct pairwise experiments in which we repeatedly run baseline and" exact="treatment" post="simulations in tandem, assuming a total population of 10,000."/>
   <result pre="record the difference in total incidence between the baseline and" exact="treatment" post="simulations, di = I0 − It, the total number of cases treated in"/>
   <result pre="simulations, di = I0 − It, the total number of cases treated in the" exact="treatment" post="simulation ni. For each treatment scenario, we report medians"/>
   <result pre="of cases treated in the treatment simulation ni. For each" exact="treatment" post="scenario, we report medians and other distributional statistics over"/>
   <result pre="averted by mass antiviral treatment, we again pair baseline and" exact="treatment" post="simulations. To translate infections averted into healthy life years"/>
   <result pre="of its generation and spreadPLoS Comput. Biol.20073e24010.1371/journal.pcbi.003024018069885 11.SmithAMPerelsonASInfluenza A virus" exact="infection" post="kinetics: quantitative data and modelsWiley Interdiscip. Rev. Syst. Biol."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="dict8/PMC7279053/results/search/testTrace/results.xml">
   <result pre="infants and children, for the implications for household contacts and" exact="isolation" post="timing. COVID-19 children gastrointestinal rectal swab In Italy, we"/>
   <result pre="long-term fecal-oral transmission.2 In March 2020, 2 infants with SARS-CoV-2" exact="infection" post="were admitted to our Pediatrics Department. The first one,"/>
   <result pre="second one, 2-months-old, presented only mild respiratory symptoms. After COVID-19" exact="infection" post="was confirmed with nasopharyngeal swab, despite the absence of"/>
   <result pre="and uncontrolled spread of the disease, implies mandatory strict home" exact="isolation" post="until the finding of 2 subsequent negative results at"/>
   <result pre="concerning rectal swabs, for further investigations, with no implications on" exact="isolation" post="timing. STATE OF THE ART AND FUTURE DIRECTIONS FOR"/>
   <result pre="contamination of airdrops and several environmental surfaces.3 In children, SARS-CoV" exact="infection" post="was associated to gastrointestinal symptoms, but there is no"/>
   <result pre="there is no evidence of rectal swabs being performed for" exact="diagnosis" post="and further surveillance. In Middle East Respiratory Syndrome-CoV epidemic"/>
   <result pre="Syndrome-CoV epidemic in 2012, there was proof of viral RNA" exact="detection" post="in fecal specimens in adults, but there were no"/>
   <result pre="Rectal Swabs in Adults and Children Wang et al5 reported" exact="detection" post="of viral RNA in respiratory tract swabs and stools,"/>
   <result pre="by also non-respiratory routes might justify the rapid diffusion of" exact="infection" post="and testing of samples from multiple sites may be"/>
   <result pre="non-respiratory routes might justify the rapid diffusion of infection and" exact="testing" post="of samples from multiple sites may be useful to"/>
   <result pre="negativization positive sputum and fecal samples, with the latter still" exact="testing" post="weakly positive 10 days after discharge. The hospital revised"/>
   <result pre="following disease course, with increasing Ct values. In addition, viral" exact="detection" post="in stool samples occurred at 7 days from onset."/>
   <result pre="population, evidence on the use of rectal swabs or viral" exact="detection" post="in stools is reported in Table 1. Xu et"/>
   <result pre="tested positive for SARS-CoV-2, showing negativization of pharyngeal swab after" exact="treatment" post="but a persistently positive rectal swab. Park et al10"/>
   <result pre="requires proper disinfection. Current evidence brings concerns on excluding SARS-CoV-2" exact="infection" post="by single time point nasopharyngeal swabs, with sensitivity being"/>
   <result pre="Indeed, rectal swabs should be considered especially in children for" exact="diagnosis" post="as well as to better define the duration of"/>
   <result pre="regardless of enteric symptoms, and to better explore viral RNA" exact="detection" post="in the early incubation or late convalescence stages. A"/>
   <result pre="disclose. Fecal shedding of human coronavirus was demonstrated with viral" exact="detection" post="in stool samples with RT-polymerase chain reaction (PCR) methods"/>
   <result pre="Including COVID-19 an overview of the epidemiology, clinical features, diagnosis," exact="treatment" post="and prevention options in children.Pediatr Infect Dis J. 2020;XX:00–00."/>
   <result pre="children.Pediatr Infect Dis J. 2020;XX:00–00. 2.XuYLiXZhuBet al.Characteristics of pediatric SARS-CoV-2" exact="infection" post="and potential evidence for persistent fecal viral shedding.Nat Med."/>
   <result pre="in the United States.N Engl J Med. 2020;382:929–936.32004427 8.ZhangJWangSXueYFecal specimen" exact="diagnosis" post="2019 Novel Coronavirus-Infected Pneumonia.J Med Virol. 2020 Mar 3."/>
   <result pre="from Asymptomatic Child, China.Emerg Infect Dis. 2020;26. 12.LiRPeiSChenBet al.Substantial undocumented" exact="infection" post="facilitates the rapid dissemination of novel coronavirus (SARS-CoV2).Science. 2020"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="dict8/PMC7283747/results/search/testTrace/results.xml">
   <result pre="these outbreaks. In particular, otolaryngologists were at greater risk of" exact="infection" post="due to shedding of virus from nasal and pharyngeal"/>
   <result pre="of virus from nasal and pharyngeal mucosa.7 The implementation of" exact="infection" post="control methods, aggressive contact tracing and isolation limited the"/>
   <result pre="and pharyngeal mucosa.7 The implementation of infection control methods, aggressive" exact="contact tracing" post="and isolation limited the spread of disease in 2003"/>
   <result pre="pharyngeal mucosa.7 The implementation of infection control methods, aggressive contact" exact="tracing" post="and isolation limited the spread of disease in 2003"/>
   <result pre="The implementation of infection control methods, aggressive contact tracing and" exact="isolation" post="limited the spread of disease in 2003 and 2012."/>
   <result pre="high rates of asymptomatic carriers which promote the spread of" exact="infection" post="to susceptible populations,13 rather than greater stability of virus"/>
   <result pre="plays an important role in the first step of viral" exact="infection" post="by binding to the host ACE‐2 receptor, and initiating"/>
   <result pre="are highly conserved, since they are necessary to propagate the" exact="infection" post="in person to person spread. The amino acid sequence"/>
   <result pre="prolonged immunity. Neutralizing antibodies to SARS CoV‐1, that prevent viral" exact="infection" post="by preventing binding of the S protein to the"/>
   <result pre="that serve as markers of an immune response to CoV‐2" exact="infection" post="are necessary for the development of serologic testing and"/>
   <result pre="to CoV‐2 infection are necessary for the development of serologic" exact="testing" post="and vaccines. Currently numerous serologic tests using antibodies against"/>
   <result pre="April 8, 2020, 2020. 20ChengMP, PapenburgJ, DesjardinsM, et al. Diagnostic" exact="testing" post="for severe acute respiratory syndrome‐related coronavirus‐2:a narrative review. Ann"/>
   <result pre="2020;368:630‐633.32245784 23CoughlinMM, BabcookJ, PrabhakarBS. Human monoclonal antibodies to SARS‐coronavirus inhibit" exact="infection" post="by different mechanisms. Virology. 2009;394(1):39‐46.19748648 24LinJT, ZhangJS, SuN, et"/>
   <result pre="Engl J Med. 202010.1056/NEJMp2005630. 26TiradoSM, YoonKJ. Antibody‐dependent enhancement of virus" exact="infection" post="and disease. Viral Immunol. 2003;16(1):69‐86.12725690 27YasuiF, KaiC, KitabatakeM, et"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="dict8/PMC7298473/results/search/testTrace/results.xml">
   <result pre="the economically important DNA virus family, Geminiviridae, Cassava mosaic begomovirus" exact="infection" post="results in an annual crop loss of 25 million"/>
   <result pre="loss of 100 million citrus trees worldwide (Nicaise, 2014). Unfortunately," exact="quarantine" post="measures are only effective in areas with a low"/>
   <result pre="quarantine measures are only effective in areas with a low" exact="infection" post="rate. The most widely distributed viral disease of cereals,"/>
   <result pre="prevention, and global health programs. With its high rate of" exact="infection" post="and severity of symptoms, it is not surprising that"/>
   <result pre="organ failure and death. Public-health policies, such as monitoring, screening," exact="contact tracing," post="and quarantine, help limit the spread of SARS-CoV-2. However,"/>
   <result pre="of plant pathogens. Asymptomatic carriers are the leading cause of" exact="infection" post="propagation and disease spread, especially for fruit crops such"/>
   <result pre="agricultural research. Vaccination is economically sound and less labor-intensive than" exact="screening" post="and quarantine measures. Although plants do not have an"/>
   <result pre="Vaccination is economically sound and less labor-intensive than screening and" exact="quarantine" post="measures. Although plants do not have an adaptive immune"/>
   <result pre="Eradication of emerging or reemerging infectious diseases requires fast affordable" exact="testing" post="and universal vaccination programs. Bioengineered expression of antiviral proteins"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="dict8/PMC7309422/results/search/testTrace/results.xml">
   <result pre="patients over 20 years to retrieve information on viral respiratory" exact="infection" post="outbreaks. Our analysis suggests that the severity of the"/>
   <result pre="the seasonal change to summer. Keywords COVID-19 Epidemiology Respiratory viral" exact="infection" post="Influenza Seasonality Pandemic The infection caused by the human"/>
   <result pre="Keywords COVID-19 Epidemiology Respiratory viral infection Influenza Seasonality Pandemic The" exact="infection" post="caused by the human corona virus COVID-19 (SARS-CoV2) resulted"/>
   <result pre="effective therapy is available and, therefore, contact precautions, hygiene measures," exact="contact tracing," post="social distancing and quarantine are the methods of choice"/>
   <result pre="is available and, therefore, contact precautions, hygiene measures, contact tracing," exact="social distancing" post="and quarantine are the methods of choice to control"/>
   <result pre="therefore, contact precautions, hygiene measures, contact tracing, social distancing and" exact="quarantine" post="are the methods of choice to control the spread"/>
   <result pre="the methods of choice to control the spread of this" exact="infection" post="[3, 4]. However, epidemics with respiratory virus such as"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="dict8/PMC7309641/results/search/testTrace/results.xml">
   <result pre="risk of hospitalization, more prolonged hospitalization and death following influenza" exact="infection" post="[4]. Since the beginning of the 21st Century, two"/>
   <result pre="of SARS and MERS-CoV-infected patients [5–8]. A case of SARS" exact="infection" post="in a 30-year old Chinese man was reported in"/>
   <result pre="Randomized control trials with LPV/RTV are currently ongoing in the" exact="treatment" post="of COVID-19 [11]. However, recent in-vitro and animal studies"/>
   <result pre="same ward of SARS-infected patients did not develop nosocomial SARS" exact="infection" post="despite long stay. This was in contrast with the"/>
   <result pre="stay. This was in contrast with the high rate of" exact="infection" post="in health-care workers (HCW) working on the same ward"/>
   <result pre="at: https://bnonews.com/index.php/2020/02/the-latest-coronavirus-cases/. (Accessed 5 March 2020) 4.CohenCMoyesJTempiaSGroomMWalazaSPretoriusMet al.Severe influenza-associated respiratory" exact="infection" post="in high HIV prevalence setting, South Africa, 2009–2011. Emerg"/>
   <result pre="March 2020) 4.CohenCMoyesJTempiaSGroomMWalazaSPretoriusMet al.Severe influenza-associated respiratory infection in high HIV" exact="prevalence" post="setting, South Africa, 2009–2011. Emerg Infect Dis2013; 19:1766–1774.24209781 5.BoothCMMatukasLMTomlinsonGARachlisARRoseDBDwoshHAet"/>
   <result pre="Arabia: a descriptive study. Lancet Infect Dis2013; 13:752–761.23891402 9.WongATYTsangOTYWongMYFLimWLZhengBJLeeSSet al.Coronavirus" exact="infection" post="in an AIDS patient. AIDS Lond Engl2004; 18:829–830. 10.ChuCMChengVCCHungIFNWongMMLChanKHChanKSet"/>
   <result pre="AIDS Lond Engl2004; 18:829–830. 10.ChuCMChengVCCHungIFNWongMMLChanKHChanKSet al.Role of lopinavir/ritonavir in the" exact="treatment" post="of SARS: initial virological and clinical findings. Thorax2004; 59:252–256.14985565"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="dict8/PMC7316359/results/search/testTrace/results.xml">
   <result pre="and A(H3N2), and type B viruses co-circulate in humans and" exact="infection" post="with one type/subtype could provide cross-protection against the others."/>
   <result pre="A(H1N1) and A(H3N2), and influenza B co-circulate in humans; and" exact="infection" post="of a certain type/subtype can result in partial immunity"/>
   <result pre="average number of secondary infections that arise from a primary" exact="infection" post="in a naïve population. We thus first estimate, for"/>
   <result pre="on the previous one until the model estimates converge. Indeed," exact="testing" post="using model-generated mock epidemics indicates that this model-inference system"/>
   <result pre="1 Seasonality of influenza epidemics in Hong Kong. Upper panel:" exact="infection" post="rate time series for the three influenza viruses (A)."/>
   <result pre="A(H1N1) (B), A(H3N2) (C), and B (D). Color lines show" exact="infection" post="rates for individuals years during Jan 1998 –July 2018;"/>
   <result pre="addition, the model-inference system was able to accurately estimate the" exact="infection" post="rates during both epidemic and non-epidemic periods for all"/>
   <result pre="seasonal cycle as years with epidemics (Fig 3A), the estimated" exact="infection" post="rates remained at near-zero over these extended time-periods when"/>
   <result pre="not in circulation (Fig 2A). Fig 2 Estimates of weekly" exact="infection" post="rate and population susceptibility for the three types/subtypes: A(H1N1)"/>
   <result pre="variables and parameters, as they are intricately linked to the" exact="infection" post="rate. Foremost, overestimation of population susceptibility would lead to"/>
   <result pre="period) replenishes the susceptible pool whereas gaining of cross-immunity from" exact="infection" post="by other types/subtypes (determined by the strength of cross-immunity)"/>
   <result pre="also be accurate in order to achieve accurate estimation of" exact="infection" post="rate. Taken together, the accurate infection rate estimates suggest"/>
   <result pre="achieve accurate estimation of infection rate. Taken together, the accurate" exact="infection" post="rate estimates suggest that the model-inference system was also"/>
   <result pre="for B, respectively. These estimates were consistent with the relative" exact="infection" post="rates of individual types/subtypes. Note, however, due to stringent"/>
   <result pre="however, due to stringent public health interventions (i.e., case isolation," exact="contact tracing," post="and school closure) implemented from early May to mid-July"/>
   <result pre="immunity period determines the duration of immune protection from prior" exact="infection" post="and is thus a key epidemiological parameter shaping the"/>
   <result pre="and S7 Fig; cij denotes cross-immunity against virus-i gained from" exact="infection" post="of virus-j). Three interesting features seem to characterize the"/>
   <result pre="among all virus-pairs, cross-immunity was the weakest when gained from" exact="infection" post="of A(H3N2) (the mean was 17% of the strength"/>
   <result pre="These results are consistent with reported estimates based on antigenic" exact="testing" post="of influenza virus isolates [4,50]. Further, interestingly, for A(H3N2),"/>
   <result pre="Multiple lines of evidence have suggested cross protection offered by" exact="infection" post="of influenza viruses of the same type/subtype as well"/>
   <result pre="estimate that there were relatively strong cross-immunity against A(H3N2) by" exact="infection" post="of A(H1N1) (~40% of the specific-immunity) and moderate level"/>
   <result pre="estimates of weak cross-immunities to A(H1N1) and B conferred by" exact="infection" post="of A(H3N2) appear to contradict the common notion that"/>
   <result pre="key epidemiological features. In particular, A(H3N2) confers shorter immunity following" exact="infection" post="and also undergoes more frequent genetic/antigenic mutations. Based on"/>
   <result pre="whose first exposure was A(H1N1) had long-term protection against subsequent" exact="infection" post="by the same subtype whereas those first exposed to"/>
   <result pre="incidence surveillance data could be an inexpensive alternative to support" exact="detection" post="of evolutionary changes in influenza viruses, especially since these"/>
   <result pre="vaccinated and unvaccinated US residents during 2010–2016 [56]to 32% confirmed" exact="infection" post="among unvaccinated individuals during 2015 in New Zealand [57]."/>
   <result pre="patients infected with A(H3N2) may be more likely to seek" exact="treatment" post="due to more severe symptoms compared to A(H1N1) and"/>
   <result pre="addition, the Public Health Laboratory Services Branch thereof conducts laboratory" exact="testing" post="for influenza viruses in samples submitted mainly from local"/>
   <result pre="weekly records of ILI consultation rate and concurrent (sub)type-specific influenza" exact="detection" post="rate from the week ending 04 Jan 1998 to"/>
   <result pre="we multiplied the weekly ILI rate by the concurrent viral" exact="isolation" post="rate for A(H1N1), A(H3N2) and B, respectively [42,49,65,66]. We"/>
   <result pre="as A(H1N1)+, A(H3N2)+, and B+. Converting ILI consultation rate to" exact="infection" post="rate The ILI consultation rate is the ratio of"/>
   <result pre="the catchment population. Previously, we showed that conversion to per-capita" exact="infection" post="rate can be made based on Bayes’ rule [65,67]."/>
   <result pre="chance of reinfection and transmission in any individual with prior" exact="infection" post="by a similar strain (i.e. leaky immunity) or protect"/>
   <result pre="leaky immunity) or protect a portion of individuals with prior" exact="infection" post="(i.e. polarized immunity). In particular, Gog and Grenfell [24]"/>
   <result pre="cij measures the strength of cross-immunity to virus-i conferred by" exact="infection" post="of virus-j (e.g., close to 0 if it is"/>
   <result pre="the Akaike Information Criterion (AIC). Supporting information S1 Text Supplemental" exact="testing" post="and results. (DOCX) LINK Click here for additional data"/>
   <result pre="using the posterior mean estimates. Colored lines show simulated weekly" exact="infection" post="rates from 1000 individual stochastic model runs (A(H1N1) in"/>
   <result pre="B in green); dashed black lines show the weekly mean" exact="infection" post="rates across 1000 simulations and solid black lines show"/>
   <result pre="to the posterior mean estimates. Colored lines show simulated weekly" exact="infection" post="rates from 1000 individual stochastic model runs (A(H1N1) in"/>
   <result pre="B in green); dashed black lines show the weekly mean" exact="infection" post="rates across 1000 simulations and solid black lines show"/>
   <result pre="to the posterior mean estimates. Colored lines show simulated weekly" exact="infection" post="rates from 1000 individual stochastic model runs (A(H1N1) in"/>
   <result pre="B in green); dashed black lines show the weekly mean" exact="infection" post="rates across 1000 simulations and solid black lines show"/>
   <result pre="lose prior immunity and return to being susceptible. While the" exact="infection" post="processes for each virus happen independently (hence the three"/>
   <result pre="reduces the induction of heterosubtypic immunity against influenza A/H5N1 virus" exact="infection" post="in ferrets. J Virol85: 2695–2702. 10.1128/JVI.02371-1021228239 9EkiertDC, BhabhaG, ElsligerMA,"/>
   <result pre="viral hierarchies are determinants of viral interference following influenza virus" exact="infection" post="in a ferret model. Eur J Immunol46: 685–686. 19AndreasenV"/>
   <result pre="(2016) Dynamics of two-strain influenza model with cross-immunity and no" exact="quarantine" post="class. Journal of mathematical biology73: 1467–1489. 10.1007/s00285-016-1000-x27059490 24GogJR, GrenfellBT"/>
   <result pre="VerguE, FergusonNM, LemaitreM, CauchemezS, et al. (2008) Time lines of" exact="infection" post="and disease in human influenza: a review of volunteer"/>
   <result pre="61WuJT, LeungK, PereraRA, ChuDK, LeeCK, et al. (2014) Inferring influenza" exact="infection" post="attack rate from seroprevalence data. PLoS Pathog10: e100405410.1371/journal.ppat.100405424699693 62LauEHY,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="dict8/PMC7320681/results/search/testTrace/results.xml">
   <result pre="crisis. Currently there is no vaccine for prophylaxis nor proven" exact="treatment" post="for COVID-19. Immune or convalescent plasma collected from people"/>
   <result pre="convalescent plasma collected from people who have fully recovered from" exact="infection" post="contains antibodies against the infectious agent. Convalescent plasma provides"/>
   <result pre="passive immunity and has been used for the prophylaxis and" exact="treatment" post="of a number of infectious diseases, including recent epidemics"/>
   <result pre="[5]. And recently, TPE has been successfully used in the" exact="treatment" post="of severe cytokine release syndrome after Chimera Antigen Receptor"/>
   <result pre="at the end of the procedure can be a valuable" exact="treatment" post="option for COVID-19 patients and warrants a comparison trial"/>
   <result pre="References 1BlochE.M.BaileyJ.A.Tobian AaronA.R.Deployment of convalescent plasma for the prevention and" exact="treatment" post="of COVID-19. Review in press preview COVID-19J Clin Invest202010.1172/JCI138745"/>
   <result pre="delaying cellular senescence – a hypothesisJ Clin Apheresis28201338738923893695 5KeithP.DayM.PerkinsL.MoyerL.HewittK.WellsA.A novel" exact="treatment" post="approach to the novel coronavirus: an argument for the"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="dict8/PMC7326430/results/search/testTrace/results.xml">
   <result pre="respiratory syndrome coronavirus 2 SARS-CoV-2 Model Epidemiology Outbreak Zoonosis Emerging" exact="infection" post="Abbreviations SARS-CoV-2, Severe Acute Respiratory Syndrome Coronavirus 2 Handling"/>
   <result pre="et al., 2020). Reactive containment interventions against SARS-CoV-2, based on" exact="testing" post="and contact tracing, are therefore unlikely to succeed as"/>
   <result pre="2020). Reactive containment interventions against SARS-CoV-2, based on testing and" exact="contact tracing," post="are therefore unlikely to succeed as a stand-alone containment"/>
   <result pre="only effective intervention options available to governments are various presumptive" exact="social distancing," post="hygiene and quarantine measures, enforced variations of which are"/>
   <result pre="available to governments are various presumptive social distancing, hygiene and" exact="quarantine" post="measures, enforced variations of which are often referred to"/>
   <result pre="(R) or number of new infections arising from any initial" exact="infection" post="over its full duration. An epidemic curve which has"/>
   <result pre="initial pre-intervention reproductive number of 4 new infections per existing" exact="infection" post="(R0 = 4.0). A and D: Controlled reproductive numbers"/>
   <result pre="0.6, Fig. 1A) every 3 weeks (Approximate mean duration of" exact="infection" post="(Killeen &amp;amp; Kiware, 2020)) before petering out after little"/>
   <result pre="many encouraging precedents exist for certifying countries as free from" exact="infection" post="with veterinary pathogens like swine fever (Martin, Cameron, Barfod,"/>
   <result pre="of SpainThe Science of the Total Environment727202013876110.1016/j.scitotenv.2020.13876132330703 TangB.XiaF.TangS.BragazziN.L.LiQ.SunX.The effectiveness of" exact="quarantine" post="and isolation determine the trend of the COVID-19 epidemics"/>
   <result pre="Science of the Total Environment727202013876110.1016/j.scitotenv.2020.13876132330703 TangB.XiaF.TangS.BragazziN.L.LiQ.SunX.The effectiveness of quarantine and" exact="isolation" post="determine the trend of the COVID-19 epidemics in the"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="dict8/PMC7332278/results/search/testTrace/results.xml">
   <result pre="10.1016/S2352-4642(20)30175-9 : Article Emergence of Kawasaki disease related to SARS-CoV-2" exact="infection" post="in an epicentre of the French COVID-19 epidemic: a"/>
   <result pre="13 No specific test exists to confirm the diagnosis. The" exact="diagnosis" post="of Kawasaki disease is based on internationally accepted clinical"/>
   <result pre="Our observations further suggest that an association exists between SARS-CoV-2" exact="infection" post="and Kawasaki disease. Interestingly, a second significant peak of"/>
   <result pre="criteria15 of the American Heart Association. Patients for whom another" exact="diagnosis" post="was confirmed during the follow-up were excluded. For each"/>
   <result pre="month.24 Because a delay between the onset of respiratory viral" exact="infection" post="and Kawasaki disease is expected on the basis of"/>
   <result pre="dilatation (Z=12) No Myocarditis Myocarditis Myocarditis, pericarditis Myocarditis No First-line" exact="treatment" post="IVIg IVIg None IVIg IVIg IVIg IVIg IVIg IVIg"/>
   <result pre="None IVIg IVIg IVIg IVIg IVIg IVIg IVIg Unsuccessful first-line" exact="treatment" post="Yes No No Yes No Yes Yes No Yes"/>
   <result pre="No No Yes No Yes Yes No Yes Yes Second-line" exact="treatment" post="IVIg plus methyl-prednisolone No No IVIg plus methyl-prednisolone No"/>
   <result pre="No No No No Yes Yes Yes Yes Yes Inotropes" exact="treatment" post="No No No No No Yes Yes Yes Yes"/>
   <result pre="(60%) 6/10 (60%) 3/6 (50%) 51/214 (24%) Need for additional" exact="treatment" post="to first dose of IVIg 6/10 (60%) 8/10 (80%)"/>
   <result pre="Admission to PICU 6/10 (60%) NA 0 14/160 (9%) Inotropes" exact="treatment" post="5/10 (50%) 2/10 (20%) NA NA Data are n,"/>
   <result pre="observe the rate of Kawasaki disease over time, enabling the" exact="detection" post="of peaks in cases. Our study also had some"/>
   <result pre="understand whether these patients should be classified as having SARS-CoV-2" exact="infection" post="with a Kawasaki disease phenotype or SARS-CoV-2-triggered Kawasaki disease."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="dict8/PMC7338960/results/search/testTrace/results.xml">
   <result pre="nearly half the population of Europe. Where does the term" exact="quarantine" post="derive from? [7] It was a health measure implemented"/>
   <result pre="of the plague. According to Hippocrates, after 40 days of" exact="isolation" post="acute illness did not manifest itself. In Venice, the"/>
   <result pre="the gospel), leper colonies were thereafter called &quot;lazarets.&quot; This 40-day" exact="isolation" post="period during Lent came from the Latin Quadragesima (fortieth),"/>
   <result pre="generally results in a public health catastrophe. In fact, only" exact="isolation" post="at home limits the spread of an epidemic and"/>
   <result pre="to have stopped transmitting or when a new means of" exact="treatment" post="is discovered, such as a vaccine or an antibiotic."/>
   <result pre="stopped? There are 2 radical methods: finding an effective antibiotic" exact="treatment" post="when the origin is bacterial or a vaccine when"/>
   <result pre="political. Nobody imagined that we would have to return to" exact="quarantine" post="and isolation in the 21st century. These measures, first"/>
   <result pre="imagined that we would have to return to quarantine and" exact="isolation" post="in the 21st century. These measures, first adopted by"/>
   <result pre="of time, but they have also facilitated discoveries, essentially for" exact="diagnosis" post="and treatment, which have led to an improvement in"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="dict8/PMC7341479/results/search/testTrace/results.xml">
   <result pre="cases, official notices of local rebound of new cases of" exact="infection" post="in the last several weeks after the end of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="dict8/PMC7341712/results/search/testTrace/results.xml">
   <result pre="first two columns). The front-line of resistance to any viral" exact="infection" post="is an individual’s immune system (shown at the centre)."/>
   <result pre="will be significantly greater than the impact of the viral" exact="infection" post="itself (Robertson et al. 2020). Finally, Fig. 1 shows"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="dict8/PMC7361333/results/search/testTrace/results.xml">
   <result pre="very high frequency of mutation, which, in turn, can affect" exact="infection" post="speed and evolution rate.5 However, the resulting genetic variability"/>
   <result pre="age. Over time, countries started adopting better policies for diagnostic" exact="polymerase chain reaction" post="testing and lockdown strategies, and, consequently, the spread of"/>
   <result pre="countries started adopting better policies for diagnostic polymerase chain reaction" exact="testing" post="and lockdown strategies, and, consequently, the spread of the"/>
   <result pre="detection, more precise, and reliable tracking methods leading to swift" exact="isolation" post="of exposed and infected subjects together with the prompt"/>
   <result pre="infected subjects together with the prompt implementation of measures of" exact="social distancing" post="may be complemented with weather pattern analysis and viral"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="dict8/PMC7362058/results/search/testTrace/results.xml">
   <result pre="animal studies or clinical investigations, and thus largely overlooked as" exact="treatment" post="prospects in the current COVID‐19 trials. This brief review"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="dict8/PMC7365411/results/search/testTrace/results.xml">
   <result pre="the response, such as the location and staffing of Ebola" exact="treatment" post="units. On the other end, public health teams may"/>
   <result pre="Feb 10]. Available from: https://www.ecdc.europa.eu/en/threats-and-outbreaks/epidemic-intelligence 14WHO | Epidemic intelligence—systematic event" exact="detection" post="[internet]. [cited 2020 Feb 10]. Available from: https://www.who.int/csr/alertresponse/epidemicintelligence/en/ 15ChowellG,"/>
   <result pre="10]. Available from: https://www.who.int/csr/alertresponse/epidemicintelligence/en/ 15ChowellG, NishiuraH. Toward unbiased assessment of" exact="treatment" post="and prevention: modeling household transmission of pandemic influenza. BMC"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="dict8/PMC7373336/results/search/testTrace/results.xml">
   <result pre="concern in China; however, few studies have reported on the" exact="prevalence" post="of COVID-19 in these areas. Methods The number of"/>
   <result pre="cases was analyzed. Results The results showed that the COVID-19" exact="prevalence" post="in areas with epidemics due to imported cases could"/>
   <result pre="from the research community. However, few studies exist on the" exact="prevalence" post="of COVID-19 in areas with epidemics due to imported"/>
   <result pre="were collected on the day of case identification, and the" exact="diagnosis" post="was based on the diagnostic criteria for COVID-19 in"/>
   <result pre="the diagnostic criteria for COVID-19 in China (including symptoms and" exact="nucleic acid test" post="results) (http://www.gov.cn/xinwen/2020-02/20/content_5481071.htm). An imported case refers to a case"/>
   <result pre="in Fujian Province Subsequently, on the 12th day after the" exact="diagnosis" post="of the first imported case (February 3, 2020), an"/>
   <result pre="that the management strategies implemented to control the source of" exact="infection" post="and prevent transmission as rapidly as possible during the"/>
   <result pre="20–28 January 2020Eurosurveillance202025200006210.2807/1560-7917.ES.2020.25.5.2000062 GuanWJNiZYHuYet al.Clinical characteristics of 2019 novel coronavirus" exact="infection" post="in ChinaN Engl J Med20203821708172010.1056/NEJMoa200203232109013 LiQGuanXWuPet al.Early transmission dynamics"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="dict8/PMC7376323/results/search/testTrace/results.xml">
   <result pre="be prolonged in people living with HIV. The 14 days" exact="isolation" post="strategy might not be long enough for them. The"/>
   <result pre="isolation strategy might not be long enough for them. The" exact="isolation" post="or discharge of these patients needs further confirmation for"/>
   <result pre="days. Case report A 49-years old female diagnosed with HIV" exact="infection" post="8 years ago under regular ART (anti-retroviral therapy) went"/>
   <result pre="Day 5(a) and Day 15(b) According to the Chinese COVID-19" exact="treatment" post="guideline at that time [7], on Day 8, we"/>
   <result pre="found asymptomatic people who were still carrying the virus after" exact="isolation" post="for 14 days [8]. The prolonged viral shedding duration"/>
   <result pre="CD4 count, these people may still be vulnerable to viral" exact="infection" post="or subsequent bacterial pneumonia than the general population. Further"/>
   <result pre="group dropped more significantly than the moderate group. So, the" exact="infection" post="of SARS-CoV-2 might be dramatically for the people living"/>
   <result pre="one hand, the immune system might be impaired after the" exact="infection" post="of SARS-CoV-2 by the depletion of T lymphocytes [12]."/>
   <result pre="be prolonged in people living with HIV. The 14 days" exact="isolation" post="strategy might not be long enough for them. The"/>
   <result pre="isolation strategy might not be long enough for them. The" exact="isolation" post="or discharge of these patients needs further confirmation for"/>
   <result pre="RNA shedding in patients with COVID-19Clin Infect Dis202010.1093/cid/ciaa35132649745 5.LuYLiYDengWLiuMHeYHuangLet al.Symptomatic" exact="infection" post="is associated with prolonged duration of viral shedding in"/>
   <result pre="WuhanPediatr Infect Dis J2020397e95e9932379191 6.AiTYangZHouHZhanCChenCLvWTaoQSunZXiaLCorrelation of chest CT and RT-PCR" exact="testing" post="in coronavirus disease 2019 (COVID-19) in China: a report"/>
   <result pre="report of 1014 casesRadiology202010.1148/radiol.20202006427233399 7.JinYHCaiLChengZSChengHDengTFanYPA rapid advice guideline for the" exact="diagnosis" post="and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia"/>
   <result pre="1014 casesRadiology202010.1148/radiol.20202006427233399 7.JinYHCaiLChengZSChengHDengTFanYPA rapid advice guideline for the diagnosis and" exact="treatment" post="of 2019 novel coronavirus (2019-nCoV) infected pneumonia (Full version)New"/>
   <result pre="(Full version)New Med2020303564 8.MaoZQWanRHeLYHuYCChenWThe enlightenment from two cases of asymptomatic" exact="infection" post="with SARS-CoV-2: is it safe after 14 days of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="dict8/PMC7392634/results/search/testTrace/results.xml">
   <result pre="Clusters of pneumonia of unknown origin in Wuhan, China. Human" exact="infection" post="probably began sometime between 9 October and 20 December"/>
   <result pre="4.5 billion persons (more than half of humanity) subjected to" exact="social distancing" post="norms and/or lockdowns.75 This progression is quite unique. New"/>
   <result pre="for remaining totally asymptomatic (estimated 5%–80%93–96). What determines that an" exact="infection" post="remains asymptomatic? Quasi-absence of disease in children: why? Case"/>
   <result pre="influenza 0.1%; common cold: 0%; SARS: 9%–10%; MERS: 30%.97 Calculated" exact="infection" post="fatality rates (cIFR) and calculated CFR (cCFR) on the"/>
   <result pre="in the 19th and the mid-20th centuries.32 42 Fortunately, measles" exact="infection" post="creates robust protective immunity and after a first wave"/>
   <result pre="authorities in response to an epidemic. These include, among others," exact="isolation" post="of the sick or the healthy, implementation of hygiene"/>
   <result pre="the sick or the healthy, implementation of hygiene practices and" exact="physical distancing" post="measures. They can also include mobility restrictions such as"/>
   <result pre="distancing measures. They can also include mobility restrictions such as" exact="quarantine" post="and cordon sanitaire. Coping strategies and collective strategies also"/>
   <result pre="and cordon sanitaire. Coping strategies and collective strategies also include" exact="treatment" post="of the sick, which critically depends on the availability"/>
   <result pre="public spaces. Avoid crowding and mass gatherings. Public authorities Tracing," exact="testing" post="and isolating cases and providing them with appropriate care."/>
   <result pre="people living in crowded shacks in urban slums to practise" exact="physical distancing" post="measures and strict hand hygiene when water is scarce"/>
   <result pre="ventilated spaces.18 106 Through fomites.107 Possibly via faecal–oral route108 109;" exact="detection" post="in sewage.110–112 Related to peak in upper respiratory tract"/>
   <result pre="showed immunity post primary infection.121 How protective immunity after first" exact="infection" post="is against subsequent infection with an identical or mutated"/>
   <result pre="infection.121 How protective immunity after first infection is against subsequent" exact="infection" post="with an identical or mutated strain has been uncertain."/>
   <result pre="recovered persons positive by real-time PCR,122 123 later attributed to" exact="testing" post="errors. Seroprevalence to SARS-CoV-2 Reported estimates for seroprevalence range"/>
   <result pre="of assay kits with varying sensitivity/specificity, and different methods for" exact="detection" post="may contribute to this large variation.125 Seemingly high seroprevalence"/>
   <result pre="and vice versa. At cluster level: a person with asymptomatic" exact="infection" post="or mild disease will on average spread lower doses"/>
   <result pre="is, is quite another. As acquired immunity after a natural" exact="infection" post="is probably not very robust (table 6), it will"/>
   <result pre="on: How strong will the acquired immunity after a first" exact="infection" post="with SARS-CoV-2 be and how long will it last?"/>
   <result pre="have quasi-universally presented less severe disease. However, their susceptibility to" exact="infection" post="remains unclear, with large heterogeneity reported between studies.138 139"/>
   <result pre="(no vaccine, no effective antiviral or immune-modulating medicine, only supportive" exact="treatment" post="such as oxygen therapy). This comes close to what"/>
   <result pre="et al.The potential effects of widespread community transmission of SARS-CoV-2" exact="infection" post="in the world Health organization African region: a predictive"/>
   <result pre="Available: https://www.who.int/influenza/human_animal_interface/influenza_h7n9/RiskAssessment_H7N9_23Feb20115.pdf?ua=1 [Accessed 17 Apr 2020]. 82collab: World Health OrganizationHuman" exact="infection" post="with avian influenza A(H5N1) virus - update (9 January"/>
   <result pre="Engl J Med2020;382:1268–9. 10.1056/NEJMe200238732109011 98RussellTW, HellewellJ, JarvisCI, et al.Estimating the" exact="infection" post="and case fatality ratio for coronavirus disease (COVID-19) using"/>
   <result pre="Mar 310.1053/j.gastro.2020.02.054 109XuY, LiX, ZhuB, et al.Characteristics of pediatric SARS-CoV-2" exact="infection" post="and potential evidence for persistent fecal viral shedding. Nat"/>
   <result pre="SARS-Coronavirus-2 in sewage. medRxiv2020. 111AhmedW, AngelN, EdsonJ, et al.First confirmed" exact="detection" post="of SARS-CoV-2 in untreated wastewater in Australia: a proof"/>
   <result pre="KendallM, et al.Quantifying SARS-CoV-2 transmission suggests epidemic control with digital" exact="contact tracing." post="Science2020;368:eabb693610.1126/science.abb693632234805 115HeX, LauEHY, WuP, et al.Temporal dynamics in viral"/>
   <result pre="CVI2010;17:1875–80. 10.1128/CVI.00278-1020943876 127TheelES, SlevP, WheelerS, et al.The role of antibody" exact="testing" post="for SARS-CoV-2: is there one?J Clin Microbiol2020:00797–20. 128collab: World"/>
   <result pre="COVID-19. JAMA2020;323:1406–7. 10.1001/jama.2020.2565 141RotheC, SchunkM, SothmannP, et al.Transmission of 2019-nCoV" exact="infection" post="from an asymptomatic contact in Germany. N Engl J"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="dict8/PMC7395586/results/search/testTrace/results.xml">
   <result pre="received particular attention. These relationships are critically important for predicting" exact="infection" post="growth rates and to counsel people on possible home"/>
   <result pre="A recent study used weather data and global reports of" exact="infection" post="to model COVID-19 growth rate before any intervention. This"/>
   <result pre="to the assumption of a substantial seasonal reprieve of the" exact="infection" post="rates. Practical Recommendations Interventions on environmental factors to mitigate"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="dict8/PMC7402518/results/search/testTrace/results.xml">
   <result pre="endemically in the inter-epidemic periods. We aimed at determining the" exact="prevalence" post="of the dengue, rift valley and chikungunya among humans"/>
   <result pre="All samples were negative by RVFV and CHIKV qPCR. Neither" exact="infection" post="nor exposure to DENV was observed in participants from"/>
   <result pre="in Magugu site. In both sites, neither DENV exposure nor" exact="infection" post="was detected. Author summary Dengue (DENV), Chikungunya (CHIKV), Rift"/>
   <result pre="Tanzania, DENV outbreaks have been more frequent since 2010. CHIKV" exact="infection" post="is an important but largely unrecognized illness in Tanzania."/>
   <result pre="we aimed to generate baseline data on the exposure and" exact="infection" post="status of DENV, RVFV and CHIKV by detecting antibodies"/>
   <result pre="viruses in human subjects in two geo-ecologically distinct sites. Neither" exact="infection" post="nor exposure to the viruses was in observed in"/>
   <result pre="Tanzania. Earlier studies conducted in north-eastern Tanzania showed that the" exact="prevalence" post="of dengue and Chikungunya were 7.9% and 12.9%, respectively"/>
   <result pre="DENV, CHKV, and RVFV[12]. It is important to understand the" exact="prevalence" post="of arboviruses in different weather conditions in Tanzania in"/>
   <result pre="This study was therefore, carried out to establish exposure and" exact="infection" post="status of RVFV, DENV and CHIKV in two geo-ecologically"/>
   <result pre="DENV IgG and IgM antibodies were done using a direct" exact="enzyme linked immunosorbent assay" post="(ELISA) kit (SD Inc, Gyeonggi-do, Korea) as described by"/>
   <result pre="were participant demographics, characteristics of households, characteristics of livestock herds," exact="treatment" post="history, travel, co-morbidities, virologic and serological parameters. Data were"/>
   <result pre="Discussion The aim of this study was to investigate the" exact="prevalence" post="of antibodies against DENV, CHIKV and RVFV and to"/>
   <result pre="humans. The study also pursued to identify potential predictors of" exact="infection" post="by the viruses and seropositivity to the viruses during"/>
   <result pre="IEP. A study conducted by Swai and Schoolman reported the" exact="prevalence" post="of antibodies to RVFV in Tanga region [23]. A"/>
   <result pre="seasons of the year to get an insight of how" exact="infection" post="and seroconversion may vary as a means of RVFV,"/>
   <result pre="outbreaks. Certain factors were associated with higher rates of RVFV" exact="infection" post="as determined by IgM/IgG competitive ELISA, including household size"/>
   <result pre="no formal education. RVFV is a mosquito borne, viral zoonotic" exact="infection" post="whose transmission involves both vector mosquitoes and intimate contact"/>
   <result pre="DENV. Magugu site was found to be free from both" exact="infection" post="and exposure to RVFV, CHIKV and DENV. Larger numbers"/>
   <result pre="van der VenA, et al.+¦-Thalassaemia trait is associated with Antibody" exact="prevalence" post="against Malaria Antigens AMA-1 and MSP-1. Journal of tropical"/>
   <result pre="et al.Defining malaria burden from morbidity and mortality records, self" exact="treatment" post="practices and serological data in Magugu, Babati District, northernTanzania."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="dict8/PMC7402651/results/search/testTrace/results.xml">
   <result pre="12 months follow-up visits. Herce and colleagues found rapid HIV" exact="testing" post="could be followed by on-site, rapid initiation of ART"/>
   <result pre="individuals achieved suppression).6 Our own experience has shown that rapid" exact="testing" post="for HIV can also be successfully implemented in US"/>
   <result pre="number of individuals received new HIV diagnoses in the rapid" exact="screening" post="group than did those who had sporadic laboratory-based screening"/>
   <result pre="rapid screening group than did those who had sporadic laboratory-based" exact="screening" post="(89 vs 15). All individuals who had rapid screening"/>
   <result pre="laboratory-based screening (89 vs 15). All individuals who had rapid" exact="screening" post="received their test result; and most could start treatment"/>
   <result pre="rapid screening received their test result; and most could start" exact="treatment" post="in jail.7, 8 Compared with the sporadic, laboratory-based screening,"/>
   <result pre="in jail.7, 8 Compared with the sporadic, laboratory-based screening, rapid" exact="screening" post="resulted in a reduction of US$2·8 million in US"/>
   <result pre="for managing the coronavirus epidemic in the community are developed—aggressive" exact="testing" post="of symptomatic and asymptomatic people with contact tracing—the same"/>
   <result pre="the role of prisons and jails as reservoirs of viral" exact="infection" post="be minimised. Failure to control and prevent the spread"/>
   <result pre="AC. Costs and outcomes associated with discontinuing a routine HIV" exact="screening" post="program in a high volume jail. Annual Meeting of"/>
   <result pre="AC, Adee MG, Bowden CJ, et al. Routine, rapid HIV" exact="screening" post="of jail entrants in Fulton County (GA, USA) not"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="dict8/PMC7402669/results/search/testTrace/results.xml">
   <result pre="of those people on treatment, and 90% of people on" exact="treatment" post="with viral suppression. With the ultimate aim of interrupting"/>
   <result pre="people diagnosed are on treatment, and 88% of people on" exact="treatment" post="have viral suppression. This means that globally 59% of"/>
   <result pre="who have sex with men. Failure to achieve targets of" exact="treatment" post="and prevention mean that since 2015 there have been"/>
   <result pre="could set many HIV programmes back by years if prolonged" exact="treatment" post="interruptions occur. In The Lancet Global Health, Alexandra Hogan"/>
   <result pre="and colleagues model the impacts of disruptions to prevention and" exact="treatment" post="for HIV, tuberculosis, and malaria in low-income and middle-income"/>
   <result pre="pandemic. Given advances in prevention, testing, and treatment, every HIV" exact="infection" post="and death in 2020 is preventable. Nonetheless, we find"/>
   <result pre="we find ourselves falling far short of global targets for" exact="treatment" post="and prevention, and in very real jeopardy of backsliding"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="dict8/PMC7404095/results/search/testTrace/results.xml">
   <result pre="COVID-19 hotspots in the United States. Rapid spread of the" exact="infection" post="to workers because of similarly unsanitary working conditions threatened"/>
   <result pre="Foods becomes largest COVID-19 hotspot In US with 518 employees" exact="testing" post="positive. International Business Timeshttps://www.ibtimes.com/meatpacker-smithfield-foods-becomes-largest-covid-19-hotspot-us-518-employees-testing-2960006. Published April 16, 2020. Accessed"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="dict8/PMC7409732/results/search/testTrace/results.xml">
   <result pre="infection? 4 Response to the concept of virus and viral" exact="infection" post="An infection can be defined by &quot;penetration into a"/>
   <result pre="Response to the concept of virus and viral infection An" exact="infection" post="can be defined by &quot;penetration into a living organism"/>
   <result pre="highlighted the ambivalence of the concepts of viruses and viral" exact="infection" post="as early as 1957: are viruses living organisms, because"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="dict8/PMC7413401/results/search/testTrace/results.xml">
   <result pre="result and other conflicting indications for single room-assignment. Accelerating biological" exact="diagnosis" post="could improve single-room assignment. Funding The author(s) received no"/>
   <result pre="Thus, EDs must deal with organisational issues related to patients’" exact="isolation" post="and the risk of viral nosocomial transmission in the"/>
   <result pre="largely increased when the roommate presented an ILI [4]. Patients’" exact="isolation" post="with single-room assignment is the cornerstone of droplet precautions"/>
   <result pre="ILI. Rapid biological confirmation is thus recommended to help with" exact="isolation" post="and single-room assignment decisions in hospital settings. Polymerase chain"/>
   <result pre="and single-room assignment decisions in hospital settings. Polymerase chain reaction" exact="testing" post="(PCR) has the highest sensitivity compared to other diagnostic"/>
   <result pre="recent study assessing the usefulness of multiplex PCR as PoC" exact="testing" post="in the ED showed that the percentage of patients"/>
   <result pre="virus was higher, although not significantly, in those with PoC" exact="testing" post="than in those with laboratory testing, owed to a"/>
   <result pre="the third period, ED physicians used a point of care" exact="testing" post="with an immune-chromatographic method in addition to PCR, therefore"/>
   <result pre="assigned to a single room. These results underline that patient’s" exact="isolation" post="remains insufficient, despite a large number of 455 single"/>
   <result pre="study and in previous works [21,22]. Thus, a rapid virological" exact="diagnosis" post="is required to appropriately decide which patient with ILI"/>
   <result pre="the proportion of patients isolated with a confirmed respiratory virus" exact="infection" post="(17 vs 9%, p = 0.02) and reduced the"/>
   <result pre="in less than 2 hours reduced the duration of antibiotic" exact="treatment" post="by half and reduced the length of hospital stay"/>
   <result pre="previous epidemics. In addition, a new algorithm for the influenza" exact="diagnosis" post="based on an immuno-chromatographic rapid influenza diagnostic test (RIDT)"/>
   <result pre="new algorithm for the influenza diagnosis based on an immuno-chromatographic" exact="rapid influenza diagnostic test" post="(RIDT) was applied in the ED at the same"/>
   <result pre="ED at the same period, in parallel to the PCR" exact="testing" post="at the virology laboratory. Based on this algorithm, all"/>
   <result pre="diagnosis. The optimal protocol to optimise both costs and patient" exact="isolation" post="management is yet to be precisely identified. Our results"/>
   <result pre="should improve patients’ management, facilitate the ED organisation, and improve" exact="isolation" post="and droplet precautions during the overcrowded influenza season. Supporting"/>
   <result pre="27 February 2019. 10YouJHS, TamL-P, LeeNLS. Cost-effectiveness of molecular point-of-care" exact="testing" post="for influenza viruses in elderly patients at ambulatory care"/>
   <result pre="PLoS ONE2017; 12:e018209110.1371/journal.pone.018209128750092 11BrendishNJ, MalachiraAK, ArmstrongL, et al.Routine molecular point-of-care" exact="testing" post="for respiratory viruses in adults presenting to hospital with"/>
   <result pre="Mol Diagn2017; 19:460–467. 10.1016/j.jmoldx.2017.01.00928341587 13LacroixS, VrignaudB, AvrilE, et al.Impact of" exact="rapid influenza diagnostic test" post="on physician estimation of viral infection probability in paediatric"/>
   <result pre="of rapid influenza diagnostic test on physician estimation of viral" exact="infection" post="probability in paediatric emergency department during epidemic period. J"/>
   <result pre="6:11710.1186/s13756-017-0275-z29177048 19BaierC, LinderkampC, BeilkenA, et al.Influenza and respiratory syncytial virus" exact="screening" post="for the detection of asymptomatically infected patients in hematology"/>
   <result pre="BeilkenA, et al.Influenza and respiratory syncytial virus screening for the" exact="detection" post="of asymptomatically infected patients in hematology and oncology. GMS"/>
   <result pre="EmukuleG, et al.Does the length of specimen storage affect influenza" exact="testing" post="results by real-time reverse transcription-polymerase chain reaction? an analysis"/>
   <result pre="EwingsS, ClarkTW. Impact of turnaround time on outcome with point-of-care" exact="testing" post="for respiratory viruses: a post hoc analysis from a"/>
   <result pre="29087054 25BouzidD, LucetJ-C, DuvalX, et al.Multiplex PCR implementation as point-of-care" exact="testing" post="in a French emergency department. J Hosp Infect2020;"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="dict8/PMC7414693/results/search/testTrace/results.xml">
   <result pre="in the United States. This article identifies similar barriers to" exact="treatment" post="and care that persons living with HIV experienced in"/>
   <result pre="in this country. Keywords HIV Opioid use disorder Epidemic Medication" exact="treatment" post="of opioid use disorder MOUD HCV Infectious disease Stigma"/>
   <result pre="concern is the increase of illicitly manufactured fentanyl used in" exact="isolation" post="or with other drugs, such as the stimulants methamphetamine"/>
   <result pre="associated with addiction to prescription opioids prescribed by clinicians for" exact="treatment" post="of pain disorders. In 2015, a new HIV and"/>
   <result pre="fentanyl, and this epidemic has been plaguing the country in" exact="isolation" post="as well as now more routinely associated with an"/>
   <result pre="the CARE Act. As a result of addressing HIV from" exact="diagnosis" post="to viral suppression, the HIV care continuum has been"/>
   <result pre="HIV care continuum has been defined with specific outcomes including" exact="diagnosis" post="of HIV; linkage to care; ART prescription; ART retention;"/>
   <result pre="to treat HIV with wraparound services such as mental health" exact="treatment" post="and SUD treatment have thus led to a reduction"/>
   <result pre="with wraparound services such as mental health treatment and SUD" exact="treatment" post="have thus led to a reduction in morbidity and"/>
   <result pre="actions, as well as the CDC’s recommendations for universal HIV" exact="screening" post="and linkage to care in the United States,44 specific"/>
   <result pre="that is responsive to effective evidence-based treatment. Further, routine OUD" exact="screening" post="and SUD screening in general is not offered universally,"/>
   <result pre="to effective evidence-based treatment. Further, routine OUD screening and SUD" exact="screening" post="in general is not offered universally, much like early"/>
   <result pre="like early in the HIV epidemic.48 However, there are available" exact="screening" post="tools for evaluation of OUD, including the Rapid Opioid"/>
   <result pre="Opioid dependency Screen (RODS)49 and others.50,51 Similar to universal HIV" exact="screening" post="services that helped identify and link PLWH to treatment"/>
   <result pre="HIV screening services that helped identify and link PLWH to" exact="treatment" post="providers, universal OUD screening could be offered to all"/>
   <result pre="helped identify and link PLWH to treatment providers, universal OUD" exact="screening" post="could be offered to all persons, and those with"/>
   <result pre="those with positive OUD screens could be linked to medication" exact="treatment" post="of OUD (MOUD). However, few persons with OUD are"/>
   <result pre="few persons with OUD are linked to OUD or SUD" exact="treatment" post="and, if they are, few providers are approved to"/>
   <result pre="in PLWH,53, 54, 55 the gold standard of care in" exact="treatment" post="of HIV, which is associated with reduced mortality and"/>
   <result pre="to prescribe buprenorphine, or making it mandatory to provide behavioral" exact="treatment" post="in order to receive MOUD; Drug Addiction Treatment Act"/>
   <result pre="be prescribed buprenorphine; lack of same-day billing for an OUD" exact="treatment" post="and other potential associated medical conditions that might require"/>
   <result pre="OUD epidemics is helpful because it identifies similar barriers to" exact="treatment" post="and how to quell the coalescing substance use and"/>
   <result pre="country that were integrating infectious disease and OUD prevention and" exact="treatment" post="services.48,58 In addition, the Infectious Disease Society of America"/>
   <result pre="is needed. 3.Removal of federal and local barriers to accessing" exact="treatment" post="of OUD, including removal of the DATA 2000 X-waiver"/>
   <result pre="also impede the ability to provide in-the-moment appropriate life-saving medication" exact="treatment" post="of OUD when a patient requests it is needed."/>
   <result pre="sites, 2005-2016MMWR Morb Mortal Wkly Rep67201862562829879096 13ConradC.BradleyH.M.BrozD.Community Outbreak of HIV" exact="infection" post="linked to injection drug use of oxymorphone--Indiana, 2015MMWR Morb"/>
   <result pre="Morb Mortal Wkly Rep68201934434930998671 16ZibbellJ.E.AsherA.K.PatelR.C.Increases in acute hepatitis C virus" exact="infection" post="related to a growing opioid epidemic and associated injection"/>
   <result pre="PreventionAIDS: the early years and CDC's responseMMWR Suppl602011646921976168 22Des JarlaisD.C.KerrT.CarrieriP.HIV" exact="infection" post="among persons who inject drugs: ending old epidemics and"/>
   <result pre="drugs: ending old epidemics and addressing new outbreaksAIDS30201681582626836787 23Des JarlaisD.C.CarrieriP.HIV" exact="infection" post="among persons who inject drugs: ending old epidemics and"/>
   <result pre="Q8342005126 26DeWeerdtS.Tracing the US opioid crisis to its rootsNature5732019S10S1231511672 27PetersP.J.PontonesP.HooverK.W.HIV" exact="infection" post="linked to injection use of oxymorphone in Indiana, 2014-2015N"/>
   <result pre="the US opioid overdose crisisInt J Drug Policy71201918318830718120 31Des JarlaisD.C.FriedmanS.R.NovickD.M.HIV-1" exact="infection" post="among intravenous drug users in Manhattan, New York City,"/>
   <result pre="JarlaisD.C.FeelemyerJ.P.ModiS.N.Are females who inject drugs at higher risk for HIV" exact="infection" post="than males who inject drugs: an international systematic review"/>
   <result pre="35Abdul-QuaderA.S.FeelemyerJ.ModiS.Effectiveness of structural-level needle/syringe programs to reduce HCV and HIV" exact="infection" post="among people who inject drugs: a systematic reviewAIDS Behav17920132878289223975473"/>
   <result pre="the Cross-sectional HIV Care CascadeClin Infect Dis62201664865426567263 40CohenM.S.ChenY.Q.McCauleyM.Prevention of HIV-1" exact="infection" post="with early antiretroviral therapyN Engl J Med365201149350521767103 41collab: Health"/>
   <result pre="DC 42Centers for Disease Control and Prevention (CDC)Diagnoses of HIV" exact="infection" post="in the United States and dependent areas, 20182018(CDC)Atlanta (GA)"/>
   <result pre="Control and Prevention (CDC)Preexposure Prophylaxis for the prevention of HIV" exact="infection" post="in the United States-2014: a Clinical Practice Guideline2014DHHS) United"/>
   <result pre="44collab: Centers for Disease Control and PreventionRevised recommendations for HIv" exact="testing" post="of adults, adolescents, and pregnant women in health-care settingsMMWR"/>
   <result pre="we come?J Int AIDS Soc1620131873424242268 46GruskinS.TarantolaD.Universal Access to HIV prevention," exact="treatment" post="and care: assessing the inclusion of human rights in"/>
   <result pre="infectious diseasesOpen Forum Infect Dis72020ofz53931993454 51SevalN.EatonE.SpringerS.A.Inpatient Opioid Use Disorder (OUD)" exact="treatment" post="for the infectious disease physicianNortonB.The opioid epidemic and infectious"/>
   <result pre="opioid epidemic and infectious diseases1st edition2020Elsevier Inc.New York 52GowingL.FarrellM.F.BornemannR.Oral substitution" exact="treatment" post="of injecting opioid users for prevention of HIV infectionCochrane"/>
   <result pre="HIV infectionCochrane Database Syst Rev82011CD004145 53SpringerS.A.ChenS.AlticeF.L.Improved HIV and substance abuse" exact="treatment" post="outcomes for released HIV-infected prisoners: the impact of buprenorphine"/>
   <result pre="suppression among HIV-infected opioid dependent released prisonersPLoS One72012e3833522719814 56SpringerS.A.KorthuisP.T.Del RioC.Integrating" exact="treatment" post="at the intersection of opioid use disorder and infectious"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="dict8/PMC7414935/results/search/testTrace/results.xml">
   <result pre="humans, thereby posing a threat to global public health. CoV" exact="infection" post="mostly occurs during winter and spring in temperate countries;"/>
   <result pre="the virus has high transmission efficiency and may have severe" exact="infection" post="outcomes. The recent SARS-CoV-2 outbreak exhibited transboundary transmission due"/>
   <result pre="CoVs. This paper outlines the biological and epidemiological characteristics and" exact="diagnosis" post="of CoVs and describes the origin, transmission route, animal-source"/>
   <result pre="recognizes specific receptors (N-acetyl-neuraminic acid) on the cell surface during" exact="infection" post="to penetrate and lyse the cell membrane so that"/>
   <result pre="subgenomic mRNA, and replication of virus genomic gRNA.32 After virus" exact="infection" post="of host cells, dendritic cells (DC) will recognize these"/>
   <result pre="self-limiting acute or chronic persistent infections and can suffer repeated" exact="infection" post="and coinfection by multiple respiratory viruses. CoV infections mainly"/>
   <result pre="years during winter and spring, but pandemics are rare. The" exact="infection" post="rate of HCoV-HKU1 is 0.3–4.4%. HCoV-NL63 mainly cause epidemics"/>
   <result pre="are most susceptible. The incidence is around 2%, while the" exact="detection" post="rate is higher than for other human CoVs, and"/>
   <result pre="2–5 days, and the disease course is 6–7 days. CoV" exact="infection" post="mainly causes fever, runny nose, cough, and headaches, while"/>
   <result pre="pneumonia and causes respiratory failure, thrombocytopenia, and coagulation disorder. MERS-CoV" exact="infection" post="tends to lead to renal failure or septic shock"/>
   <result pre="septic shock in immunocompromised people. The incubation period of SARS-CoV-23" exact="infection" post="is 1–14 days, of which 3–7 days is the"/>
   <result pre="the most common incubation period. The main symptoms of SARS-CoV-2" exact="infection" post="include fever, fatigue, and dry cough along with ground-glass"/>
   <result pre="present, the patient should be considered a suspected case for" exact="quarantine" post="and clinical diagnosis. This should be combined with the"/>
   <result pre="history and clinical symptoms for integrated analysis, and a clinical" exact="diagnosis" post="should be made. Respiratory tract samples or blood samples"/>
   <result pre="Respiratory tract samples or blood samples should be used for" exact="immunofluorescence" post="assay (IFA), reverse transcription polymerase chain reaction (RT-PCR), enzyme-linked"/>
   <result pre="or blood samples should be used for immunofluorescence assay (IFA)," exact="reverse transcription polymerase chain reaction" post="(RT-PCR), enzyme-linked immunosorbent assay (ELISA), or virus cell culture"/>
   <result pre="samples should be used for immunofluorescence assay (IFA), reverse transcription" exact="polymerase chain reaction" post="(RT-PCR), enzyme-linked immunosorbent assay (ELISA), or virus cell culture"/>
   <result pre="for identification. Additional stool samples can be used for virus" exact="isolation" post="and testing to supplement data on digestive tract infection.43"/>
   <result pre="Additional stool samples can be used for virus isolation and" exact="testing" post="to supplement data on digestive tract infection.43 Prevention and"/>
   <result pre="density and widespread distribution of bats provide opportunities for pathogen" exact="infection" post="and rapid transmission. When there is frequent contact between"/>
   <result pre="frequent, is present throughout the world that might be an" exact="infection" post="pathway of COVID-19. In addition, excessive emphasis on food"/>
   <result pre="addition, excessive emphasis on food freshness has resulted in the" exact="prevalence" post="of cold foods, raw foods and other consumption methods."/>
   <result pre="camels, and birds. Therefore, it is a high risk of" exact="infection" post="from uncooked animal-source foods such as milk and meat."/>
   <result pre="bats are the main reservoir for CoVs (Figure 1). The" exact="virus detection" post="rates of intestinal and stool samples are higher than"/>
   <result pre="are the main reservoir for CoVs (Figure 1). The virus" exact="detection" post="rates of intestinal and stool samples are higher than"/>
   <result pre="And coronavirus’ apparent ability to thrive in cold, humid air," exact="infection" post="control should be strengthened in the processing of animal-source"/>
   <result pre="and sharing limited space, measures should be adopted to prevent" exact="infection" post="in company staff. Routine Control Measures in Foodstuff Manufacturing"/>
   <result pre="should be carried out at a suitable time, and medical" exact="quarantine" post="should be initiated for close contacts. Health Control For"/>
   <result pre="and must wear clean attire in the workplace. Inspection and" exact="quarantine" post="tests should be carried out before animals enter the"/>
   <result pre="be carried out before animals enter the slaughterhouse, and pre-slaughter" exact="testing" post="should be done. Abnormal livestock and poultry should be"/>
   <result pre="above measures. The members of the team would include CoV" exact="testing" post="staff, basic medical staff, company directors, and disease prevention"/>
   <result pre="among the staff. Confirmed cases should be treated promptly, and" exact="quarantine" post="should be implemented for close contacts. When the raw"/>
   <result pre="control center and the National Medical Products Administration, and pathogen" exact="tracing" post="of the upstream production chain should be carried out."/>
   <result pre="stuffs in supply chain are confirmed, they need to be" exact="quarantine" post="and stricter disinfections should be taken. If an intermediate"/>
   <result pre="Immunol. 2017;33:488–493. 38.DominguezSR, TravantyEA, QianZ, et al. Human coronavirus HKU1" exact="infection" post="of primary human type II alveolar epithelial cells: cytopathic"/>
   <result pre="58.Vergara-AlertJ, van de BrandJMA, WidagdoW, et al. Livestock susceptibility to" exact="infection" post="with Middle East respiratory syndrome coronavirus. Emerg Infect Dis."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="dict8/PMC7416915/results/search/testTrace/results.xml">
   <result pre=": Epidemiology: Social Epidemiology Modeling the role of asymptomatics in" exact="infection" post="spread with application to SARS-CoV-2 Asymptomatics in SARS-CoV-2 http://orcid.org/0000-0003-3592-6770DobrovolnyHana"/>
   <result pre="compartmental mathematical model of a viral epidemic that includes asymptomatic" exact="infection" post="to examine the role of asymptomatic individuals in the"/>
   <result pre="in all four states. The model suggests that relaxing of" exact="social distancing" post="measures too quickly could lead to a rapid rise"/>
   <result pre="found ∼30% of patients were asymptomatic on the day of" exact="testing" post="for SARS-CoV-2, with ∼4% remaining asymptomatic upon followup a"/>
   <result pre="in hospitalized patients in Beijing found that ∼5% of patients" exact="testing" post="positive for SARS-CoV-2 had asymptomatic infections [15]. While the"/>
   <result pre="individual [18]. In a more large-scale scenario, identification and rapid" exact="isolation" post="of asymptomatic SARS-CoV-2 positive individuals led to quick decline"/>
   <result pre="epidemic [19, 23, 24] or affect mitigation strategies such as" exact="quarantine" post="[23] and vaccination [20, 21]. In the current SARS-CoV-2"/>
   <result pre="[23] and vaccination [20, 21]. In the current SARS-CoV-2 pandemic," exact="isolation" post="and social distancing are the primary weapons in stopping"/>
   <result pre="vaccination [20, 21]. In the current SARS-CoV-2 pandemic, isolation and" exact="social distancing" post="are the primary weapons in stopping the spread of"/>
   <result pre="of infections in these states are unreported and that relaxing" exact="social distancing" post="measures too early will cause a rapid spike in"/>
   <result pre="the asymptomatics can infect susceptible individuals, but with a different" exact="infection" post="rate, determined by the proportionality constant r. We assume"/>
   <result pre="that to the cumulative infected individuals. Early in the pandemic," exact="testing" post="was primarily limited to individuals who displayed symptoms, so"/>
   <result pre="through bootstrapping with 1000 replicates. Results Effect of asymptomatics on" exact="infection" post="size and deaths We explored the effect of asymptomatics"/>
   <result pre="explored the effect of asymptomatics on the course of the" exact="infection" post="using a base set of parameters given in Table"/>
   <result pre="Infections are initiated with a single symptomatic infected individual. The" exact="infection" post="rate was taken from a model fit to data"/>
   <result pre="to data of coronavirus infections from China [9]; they estimate" exact="infection" post="rates before and after travel bans and social distancing"/>
   <result pre="they estimate infection rates before and after travel bans and" exact="social distancing" post="measures were put in place. We use both values"/>
   <result pre="1 for both high (left column) and low (right column)" exact="infection" post="rates. We see that the relative infectivity (r) of"/>
   <result pre="mortality is zero; this is particularly evident for the lower" exact="infection" post="rate. This pocket is more clearly defined for the"/>
   <result pre="(bottom row). The left column shows results for a high" exact="infection" post="rate and the right column shows results for a"/>
   <result pre="rate and the right column shows results for a low" exact="infection" post="rate. The relative infectivity of asymptomatics (r) has little"/>
   <result pre="(Fig 2 (left)) and low (Fig 2 (right)) values of" exact="infection" post="rate. Solving for p in the R0 equation gives"/>
   <result pre="+ δ ) - k β . (3) When the" exact="infection" post="rate is high, a high proportion of asymptomatics and"/>
   <result pre="higher values of r for a particular R0. When the" exact="infection" post="rate is low, we see a slightly different relationship"/>
   <result pre="to achieve a particular basic reproduction number for a high" exact="infection" post="rate (left) and low infection rate (right). In the"/>
   <result pre="reproduction number for a high infection rate (left) and low" exact="infection" post="rate (right). In the current COVID pandemic, public health"/>
   <result pre="pandemic, public health authorities have been attempting to lower the" exact="infection" post="rate through social distancing measures, so we more closely"/>
   <result pre="authorities have been attempting to lower the infection rate through" exact="social distancing" post="measures, so we more closely examined the dependence of"/>
   <result pre="more closely examined the dependence of the epidemic threshold on" exact="infection" post="rate. Fig 3 shows the R0 = 1 (the"/>
   <result pre="1 (the epidemic threshold value) curves for different values of" exact="infection" post="rate (β). R0 &amp;lt; 1 is to the left"/>
   <result pre="the left of each curve. We see that as the" exact="infection" post="rate is lowered, there are more combinations of r"/>
   <result pre="p that result in no epidemic. That is, the general" exact="infection" post="rate is just not high enough to support spread"/>
   <result pre="is just not high enough to support spread of the" exact="infection" post="no matter what the proportion of asymptomatic individuals or"/>
   <result pre="asymptomatic individuals or their relative infectivity. Fig 3 Effect of" exact="infection" post="rate on epidemic threshold. The contours indicate the points"/>
   <result pre="All four of these states have implemented some form of" exact="social distancing" post="for a period of time, and the majority of"/>
   <result pre="on the low end for unmitigated SARS-CoV-2, suggesting that the" exact="social distancing" post="measures are having some effect, but the measures taken"/>
   <result pre="in all four states, indicating that the spread of the" exact="infection" post="is largely driven by asymptomatic individuals, at least in"/>
   <result pre="in China [9] and might be indicative of the limited" exact="testing" post="availability in the United States early in the pandemic."/>
   <result pre="classified as recovered. Therefore, asymptomatic individuals participate in transmitting the" exact="infection" post="for a longer period of time and in greater"/>
   <result pre="This could have repercussions for decisions on when to relax" exact="social distancing" post="measures since we will observe a decline in infections"/>
   <result pre="the time at which the initial infected individual initiated the" exact="infection" post="in each state. Using our estimates of Td, we"/>
   <result pre="as early as January 15, while for Florida the estimated" exact="infection" post="start date is January 14. New York has the"/>
   <result pre="the latest is in Texas on January 24. Changing the" exact="infection" post="rate Strict stay-at-home measures have severe economic implications and"/>
   <result pre="to maintain [35, 36], so government officials want to relax" exact="social distancing" post="measures as early as possible. Given the large number"/>
   <result pre="we decided to investigate model predictions of what happens as" exact="social distancing" post="measures are relaxed. Based on a previous modeling study,"/>
   <result pre="previous modeling study, we assume that stay-at-home orders cut the" exact="infection" post="rate β in half [9], so double the infection"/>
   <result pre="the infection rate β in half [9], so double the" exact="infection" post="rate at two week intervals starting on the last"/>
   <result pre="6 with the solid line indicating the original epidemic where" exact="social distancing" post="was not relaxed, and dashed lines indicating predicted epidemics"/>
   <result pre="was not relaxed, and dashed lines indicating predicted epidemics when" exact="social distancing" post="is relaxed. We see that there is an immediate"/>
   <result pre="rate would be faster than if the states continued with" exact="social distancing" post="measures indefinitely. Fig 6 Estimated dynamics during epidemics when"/>
   <result pre="distancing measures indefinitely. Fig 6 Estimated dynamics during epidemics when" exact="social distancing" post="measures are relaxed. Shown are epidemics in California (upper"/>
   <result pre="(bottom right) where each dashed line shows the trajectory if" exact="social distancing" post="measures are relaxed at different two week intervals. To"/>
   <result pre="the next 10 weeks, as compared to no relaxation of" exact="social distancing" post="measures for the duration of the epidemic. Fig 7"/>
   <result pre="for different reopening timelines. We examined the effect of relaxing" exact="social distancing" post="measures at different times from the end of our"/>
   <result pre="asymptomatic infections plays a larger role in determining mortality. Yet" exact="testing" post="in many countries is limited to people who are"/>
   <result pre="could also lead to inaccurate predictions of the effect of" exact="isolation" post="[23] and contact-tracing mitigation strategies. If a vaccine is"/>
   <result pre="then isolated thereby being removed from further participation in the" exact="infection" post="as might be the case for these four states"/>
   <result pre="as might be the case for these four states since" exact="testing" post="for SARS-CoV-2 in all these states at the time"/>
   <result pre="pre-symptomatic phase, which also lumps people who likely have different" exact="infection" post="rates into one compartment. This mixing of individuals who"/>
   <result pre="parameters were correlated between the four data sets used. Adequate" exact="testing" post="protocols that capture both symptomatic and asymptomatic infections will"/>
   <result pre="These low values of R0 likely reflect the effect of" exact="social distancing" post="measures in the US, although these measures have not"/>
   <result pre="oubreaks with R0 &amp;lt; 1.5 can be contained with 50%" exact="contact tracing." post="Even for R0 up to 2.5, contact tracing only"/>
   <result pre="with 50% contact tracing. Even for R0 up to 2.5," exact="contact tracing" post="only needs to capture 70% of infections to be"/>
   <result pre="50% contact tracing. Even for R0 up to 2.5, contact" exact="tracing" post="only needs to capture 70% of infections to be"/>
   <result pre="10.1111/irv.12743 9LiR, PeiS, ChenB, SongY, ZhangT, YangW, et al.Substantial undocumented" exact="infection" post="facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2). Science."/>
   <result pre="15TianS, HuN, LouJ, ChenK, KangX, XiangZ, et al.Characteristics of COVID-19" exact="infection" post="in Beijing. J Infect. 2020;80(4):401–406. 10.1016/j.jinf.2020.02.01832112886 16ZhangJ, TianS, LouJ,"/>
   <result pre="2020;80(4):401–406. 10.1016/j.jinf.2020.02.01832112886 16ZhangJ, TianS, LouJ, ChenY. Familial cluster of COVID-19" exact="infection" post="from an asymptomatic. Crit Care. 2020;24(1):11910.1186/s13054-020-2817-732220236 17HuZ, SongC, XuC,"/>
   <result pre="20WangJ, WuD, SunH. Analysis of an SVIC model with age-dependent" exact="infection" post="and asymptomatic carriers. Appl Anal. 2018;97(9):1467–1495. 10.1080/00036811.2017.1313409 21ManyombeMLM, MbangJ,"/>
   <result pre="BosseN, JarvisC, RussellTW, et al.Feasibility of controlling COVID-19 outbreaks by" exact="isolation" post="of cases and contacts. Lancet Global Health. 2020;8(4):E488–E496. 10.1016/S2214-109X(20)30074-732119825"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="dict8/PMC7419580/results/search/testTrace/results.xml">
   <result pre="data and current knowledge of secondary bacterial infections and their" exact="treatment" post="in SARS-CoV-2 positive patients; case reports from SARS-CoV, MERS-CoV,"/>
   <result pre="antibiotic-resistant strains of Staphylococcus aureus and Klebsiella pneumoniae. secondary bacterial" exact="infection" post="pulmonary viruses viral pneumonia SARS-CoV-2 COVID-19 influenza SARS antibiotic"/>
   <result pre="MERS-CoV: 2012–2020; Ebola virus: 2013–2016; Zika virus: 2015–2016; SARS-CoV-2: 2019-present)," exact="infection" post="with four of which (SARS-CoV, H1N1 Influenza, MERS-CoV, SARS-CoV-2)"/>
   <result pre="or following initial infection. In addition, co-infections - the simultaneous" exact="infection" post="with a second pathogen of viral or bacterial origin-"/>
   <result pre="1B) (6, 7). Figure 1 (A) Possible disease progression after" exact="infection" post="with a respiratory virus. (B) Overview of case reports"/>
   <result pre="virus. (B) Overview of case reports of all respiratory virus" exact="infection" post="data reviewed in this study, including rate of secondary"/>
   <result pre="alter the immunity to other infectious agent(s), resulting in increased" exact="prevalence" post="of viral-induced secondary bacterial infections (10). Mammalian cells are"/>
   <result pre="attachment and colonization when infected by a virus (11, 12);" exact="infection" post="with respiratory syncytial virus (RSV), rhinovirus and influenza virus"/>
   <result pre="During active viral infections, the route of infection, proximity of" exact="infection" post="as well as virulence factors varies between bacterial strains"/>
   <result pre="factors varies between bacterial strains resulting in different outcomes. Effective" exact="treatment" post="of both the viral and the secondary bacterial infection(s)"/>
   <result pre="initially do not treat secondary bacterial infections (15). The preferred" exact="treatment" post="for bacterial infections is generally broad-spectrum antibiotics, but this"/>
   <result pre="Carbapenem-resistant Acinetobacter baumannii (20). If a patient with a viral" exact="infection" post="is unfortunate to become infected by MDR bacteria, no"/>
   <result pre="is unfortunate to become infected by MDR bacteria, no standard" exact="treatment" post="is currently available. In one COVID-19 cohort study, described"/>
   <result pre="meropenem and linezolid to children with a rate of prophylactic" exact="treatment" post="between 19.4 and 100.0% (24). In adults mainly quinolones,"/>
   <result pre="In adults mainly quinolones, cephalosporins and macrolides were used for" exact="treatment" post="with rates of prophylaxis between 13.2 and 100.0%. In"/>
   <result pre="COVID-19 requiring hospitalization and critical care. Early stages of SARS-CoV-2" exact="infection" post="typically include symptoms of mild fever and shortness of"/>
   <result pre="may result in pneumonia. In almost all severe cases, SARS-CoV-2" exact="infection" post="results in pneumonia and the inflamed fluid-filled alveolar tissue"/>
   <result pre="of secondary bacterial infections in those infected with SARS-CoV-2 complicates" exact="treatment" post="(26, 27). An overview of all COVID-19 case studies,"/>
   <result pre="Information, where we have analyzed 15 case studies reporting SARS-CoV-2" exact="infection" post="(Supplemental Data Sheet 1). In particular for data obtained"/>
   <result pre="risk of nosocomial infections, a prophylactic strategy. Should a bacterial" exact="infection" post="occur despite the prophylactic use of antibiotics, caused by"/>
   <result pre="of superinfection with MDR bacteria poses additional challenges for the" exact="treatment" post="of severely sick COVID-19 patients in intensive care units"/>
   <result pre="in China, were examined to provide information of the occurrence," exact="treatment" post="of or prophylactic measures for bacterial secondary infections during"/>
   <result pre="(25, 26, 29, 36, 38). Three studies reported therapeutic antibiotic" exact="treatment" post="in 92 of 146 patients (63%), which were administered"/>
   <result pre="prophylactic antibiotic therapy (48, 50–53). The antibiotics used for prophylactic" exact="treatment" post="were levofloxacin, clarithromycin, amoxicillin-clavulanic acid, piperacillin-tazobactum, maxipime, azithromycin, amoxicillin-clavulanate,"/>
   <result pre="= 866), the highest among all coronavirus diseases (52). The" exact="infection" post="often starts as a mild viral respiratory illness but"/>
   <result pre="commonly deployed with secondary bacterial infections rarely occurring under this" exact="treatment" post="regime (53–55). Here, we review MERS-related case studies, outlining"/>
   <result pre="antibiotics (55, 56, 58, 59). The development of secondary bacterial" exact="infection" post="was reported in two studies, with 32 of 82"/>
   <result pre="VRE and S. pneumoniae. No detailed report was provided about" exact="treatment" post="antibiotics and one study reported (patients n = 15)"/>
   <result pre="influenza viruses and secondary bacterial infections (Supplementary File). Details on" exact="treatment" post="and disease progression of a total of 910 patients"/>
   <result pre="cephalosporin (65). In general, all eight case studies reported the" exact="treatment" post="complications due to secondary bacterial infections. Discussion The lack"/>
   <result pre="antibiotic-resistant bacterial infections are increasing, providing such data of secondary" exact="infection" post="is important, almost critical. Clinical reports are a valuable"/>
   <result pre="bacterial pathogen, but rather target pathogen-intrinsic components important for the" exact="infection" post="process. These include bacterial components such as exo- and"/>
   <result pre="https://www.frontiersin.org/articles/10.3389/fmed.2020.00420/full#supplementary-material Supplementary Figure 1 Overview of case reports of SARS-CoV-2" exact="infection" post="data reviewed in this study, including rate of secondary"/>
   <result pre="Front Microbiol. (2017) 8:1041. 10.3389/fmicb.2017.0104128690590 3.WangHAnthonyDSelemidisSVlahosRBozinovskiS. Resolving viral-induced secondary bacterial" exact="infection" post="in COPD: a concise review. Front Immunol. (2018) 9:2345."/>
   <result pre="concise review. Front Immunol. (2018) 9:2345. 10.3389/fimmu.2018.0234530459754 4.MalliaPFootittJSoteroRJepsonAContoliMTrujillo-TorralboMBet al.. Rhinovirus" exact="infection" post="induces degradation of antimicrobial peptides and secondary bacterial infection"/>
   <result pre="Rhinovirus infection induces degradation of antimicrobial peptides and secondary bacterial" exact="infection" post="in chronic obstructive pulmonary disease. Am J Respir Crit"/>
   <result pre="10.1016/j.ajpath.2014.08.03025747532 7.MacIntyreCRChughtaiAABarnesMRiddaISealeHTomsRet al.. The role of pneumonia and secondary bacterial" exact="infection" post="in fatal and serious outcomes of pandemic influenza a"/>
   <result pre="pdm09. BMC Infect Dis. (2018) 18:637. 10.1186/s12879-018-3548-030526505 8.KimYGParkJHReimerTBakerDPKawaiTKumarHet al.. Viral" exact="infection" post="augments Nod1/2 signaling to potentiate lethality associated with secondary"/>
   <result pre="PLoS Neglect Trop D. (2017) 11:e0005901. 10.1371/journal.pntd.000590128886013 12.PittetLAHall-StoodleyLRutkowskiMRHarmsenAG. Influenza virus" exact="infection" post="decreases tracheal mucociliary velocity and clearance of Streptococcus pneumoniae."/>
   <result pre="Med Microbiol. (2002) 51:808–12. 10.1099/0022-1317-51-10-80812435058 17.BrookI. Microbiology of secondary bacterial" exact="infection" post="in scabies lesions. J Clin Microbiol. (1995) 33:2139–40. 10.1128/JCM.33.8.2139-2140.19957559963"/>
   <result pre="J Clin Microbiol. (1995) 33:2139–40. 10.1128/JCM.33.8.2139-2140.19957559963 18.MaharPDWasiakJClelandHPaulEGinDWattersDAet al.. Secondary bacterial" exact="infection" post="and empirical antibiotic use in toxic epidermal necrolysis patients."/>
   <result pre="Res. (2014) 35:518–24. 10.1097/BCR.000000000000006224988228 19.SmithAMMcCullersJASecondary bacterial infections in influenza virus" exact="infection" post="pathogenesis in influenza pathogenesis and control. Curr Top Microbiol"/>
   <result pre="Dis. (2020) 29:ciaa19910.1093/cid/ciaa199 35.GautretPLagierJCParolaPMeddebLMailheMDoudierBet al.. Hydroxychloroquine and azithromycin as a" exact="treatment" post="of COVID-19: results of an open-label non-randomized clinical trial."/>
   <result pre="Am J Pathol. (2007) 170:1136–47. 10.2353/ajpath.2007.06108817392154 44.ChengVCChanJFToKKYuenKY. Clinical management and" exact="infection" post="control of SARS: lessons learned. Antiviral Res. (2013) 100:407–19."/>
   <result pre="Med. (2004) 128:195–204. 10.1043/1543-2165(2004)128&amp;lt;195:AODDTS&amp;gt;2.0.CO;214736283 46.SoLKLauACYamLYCheungTMPoonEYungRWet al.. Development of a standard" exact="treatment" post="protocol for severe acute respiratory syndrome. Lancet. (2003) 361:1615–7."/>
   <result pre="study. Lancet. (2003) 361:1767–72. 10.1016/S0140-6736(03)13412-512781535 50.ZhaoZZhangFXuMHuangKZhongWCaiWet al.. Description and clinical" exact="treatment" post="of an early outbreak of severe acute respiratory syndrome"/>
   <result pre="(2003) 52:715–20. 10.1099/jmm.0.05320-012867568 51.WangJTShengWHFangCTChenYCWangJLYuCJet al.. Clinical manifestations, laboratory findings, and" exact="treatment" post="outcomes of SARS patients. Emerg Infect Dis. (2004) 10:818–24."/>
   <result pre="10.1056/NEJMoa130372923718156 60.Available, online at: https://www.cdc.gov/flu/about/viruses/types.htm 61.https://www.who.int/influenza/surveillance_monitoring/updates/latest_update_GIP_surveillance/en/ 62.McCullersJA. Effect of antiviral" exact="treatment" post="on the outcome of secondary bacterial pneumonia after influenza."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="dict8/PMC7423094/results/search/testTrace/results.xml">
   <result pre="recuperated from an infection, and administered to patients with the" exact="infection" post="in order to improve clinical outcome [6]. Although the"/>
   <result pre="patients with severe COVID-19 and the mainstay of current clinical" exact="treatment" post="consisting of symptomatic management and mechanical ventilation, administering convalescent"/>
   <result pre="of symptomatic management and mechanical ventilation, administering convalescent plasma for" exact="treatment" post="purposes is currently being deployed [7–12]. Although it is"/>
   <result pre="Medicine for his work, which served as a basis for" exact="treatment" post="of multiple diseases in the 1900s as well as"/>
   <result pre="notion that convalescent plasma could be a viable option for" exact="treatment" post="of COVID-19 patients, particularly upon early administration [6, 9,"/>
   <result pre="antibodies from the blood of someone who recovered from an" exact="infection" post="can be administered to protect or treat another person"/>
   <result pre="case of prophylaxis, a subject considered at high risk for" exact="infection" post="(because of age or underlying medical conditions or who"/>
   <result pre="can be administered to treat subjects who have contracted the" exact="infection" post="but have not made sufficient antibodies against the virus"/>
   <result pre="who recovered from COVID-19 can be administered prophylactically to prevent" exact="infection" post="in vulnerable individuals and those with known exposure to"/>
   <result pre="antibody-dependent enhancement (ADE), whereby antibodies that developed during a prior" exact="infection" post="exacerbate severity of the disease [12, 28]. The transfer"/>
   <result pre="recruitment of proinflammatory cytokines and chemokines to the site of" exact="infection" post="and causing severe tissue damage [29–31]. Additionally, the presence"/>
   <result pre="low because of strict transfusion protocols, and when used for" exact="treatment" post="purposes, the recipient is already infected [12, 36]. The"/>
   <result pre="to develop convalescent plasma therapy into a viable (albeit short-term)" exact="treatment" post="option particularly for the critically ill. Although its efficacy"/>
   <result pre="focused not only on evaluation of the feasibility of plasma" exact="treatment" post="for infectious diseases but also ensure that use of"/>
   <result pre="Epub 2020/04/16. 10.1002/jmv.25577 .31502247 11SheridanC.Convalescent serum lines up as first-choice" exact="treatment" post="for coronavirus. Nat Biotechnol. 2020;(38):655–658. Epub 2020/05/03. 10.1038/d41587-020-00011-1 .32358594"/>
   <result pre="Experimental Streptococcal Arthritis. J Infect Dis. 1914;15(1):215–26. 17Smith DD. Serum" exact="treatment" post="of scarlet fever [doctoral thesis]. Omaha (Nebraska): University of"/>
   <result pre="of Nebraska; 1934. 18The use of convalescent serum in the" exact="treatment" post="of measles, chickenpox, mumps and whooping cough, including the"/>
   <result pre="1938;111(26):2361–4. 10.1001/jama.1938.02790520017004 20CasadevallA, ScharffMD. Serum therapy revisited: animal models of" exact="infection" post="and development of passive antibody therapy. Antimicrob Agents Chemother."/>
   <result pre="WintersJL, et al.Deployment of convalescent plasma for the prevention and" exact="treatment" post="of COVID-19. J Clin Invest. 2020 Epub 2020/04/08. 10.1172/JCI138745"/>
   <result pre=".32254064 22HungIF, ToKK, LeeCK, LeeKL, ChanK, YanWW, et al.Convalescent plasma" exact="treatment" post="reduced mortality in patients with severe pandemic influenza A"/>
   <result pre="LiPH, CheungCY, DutryI, LiD, et al.Antibody-dependent enhancement of SARS coronavirus" exact="infection" post="and its role in the pathogenesis of SARS. Hong"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="dict8/PMC7423499/results/search/testTrace/results.xml">
   <result pre="from the Korean Peninsula (O’Hanlon et al. 2018), with subsequent" exact="infection" post="of the American bullfrog, an invasive amphibian species now"/>
   <result pre="are unknown to science and cannot be readily detected through" exact="quarantine" post="or border controls. A revaluation of trade rules is"/>
   <result pre="the current Covid-19 pandemic could be. Despite the far lower" exact="infection" post="fatality rate of just over 1% (Verity et al."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="dict8/PMC7427094/results/search/testTrace/results.xml">
   <result pre="this virus and possibly other pandemic viruses. Subject terms Viral" exact="infection" post="Phylogenetics Funding Wood-Whelan Research Fellowships 2007 Funding VLIR-UOS project"/>
   <result pre="five to 63 different types, with no cross neutralization, i.e." exact="infection" post="with one type does not infer immunity against another"/>
   <result pre="at least one intratypic recombination event, which was verified by" exact="testing" post="complete sequences of some CVA24v and other Enterovirus C"/>
   <result pre="reconstructed network analysis based on a random walk based community" exact="detection" post="algorithm (Walktrap analysis32) was performed to identify molecular signatures"/>
   <result pre="at low levels and escape the surveillance system since asymptomatic" exact="infection" post="is the most common outcome, (2) the virus cause"/>
   <result pre="even if these studies did not relate to time of" exact="isolation" post="of the strains or ancestral relationships between the sequences5,10,25,37,38."/>
   <result pre="the epidemics CVA24v could be originated in Cuba. The unexpected" exact="detection" post="of strains of CVA24v belonging to genotype IV during"/>
   <result pre="algorithm: alignment (multiple sequences alignment), quality control, evolutionary model selection," exact="testing" post="phylogeny and phylodynamics (modified from55). For the phylodynamic step,"/>
   <result pre="period in southern TaiwanGraefes Arch. Clin. Exp. Ophthalmol.2003241755456010.1007/s00417-003-0680-212768288 4.LevequeNet al.Rapid" exact="diagnosis" post="of acute hemorrhagic conjunctivitis due to coxsackievirus A24 variant"/>
   <result pre="newer enterovirusesFields Virology20136PhiladelphiaLippincott Williams &amp;amp; Wilkins490529 44.Yin-MurphyMSimple tests for the" exact="diagnosis" post="of picornavirus epidemic conjunctivitis (acute haemorrhagic conjunctivitis)Bull. World Health"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="dict8/PMC7427313/results/search/testTrace/results.xml">
   <result pre="share several features of clinical and laboratory presentation, and differential" exact="diagnosis" post="should rely on specific diagnostic tests.5 Recently, two cases"/>
   <result pre="rapid diagnostic test (RDT) for dengue in patients with SARS-CoV-2" exact="infection" post="were reported from Singapore.6 If serological cross-reactivity between patients"/>
   <result pre="between COVID-19 and dengue patients, by performing commercial assays for" exact="detection" post="of anti-Dengue virus (DENV) and anti-SARS-CoV-2 antibodies on sera"/>
   <result pre="of whom confirmed by NS1 antigen positivity, plus 17 probable" exact="diagnosis" post="with only IgM and IgG positivity), were tested by"/>
   <result pre="The risk of false-positive results is reduced when dengue IgM/IgG" exact="testing" post="is paired with NS1 antigen capture.8 According with our"/>
   <result pre="elucidate the accuracy of commercially available RDTs for SARS-CoV-2 antibodies" exact="detection" post="and their role within the strategy for COVID-19 diagnosis"/>
   <result pre="antibodies detection and their role within the strategy for COVID-19" exact="diagnosis" post="and control. Financial support: This article has been supported"/>
   <result pre="and false-positive dengue serology in SingaporeLancet Infect Dis202020553653632145189 7LiRPeiSChenBSongYZhangTYangWSubstantial undocumented" exact="infection" post="facilitates the rapid dissemination of novel coronavirus (SARS-CoV2)Science2020368649048949332179701 8MullerDADepelsenaireACYoungPRClinical"/>
   <result pre="the rapid dissemination of novel coronavirus (SARS-CoV2)Science2020368649048949332179701 8MullerDADepelsenaireACYoungPRClinical and laboratory" exact="diagnosis" post="of dengue virus infectionJ Infect Dis2017215Suppl. 2 9SethuramanNJeremiahSSRyoAInterpreting diagnostic"/>
   <result pre="Infect Dis2017215Suppl. 2 9SethuramanNJeremiahSSRyoAInterpreting diagnostic tests for SARS-CoV-2.JAMA2020 10BokhariSMMAMahmoodFBokhariSMSACase report" exact="diagnosis" post="of novel Coronavirus disease (COVID-19) versus tropical diseases in"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="dict8/PMC7428060/results/search/testTrace/results.xml">
   <result pre="Q fever [11], leptospirosis, influenza, Amazonian toxoplasmosis, and primary HIV" exact="infection" post="can be potential differential diagnoses during a dengue epidemic"/>
   <result pre="positive predictive value and clinical variability do not guarantee a" exact="diagnosis" post="of certainty (Table 1). Thus, some studies report 25%"/>
   <result pre="potentially fatal viruses, it is key to enable a combined" exact="diagnosis" post="(COVID-19–dengue) for ambulatory patients and at least complete blood"/>
   <result pre="treated in the hospital with the necessary precautions until the" exact="diagnosis" post="is made. For other patients, they can consult the"/>
   <result pre="they can consult the hospital in a specific location for" exact="diagnosis" post="and follow-up of fever during COVID-19 + dengue epidemics."/>
   <result pre="Mayaro virus (French Guiana reports no case of chikungunya virus" exact="infection" post="from early 2016 and no case of Zika virus"/>
   <result pre="infection from early 2016 and no case of Zika virus" exact="infection" post="from early 2017) [22], malaria, Q fever, leptospirosis, salmonellosis,"/>
   <result pre="2017) [22], malaria, Q fever, leptospirosis, salmonellosis, and HIV primary" exact="infection" post="[10,12,23,24]. This list will vary between regions. The objectives"/>
   <result pre="objectives of paraclinical explorations are 2-fold: to make the differential" exact="diagnosis" post="and to look for signs of severity (white blood"/>
   <result pre="a malaria test, blood and urine cultures, serologies, or molecular" exact="diagnosis" post="of differential diagnoses. What is the impact of social"/>
   <result pre="molecular diagnosis of differential diagnoses. What is the impact of" exact="social distancing" post="on dengue epidemics? In French Guiana, with social distancing,"/>
   <result pre="of social distancing on dengue epidemics? In French Guiana, with" exact="social distancing," post="vector control has been scaled back by only relying"/>
   <result pre="circulation [28]. Currently, in French Guiana transmission has increased during" exact="social distancing," post="which was implemented simultaneously with the second rainy season."/>
   <result pre="contributions of rainfall and suboptimal mosquito control measures due to" exact="social distancing." post="Transmission depends on the frequency of mosquito bites, and"/>
   <result pre="distancing. Transmission depends on the frequency of mosquito bites, and" exact="infection" post="incidence in the human and mosquito populations is almost"/>
   <result pre="human movement enhances the rescue effect. Thus, modeling suggests that" exact="infection" post="hubs and reservoirs can be locations people visit frequently,"/>
   <result pre="population and the variability in human travel patterns. Does COVID-19" exact="social distancing" post="have the potential to increase dengue morbidity? With the"/>
   <result pre="the lockdown, people stay home, and the risk of dengue" exact="infection" post="may increase as A. aegypti, the vector of dengue"/>
   <result pre="led to global shortages in certain laboratory reagents. Hence, molecular" exact="diagnosis" post="of COVID-19 and dengue requires extraction kits and enzymes"/>
   <result pre="of public spaces, intra-domiciliary interventions, notably around cases). Regarding COVID-19," exact="testing" post="of suspected cases should expand (it has been hampered"/>
   <result pre="constraints and insufficient supplies of swabs and reagents), and aggressive" exact="contact tracing" post="and isolation should continue. Diagnosis of febrile patients should"/>
   <result pre="and insufficient supplies of swabs and reagents), and aggressive contact" exact="tracing" post="and isolation should continue. Diagnosis of febrile patients should"/>
   <result pre="supplies of swabs and reagents), and aggressive contact tracing and" exact="isolation" post="should continue. Diagnosis of febrile patients should be organized"/>
   <result pre="network for a population of 260,000 [34]. The impact of" exact="social distancing" post="relaxation on population movements and the epidemic is hard"/>
   <result pre="surge has not happened due to the early implementation of" exact="social distancing," post="border closure, and cancelation of most air traffic. Most"/>
   <result pre="imported with secondary transmission clusters around imported cases. However, as" exact="social distancing" post="relaxes in the weeks ahead and flights from France"/>
   <result pre="will increase. Authorities will need to be very aggressive on" exact="contact tracing" post="and vigilant on testing and tracking arriving passengers. With"/>
   <result pre="increase. Authorities will need to be very aggressive on contact" exact="tracing" post="and vigilant on testing and tracking arriving passengers. With"/>
   <result pre="to be very aggressive on contact tracing and vigilant on" exact="testing" post="and tracking arriving passengers. With a single international airport"/>
   <result pre="from Brazil in French Guiana. As the Brazilian president resists" exact="social distancing," post="there are risks of importing cases through the interior"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="dict8/PMC7431640/results/search/testTrace/results.xml">
   <result pre="and oropharyngeal swabs were collected from enrolled patients, and diagnostic" exact="testing" post="was performed. Upper respiratory tract specimens were tested for"/>
   <result pre="virus (RSV), coronavirus, parainfluenza viruses and human metapneumovirus by real‐time" exact="reverse transcription polymerase chain reaction" post="(RT–PCR) as previously described.13, 14, 15 For each respiratory"/>
   <result pre="coronavirus, parainfluenza viruses and human metapneumovirus by real‐time reverse transcription" exact="polymerase chain reaction" post="(RT–PCR) as previously described.13, 14, 15 For each respiratory"/>
   <result pre="investigation leveraged a large study with consistent recruiting and diagnostic" exact="testing" post="over multiple influenza seasons, yet still is subject to"/>
   <result pre="the final draft of the paper. JM supervised the laboratory" exact="testing" post="and reviewed the final draft of the paper. LIA"/>
   <result pre="Negl Trop Dis. 2016;10:e0005025.27727271 13PaulinoRDS, BenegaMA, SantosKCDO, et al. Differential" exact="diagnosis" post="of respiratory viruses by using real time RT‐PCR methodology."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="dict8/PMC7435559/results/search/testTrace/results.xml">
   <result pre="Whereas the COVID‐19 global scare resulted in different countries to" exact="quarantine" post="its flown back citizens (Denise, 2020), the world's increased"/>
   <result pre="Organization to digitally share its interim guidance on the COVID‐19" exact="infection" post="prevention and needed health care when the novel coronavirus"/>
   <result pre="infection prevention and needed health care when the novel coronavirus" exact="infection" post="was suspected (World Health Organization [WHO/2019‐nCoV/IPC/v20202.2], 2020). For instance,"/>
   <result pre="organizations sharing related information that is vital in prevention and" exact="treatment" post="of epidemics. However, with continued funding aimed at boosting"/>
   <result pre="prevention and control during health care when novel coronavirus (nCoV)" exact="infection" post="is suspected. World Health Organization Retrieved from https://www.who.int/publications‐detail/infection‐prevention‐and‐control‐during‐health‐care‐when‐novel‐coronavirus‐(ncov)o‐infection‐is‐suspected‐20200125"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="dict8/PMC7440033/results/search/testTrace/results.xml">
   <result pre="case of COVID-19 in Egypt on February 14th, 2020, the" exact="infection" post="rate remains at an exponential phase with forty-seven African"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="dict8/PMC7441048/results/search/testTrace/results.xml">
   <result pre="7441048S1201-9712(20)30671-8 doi: 10.1016/j.ijid.2020.08.041 : Short Communication Current approaches in laboratory" exact="testing" post="for SARS-CoV-2 XuYuzhongabChengMinggangaChenXinchunbZhuJialoubc⁎[a], [b], [c], ⁎Corresponding author at: Guangdong"/>
   <result pre="remains active. Highlights •All types and characteristics of available laboratory" exact="testing" post="for SARS-CoV-2 were reviewed. •The selection strategies of testing"/>
   <result pre="laboratory testing for SARS-CoV-2 were reviewed. •The selection strategies of" exact="testing" post="and sampling sites were examined at different disease stages."/>
   <result pre="been dramatically growing in recent months. Early, rapid and accurate" exact="diagnosis" post="is of great significance for curtailing the spread of"/>
   <result pre="these methods are quite different, with the sample source and" exact="detection" post="limit varying greatly. This study reviewed all types and"/>
   <result pre="of the currently available laboratory diagnostic assays for detecting SARS-CoV-2" exact="infection" post="and summarized the selection strategies of testing and sampling"/>
   <result pre="for detecting SARS-CoV-2 infection and summarized the selection strategies of" exact="testing" post="and sampling sites at different disease stages to improve"/>
   <result pre="Coronavirus Disease 2019 (COVID-19). Keywords Novel coronavirus SARS-CoV-2 COVID-19 Laboratory" exact="testing" post="Laboratory diagnosis An outbreak of coronavirus disease 2019 (COVID-19)"/>
   <result pre="2019 (COVID-19). Keywords Novel coronavirus SARS-CoV-2 COVID-19 Laboratory testing Laboratory" exact="diagnosis" post="An outbreak of coronavirus disease 2019 (COVID-19) caused by"/>
   <result pre="in the community, early and reliable laboratory confirmation of SARS-CoV-2" exact="infection" post="is of crucial importance. This review summarized advances made"/>
   <result pre="importance. This review summarized advances made in technologies for rapid" exact="diagnosis" post="and confirmation of respiratory infections caused by SARS-CoV-2, as"/>
   <result pre="caused by SARS-CoV-2, as well as the selection strategies of" exact="testing" post="and sampling sites in SARS-CoV-2 detection. Since the initial"/>
   <result pre="as a powerful tool for discovering pathogens (Table 1). A" exact="detection" post="assay (BGI, Shenzhen, China), based on next-generation sequencing, was"/>
   <result pre="is not recommended for widespread clinical use. Table 1 Laboratory" exact="testing" post="for detection of SARS-CoV-2. Table 1 Testing type Specimen"/>
   <result pre="recommended for widespread clinical use. Table 1 Laboratory testing for" exact="detection" post="of SARS-CoV-2. Table 1 Testing type Specimen type Characteristics"/>
   <result pre="time Limitation Viral culture Respiratory sample Gold standard for virus" exact="diagnosis" post="and useful in the initial phase of emerging epidemics"/>
   <result pre="and blood Most widely used for laboratory confirmation of SARS-CoV-2" exact="infection" post="1.5–3 h Time-consuming procedure, requires biosafety conditions, expensive equipment,"/>
   <result pre="equipment 0.5–2 h False negative results, as real-time RT-PCR Serological" exact="testing" post="Serum, plasma and blood Less time required, simple to"/>
   <result pre="and lack of cost-effectiveness NAAT, nucleic acid amplification test; RT-PCR," exact="reverse transcription polymerase chain reaction." post="Real-time reverse transcription polymerase chain reaction (RT-PCR) is routinely"/>
   <result pre="of cost-effectiveness NAAT, nucleic acid amplification test; RT-PCR, reverse transcription" exact="polymerase chain reaction." post="Real-time reverse transcription polymerase chain reaction (RT-PCR) is routinely"/>
   <result pre="acid amplification test; RT-PCR, reverse transcription polymerase chain reaction. Real-time" exact="reverse transcription polymerase chain reaction" post="(RT-PCR) is routinely used in acute respiratory infection to"/>
   <result pre="test; RT-PCR, reverse transcription polymerase chain reaction. Real-time reverse transcription" exact="polymerase chain reaction" post="(RT-PCR) is routinely used in acute respiratory infection to"/>
   <result pre="polymerase chain reaction (RT-PCR) is routinely used in acute respiratory" exact="infection" post="to detect causative viruses from respiratory specimens. The World"/>
   <result pre="by China and the US, respectively, with the limit of" exact="detection" post="varying from 100 to 1000 copies/mL (Table S1). Although"/>
   <result pre="the specimen, incorrect storage and transportation, as well as laboratory" exact="testing" post="conditions and personnel operations. If a highly suspected patient"/>
   <result pre="assay, targeting the N gene of the virus, displayed a" exact="detection" post="limit of 100 RNA copies in 30 min combined"/>
   <result pre="assays could be used as a sensitive and specific early" exact="detection" post="method with which to identify SARS-CoV-2 cases. Currently, several"/>
   <result pre="cases. Currently, several isothermal amplification-based nucleic acid tests for SARS-CoV-2" exact="detection" post="have received EUAs from China's NMPA (Table S1). Serological"/>
   <result pre="diagnostic approach for the current rapidly growing demand for rapid" exact="diagnosis" post="of suspected patients and asymptomatic infections. The entire test"/>
   <result pre="are suggested to be used either in combination with molecular" exact="testing" post="or for additional testing in suspected cases with negative"/>
   <result pre="used either in combination with molecular testing or for additional" exact="testing" post="in suspected cases with negative nucleic acid results to"/>
   <result pre="in suspected cases with negative nucleic acid results to improve" exact="detection" post="accuracy of COVID-19. In a study of 397 real-time"/>
   <result pre="coronaviruses has been observed (Guo et al., 2020). Besides, serological" exact="testing" post="is critically useful in disease surveillance and epidemiologic research."/>
   <result pre="A community seroprevalence study of 863 individuals showed that the" exact="prevalence" post="of antibodies to SARS-CoV-2 was 4.65% in Los Angeles"/>
   <result pre="(Kozel and Burnham-Marusich, 2017). At the time of writing, three" exact="detection" post="assays have been issued EUAs for point of care"/>
   <result pre="detection assays have been issued EUAs for point of care" exact="diagnosis" post="of SARS-CoV-2 in the US (Table S1), including Xpert"/>
   <result pre="of specimens for molecular assays is crucial in the laboratory" exact="diagnosis" post="of SARS-CoV-2 (Table 2). To prevent misdiagnosis caused by"/>
   <result pre="viral RNA in fecal samples and potential fecal-oral transmission, fecal" exact="testing" post="for SARS-CoV-2 is highly recommended when there is virus"/>
   <result pre="2 Specimen type Positive ratea Priority of specimen Early stage/initial" exact="diagnosis" post="Advanced stage Recovery/follow-up Remarks Oropharyngeal swab 32–48% ⋆ Recommended"/>
   <result pre="swab 29% ⋆ Not recommended Not recommended Highly recommend Fecal" exact="testing" post="for SARS-CoV-2 is highly recommended after viral clearance in"/>
   <result pre="in the respiratory samples. aAll patients were confirmed by SARS-CoV-2" exact="detection" post="(Wang et al., 2020, Yang et al., 2020). This"/>
   <result pre="scenarios and requirements into full consideration. Moreover, to improve the" exact="detection" post="accuracy of infectious diseases with COVID-19, proper collection of"/>
   <result pre="32198501. Pubmed Central PMCID: PMC7184472. Epub 22 March 2020 KozelT.R.Burnham-MarusichA.R.Point-of-care" exact="testing" post="for infectious diseases: past, present, and futureJ Clin Microbiol558201723132320PubMed"/>
   <result pre="PMCID: PMC5527409. Epub 26 May 201728539345 LiY.YaoL.LiJ.ChenL.SongY.CaiZ.Stability issues of RT-PCR" exact="testing" post="of SARS-CoV-2 for hospitalized patients clinically diagnosed with COVID-19J"/>
   <result pre="application of a rapid IgM-IgG combined antibody test for SARS-CoV-2" exact="infection" post="diagnosisJ Med Virol2020PubMed PMID: 32104917. Pubmed Central PMCID: PMC7228300."/>
   <result pre="Central PMCID: PMC7233363. Epub 13 February 2020 YanC.CuiJ.HuangL.DuB.ChenL.XueG.Rapid and visual" exact="detection" post="of 2019 novel coronavirus (SARS-CoV-2) by a reverse transcription"/>
   <result pre="YangY.YangM.ShenC.WangF.YuanJ.LiJ.Evaluating the accuracy of different respiratory specimens in the laboratory" exact="diagnosis" post="and monitoring the viral shedding of 2019-nCoV infectionsmedRxiv20202020.02.11.20021493 ZhuN.ZhangD.WangW.LiX.YangB.SongJ.A"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="dict8/PMC7445369/results/search/testTrace/results.xml">
   <result pre="Coronavirus Neurological disorders Outbreak Infection ref-count: page-count: Introduction An unexpected" exact="infection" post="caused by a coronavirus, SARS-CoV-2, is devastating the health"/>
   <result pre="consequently, the global economy. Although the primary manifestation of COVID-19" exact="infection" post="is pneumonia, there is increasing evidence that suggests the"/>
   <result pre="microglia, or astrocytes [3] and cause nerve damage through direct" exact="infection" post="pathways (circulatory and neuronal), hypoxia, immune injury, attack to"/>
   <result pre="31% incidence of thrombotic complications in ICU patients with COVID-19" exact="infection" post="has been documented in 184 ICU patients with proven"/>
   <result pre="disease might be related to a direct effect of the" exact="infection" post="itself or an inappropriate host response. However, in case"/>
   <result pre="Lessons from the Past Neurological complications as sequelae of influenza" exact="infection" post="have been documented for over a century. In an"/>
   <result pre="and 8.6% experiencing seizures [27]. Neurological symptoms occurring during the" exact="infection" post="process also included disturbance of consciousness, paralysis, ischemic stroke,"/>
   <result pre="contrasted with the intrinsic heterogeneity of the interaction of viral" exact="infection" post="and host reaction, which includes (1) the reproductive number;"/>
   <result pre="not least, (4) the possible adverse effects of treatments and" exact="treatment" post="categories. Thus, the insurgence of a neurological disease in"/>
   <result pre="of a neurological disease in the acute phase of the" exact="infection" post="must be assessed in the light of this complex"/>
   <result pre="not requiring immediate neurological consultation might have delayed a timely" exact="diagnosis" post="and proper treatment. This might have occurred for people"/>
   <result pre="contagion or who presented with general or neurological manifestations of" exact="infection" post="had perhaps a negative impact on the introduction of"/>
   <result pre="others, the measurement of D-dimer at the onset of the" exact="infection" post="to prevent thrombosis [44]. Last, the uncontrolled use of"/>
   <result pre="provide the basis to implement surveillance programs directed at the" exact="detection" post="of selected neurological disorders as epidemiological markers of immune-mediated"/>
   <result pre="most severe complications of the infectious disease, and, conversely, the" exact="infection" post="itself might be a source of neurological complications. These"/>
   <result pre="sclerosis, neurodegenerative disorders, and myasthenia gravis. Furthermore, the implementation of" exact="social distancing" post="and interruption of all nonurgent clinical activities, thus limiting"/>
   <result pre="to medical care is part of the impact of COVID-19" exact="infection" post="that should be measured [48]. Curbing the impact of"/>
   <result pre="the blood brain barrier is vital property of neurotropic viral" exact="infection" post="of the central nervous systemActa Virol201862(1)162729521099 4WuYXuXChenZDuanJHashimotoKYangLet al.Nervous system"/>
   <result pre="the central nervous systemActa Virol201862(1)162729521099 4WuYXuXChenZDuanJHashimotoKYangLet al.Nervous system involvement after" exact="infection" post="with COVID-19 and other coronavirusesBrain Behav Immun2020Mar 30S0889-1591(20)303573 5MaoLJinHWangMHuYChenSHeQet"/>
   <result pre="RajuTZika virus outbreak: a review of neurological complications, diagnosis, and" exact="treatment" post="optionsJ Neurovirol201824(3)2557229441490 17Carod-ArtalFJNeurological complications of Zika virus infectionExpert Rev"/>
   <result pre="virus diseaseCurr Infect Dis Rep201719(5)1928391498 22WongGQiuXBiYFormentyPSprecherAJacobsMet al.More challenges from Ebola:" exact="infection" post="of the central nervous systemJ Infect Dis2016214(Suppl 3)S294627707893 23BaggenJThibautHStratingJvan"/>
   <result pre="in severe acute respiratory syndromeActa Neurol Taiwan200514(3)113916252612 26GuJGongEZhangBZhengJGaoZZhongYet al.Multiple organ" exact="infection" post="and the pathogenesis of SARSJ Exp Med2005202(3)4152416043521 27SaadMOmraniASBaigKBahloulAElzeinFMatinMAet al.Clinical"/>
   <result pre="in Saudi ArabiaInt J Infect Dis201429301625303830 28KimJEHeoJHKimHOSongSHParkSSParkTHet al.Neurological complications during" exact="treatment" post="of Middle East respiratory syndromeJ Clin Neurol201713(3)2273328748673 29LiYLiHFanRWenBZhangJCaoXet al.Coronavirus"/>
   <result pre="during COVID19 pandemic infectionNeurol Sci202041(5)999100132270358 44KermaliMKhalsaRKPillaiKIsmailZHarkyAThe role of biomarkers in" exact="diagnosis" post="of COVID-19: a systematic reviewLife Sci2020May 1325411778832475810 45KisslerSMTedijantoCGoldsteinEGradYHLipsitchMProjecting the"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="dict8/PMC7448857/results/search/testTrace/results.xml">
   <result pre="work is properly cited. http://creativecommons.org/licenses/by/4.0/TEMI_9_1772676.pdf Abstract ABSTRACT The emerging SARS-CoV-2" exact="infection" post="associated with the outbreak of viral pneumonia in China"/>
   <result pre="that broad-spectrum antiviral compounds may have a priority for the" exact="screening" post="of antiviral compounds against newly emerging viruses to control"/>
   <result pre="It is urgent to develop some antiviral compounds for the" exact="treatment" post="of SARS-CoV-2 infection because of its high infectivity and"/>
   <result pre="to develop some antiviral compounds for the treatment of SARS-CoV-2" exact="infection" post="because of its high infectivity and morbidity and its"/>
   <result pre="tested antiviral activity of gemcitabine, lycorine and oxysophoridine against SARS-CoV-2" exact="infection" post="in cell culture, and chloroquine was used as a"/>
   <result pre="cells infected with SARS-CoV-2 (WIV04) [2] at a multiplicity of" exact="infection" post="(MOI) of 0.005 were treated with increased concentrations of"/>
   <result pre="33, 129, 222 and 30, respectively. We then performed indirect" exact="immunofluorescence" post="assay (IFA) for viral protein expression using anti-NP antibody"/>
   <result pre="dependent. Given the successful application of antiviral combination therapy for" exact="treatment" post="of HIV and enterovirus infection, the antiviral effect of"/>
   <result pre="is a cytidine analog approved by the FDA for the" exact="treatment" post="of various cancers [3]. Increasing evidence has shown that"/>
   <result pre="vivo evaluation about the antiviral activity of gemcitabine against SARS-CoV-2" exact="infection" post="is going to be carried out in the near"/>
   <result pre="a new indication for oxysophoridine as a compound inhibiting SARS-CoV-2" exact="infection" post="in cell culture. To our knowledge, this is the"/>
   <result pre="wide range of biological functions for cancer and infectious diseases" exact="treatment" post="[13]. Unlike oxysophoridine, lycorine has been well known to"/>
   <result pre="or block the elongation of viral RNA translation during EV71" exact="infection" post="[13] to suppress viral replication. Altogether, we speculate that"/>
   <result pre="JohansenLM, Lear-RooneyCM, GlassPJ, HensleyLE, FriemanMB.2014Repurposing of clinically developed drugs for" exact="treatment" post="of Middle East respiratory syndrome coronavirus infection. Antimicrob Agents"/>
   <result pre="BespalovMM, NandaniaJ, et al.Obatoclax, saliphenylhalamide and gemcitabine inhibit Zika virus" exact="infection" post="in vitro and differentially affect cellular signaling, transcription and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="dict8/PMC7454301/results/search/testTrace/results.xml">
   <result pre="genomic signal processing (GSP)-based system for automatic feature analysis and" exact="detection" post="of COVID-19 NaeemSafaa M1MabroukMai S2http://orcid.org/0000-0001-7958-937XMarzoukSamir Y3EldosokyMohamed A4[1], Biomedical Engineering"/>
   <result pre="recorded in the NCBI GenBank in order to facilitate the" exact="diagnosis" post="process and increase the accuracy of disease detection in"/>
   <result pre="facilitate the diagnosis process and increase the accuracy of disease" exact="detection" post="in less time. The selected database contains 76 genes"/>
   <result pre="SARS patients. Al-Tawfiq et al. [18] discussed the asymptomatic coronavirus" exact="infection" post="through a comparison between MERS-CoV and COVID-19. Gorbalenya et"/>
   <result pre="and used domain extension transfer learning (DETL) for an alternative" exact="screening" post="of COVID-19 so that the overall accuracy was measured"/>
   <result pre="classification accuracy obtained is 92.18%. On the other hand, the" exact="diagnosis" post="of COVID-19 is currently based on some analyses performed"/>
   <result pre="of disease using its genome which leads to a rapid" exact="diagnosis" post="of COVID-19 avoiding the disadvantages of the previous traditional"/>
   <result pre="the training data consists of 46 complete genomes, and the" exact="testing" post="data consists of 30 complete genomes for each epidemic."/>
   <result pre="NN and the KNN algorithm succeeded to recognize all the" exact="testing" post="genes successfully (Tp = 30, Fp = 0, Tn = 30 and Fn = 0). But in"/>
   <result pre="COVID-19/MERS-CoV classification process, the KNN algorithm could recognize all the" exact="testing" post="genes successfully (Tp = 30, Fp = 0, Tn = 30 and Fn = 0), while the"/>
   <result pre="and Fn = 0), while the cascade-forward NN failed to identify one" exact="testing" post="gene of MERS-CoV epidemic (Tp = 30, Fp = 0, Tn = 29 and Fn = 1)."/>
   <result pre="showed that the KNN algorithm succeeded to recognize all the" exact="testing" post="genes successfully (T1 = 30, F1 = 0, T2 = 30, F2 = 0, T3 = 30 and F3 = 0)"/>
   <result pre="SARS-CoV and MERS-CoV. This system can assist in the rapid" exact="diagnosis" post="of COVID-19 with highly acceptable accuracy results as it"/>
   <result pre="the created classification system getting the best and most efficient" exact="diagnosis" post="method. In the future work, either other features will"/>
   <result pre="Cell Mol Immunol2020https://www.nature.com/articles/s41423-020-0400-4#citeas. 2.CascellaM, RajnikM, CuomoA, et al.Features, evaluation and" exact="treatment" post="coronavirus (COVID-19) In: StatPearls [Internet]. Treasure Island (FL): StatPearls"/>
   <result pre="machine learning methods. arXiv:2020:2003:09424, preprint. 23.BasuS, MitraS, SahaNDeep learning for" exact="screening" post="COVID-19 using chest X-ray images. arXiv:2020:2004:10507. preprint. 24.OzturkT, TaloM,"/>
   <result pre="using chest X-ray images. arXiv:2020:2004:10507. preprint. 24.OzturkT, TaloM, et al.Automated" exact="detection" post="of covid-19 cases using deep neural networks with X-ray"/>
   <result pre="10.1016/j.compbiomed.2020.103792. 25.ElasnaouiK, ChawkiYUsing X-ray images and deep learning for automated" exact="detection" post="of coronavirus disease. J Biomol Struct Dyn2020;1–12. doi: 10.1080/07391102.2020.1767212."/>
   <result pre="feature selection. Cancer Control2019;26(1):1–8. doi: 10.1177/1073274819876598. 49.MedjahedSA, SaadiTA, BenyettouABreast cancer" exact="diagnosis" post="by using k-nearest neighbor with different distances and classification"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="dict8/PMC7454384/results/search/testTrace/results.xml">
   <result pre="protections.ciaa1028.pdf Abstract Abstract Background COVID-19 has highlighted deficiencies in the" exact="testing" post="capacity of many developed countries during the early stages"/>
   <result pre="greatly assist management of emerging pandemics through prioritization of high-resolution" exact="testing" post="or isolation measures. Targeting highly conserved genomic regions make"/>
   <result pre="management of emerging pandemics through prioritization of high-resolution testing or" exact="isolation" post="measures. Targeting highly conserved genomic regions make pan-family assays"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="dict8/PMC7458341/results/search/testTrace/results.xml">
   <result pre="2016, to describe seasonal trends, outbreak years, and the fluctuating" exact="prevalence" post="of the four dengue serotypes. Laboratory data from 91,554"/>
   <result pre="the likelihood of dengue infections being followed by a new" exact="infection" post="with a different serotype, which can lead to severe"/>
   <result pre="report that adults in Guatemala have a lower likelihood of" exact="infection" post="the year after an epidemic, which might be linked"/>
   <result pre="without significant cross protection for other serotypes and a follow-on" exact="infection" post="with a different DENV serotype carries an increased risk"/>
   <result pre="emerging arboviruses, particularly Zika and Chikungunya [15], have complicated dengue" exact="diagnosis" post="and surveillance, as symptoms and geographic ranges are similar"/>
   <result pre="for dengue, chikungunya and Zika infections, with the aim of" exact="testing" post="samples for all three viruses, except during outbreaks, when"/>
   <result pre="three viruses, except during outbreaks, when the most likely causative" exact="infection" post="is prioritised. The LNS reports surveillance data to the"/>
   <result pre="and updates of international case definitions. Between 2000 and 2010," exact="testing" post="for DENV was based on culture in clone C6/36"/>
   <result pre="(ELISA) to detect DENV antigens in serum, and since 2010" exact="testing" post="of acute cases has utilised the Centers for Disease"/>
   <result pre="RT-qPCR assay that serotypes the virus with a limit of" exact="detection" post="of between 5–10 copies [19]. A further assay that"/>
   <result pre="of samples received varied over the years (Fig 1). Dengue" exact="infection" post="was confirmed by RT-qPCR, viral culture or NS1 ELISA"/>
   <result pre="and DENV1 outbreak in 2005 also had the highest case" exact="detection" post="in October. Fig 1 Temporal distribution of dengue in"/>
   <result pre="among all serotypes. Interestingly the later peaks in dengue case" exact="detection" post="between 2003 and 2005 occurred around two El Niño"/>
   <result pre="serotypes combined account for most cases in Guatemala. The infrequent" exact="detection" post="of DENV4 is also mirrored from other settings, with"/>
   <result pre="[26] is thought to reflect herd immunity afforded by previous" exact="infection" post="with the same serotype. Although it is widely believed"/>
   <result pre="with the same serotype. Although it is widely believed that" exact="infection" post="by a serotype confers lifelong immunity thanks to the"/>
   <result pre="were present in 32% of samples in 2015 [35]. Thus," exact="testing" post="samples with more comprehensive diagnostic panels could generate broader"/>
   <result pre="multiplex diagnostics such as the CDC Trioplex [20] has simplified" exact="testing" post="algorithms and improved detection of acute co-infections. However, serological"/>
   <result pre="the CDC Trioplex [20] has simplified testing algorithms and improved" exact="detection" post="of acute co-infections. However, serological tests still struggle to"/>
   <result pre="due, in part, to the cost of implementing active case" exact="detection" post="strategies for a disease with no specific treatment and"/>
   <result pre="active case detection strategies for a disease with no specific" exact="treatment" post="and limited vaccine uptake. Passive surveillance for dengue in"/>
   <result pre="of dengue, but does not provide reliable data of its" exact="prevalence" post="across geographical areas. A further limitation of our data"/>
   <result pre="it replaced, and are more efficient to process samples, increasing" exact="testing" post="capacity and allowing screening a larger numbers of cases."/>
   <result pre="more efficient to process samples, increasing testing capacity and allowing" exact="screening" post="a larger numbers of cases. Therefore the proportion of"/>
   <result pre="the samples for screening. Dengue is the most prevalent mosquito-transmitted" exact="infection" post="worldwide and causes important economic and human costs [45]."/>
   <result pre="St. ClaireM, PurcellRH, LaiC-J. Monoclonal antibody-mediated enhancement of dengue virus" exact="infection" post="in vitro and in vivo and strategies for prevention."/>
   <result pre="clinical performance of the CDC real time RT-PCR assay for" exact="detection" post="and typing of dengue virus. PLoS Neglect Trop Dis."/>
   <result pre="ColónC, et al.Performance of the Trioplex real-time RT-PCR assay for" exact="detection" post="of Zika, dengue, and chikungunya viruses. Nat Comms. 2018;9(1):1391."/>
   <result pre="EnriaDA, et al.Evaluation of commercially available diagnostic tests for the" exact="detection" post="of dengue Virus NS1 antigen and anti-dengue virus IgM"/>
   <result pre="season. Int J Infect Dis. 2016;45:446. 25GuzmanMG, AlvarezM, HalsteadSB. Secondary" exact="infection" post="as a risk factor for dengue hemorrhagic fever/dengue shock"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="dict8/PMC7461001/results/search/testTrace/results.xml">
   <result pre="actively engaged in finding ways to reduce the rate of" exact="infection" post="until a cure or vaccination procedure is established. We"/>
   <result pre="Ogunbanjo, 2020). A notable consensus has been the adoption of" exact="social distancing" post="and practice of good hygiene as a measure to"/>
   <result pre="an incubation period or exposed state in an individual following" exact="infection" post="until the symptoms are observed. In other words, the"/>
   <result pre="which the virus is incubated but does not transmit the" exact="infection" post="to anyone, so with the onset of symptoms the"/>
   <result pre="in the population in a situation without any interventions. Individuals" exact="testing" post="positive in serological tests or blood tests for disease"/>
   <result pre="have been on full or partial lockdown while adhering to" exact="social distancing" post="measures as they wait for a specific treatment modality"/>
   <result pre="to social distancing measures as they wait for a specific" exact="treatment" post="modality such as vaccines (Sinha, 2020). Public information such"/>
   <result pre="as vaccines (Sinha, 2020). Public information such as incidence or" exact="prevalence" post="of infection, morbidity, or mortality due to COVID‐19 could"/>
   <result pre="an SEIR model that describes multiple transmission pathways in the" exact="infection" post="dynamics. It also emphasized the role of the environmental"/>
   <result pre="of how non‐pharmaceutical prevention and intervention measures such as lockdowns," exact="social distancing," post="self‐isolation; can significantly affect the morbidity and mortality of"/>
   <result pre="an incubation period or exposed state in an individual following" exact="infection" post="until the symptoms are observed, the SEIR account for"/>
   <result pre="Meng, L., &amp;amp; Lu, S. (2020). Molecular immune pathogenesis and" exact="diagnosis" post="of COVID‐19. Journal of Pharmaceutical Analysis, 10(2), 102–108. 10.1016/j.jpha.2020.03.00132282863"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="dict8/PMC7461190/results/search/testTrace/results.xml">
   <result pre="The causes of this phenomenon are different. Certainly, thanks to" exact="social distancing," post="the lockdown and the closure of schools led to"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="dict8/PMC7462751/results/search/testTrace/results.xml">
   <result pre="globally, has led the scientific community to look for undetected" exact="infection" post="pathways [1]. The SARS-CoV-2 has been shown to spread"/>
   <result pre="viral material on the surface of MPs and on the" exact="isolation" post="of viruses that may be present, in order to"/>
   <result pre="for microbial transmission: a scoping reviewTrav Med Infect Dis35202010170410.1016/j.tmaid.2020.101704 2PascarellaG.StrumiaA.PiliegoC.COVID-19" exact="diagnosis" post="and management: a comprehensive reviewJ Intern Med2882202019220610.1111/joim.1309132348588 3PanigrahiS.K.PathakV.K.KumarM.M.RajU.PriyaP.K.Covid-19 and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="dict8/PMC7466926/results/search/testTrace/results.xml">
   <result pre="transmission of viruses, viral pathogenesis, the associated host immunity, effectual" exact="diagnosis" post="of the disease, and the preventive therapeutic strategies including"/>
   <result pre="to the high mortality due to the 1918 H1N1 virus" exact="infection" post="[9]. Though the 1918 influenza pandemic is known as"/>
   <result pre="5.6% of the adults having symptomatic influenza A, developed the" exact="infection" post="earlier during the pandemic, despite living in households with"/>
   <result pre="living in households with participants who had influenza; whereas the" exact="infection" post="frequency was much higher (55.2%) in the children having"/>
   <result pre="is very likely to reduce NA-antibody-based protection against the viral" exact="infection" post="as revealed from the in vivo studies [30]. It"/>
   <result pre="emerging disease [32–34]. In 2012, some incidences of novel coronavirus" exact="infection" post="were reported in Arabian Peninsula with pneumonia and acute"/>
   <result pre="17]. It is to be pondered that both the ongoing" exact="infection" post="SARS-CoV-2 and the previous SARS-CoV infections are associated with"/>
   <result pre="entry into the host as also happens during the MERS-CoV" exact="infection" post="[32, 38, 40]. Indeed, using the spike (S) protein,"/>
   <result pre="can be another promoting factor for the onset of viral" exact="infection" post="[20]. Thus the anti-HA antibody, anti-NA antibody, and cell-mediated"/>
   <result pre="as the development of rapid diagnostic tests may facilitate the" exact="isolation" post="of the infected persons to ensure others’ safety [3,"/>
   <result pre="ensure others’ safety [3, 41]. In the current time, the" exact="diagnosis" post="of viral strains responsible for influenza has spectacularly improved"/>
   <result pre="assessment of the pandemic viruses has also improved through the" exact="screening" post="of the viral genome within the infected individuals. Monitoring"/>
   <result pre="the SARS pandemic in 2003 the need for the quick" exact="detection" post="of the nucleic acid sequence evolved which is major"/>
   <result pre="nucleic acid sequence evolved which is major breakthrough in the" exact="diagnosis" post="of viral infections [35]. Also, a forceful home quarantine"/>
   <result pre="the diagnosis of viral infections [35]. Also, a forceful home" exact="quarantine" post="strategy was launched which is currently being practiced to"/>
   <result pre="been developed including the development of drug/vaccine development, implementation of" exact="quarantine" post="measures, wearing protective cloths with glove and masks, limiting"/>
   <result pre="J Med. 2003; 348(20):1953–66. 10.1056/nejmoa030781 3.LeungYToMLamTYauSLeungOChuangSEpidemiology of human influenza A(H7N9)" exact="infection" post="in Hong KongJ Microbiol Immunol Infect201750218318810.1016/j.jmii.2015.06.00426220305 4.LinQZhaoSGaoDLouYYangSMusaSSWangMHCaiYWangWYangLHeDA conceptual model"/>
   <result pre="of the 1957–1959 influenza pandemicJ Infect Dis2016213573874510.1093/infdis/jiv53426908781 28.EpsteinSLPrior H1N1 influenza" exact="infection" post="and susceptibility of Cleveland Family Study participants during the"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="dict8/PMC7467230/results/search/testTrace/results.xml">
   <result pre="include leveraging harm reduction tools and improving integrated prevention and" exact="treatment" post="services for the infectious diseases and substance use disorder"/>
   <result pre="and addiction specialists, including increasing training in substance use disorder" exact="treatment" post="among infectious diseases and addiction specialists, we can decrease"/>
   <result pre="these overlapping epidemics. injection drug use opioid epidemic medications for" exact="treatment" post="of opioid use disorder Funding National Institute on Drug"/>
   <result pre="10–12]. In addition to HIV, both acute HCV and HBV" exact="infection" post="incidence has mirrored the rise in injection opioids [5,"/>
   <result pre="recommend expanding Medicaid, expanding access to harm reduction services, improving" exact="treatment" post="and surveillance to enhance the continuum of care, and"/>
   <result pre="WHY DOES IT MATTER TO INFECTIOUS DISEASES CLINICIANS? Medications for" exact="treatment" post="of opioid use disorder (MOUDs, which is now the"/>
   <result pre="people living with HIV, the gold standard of care in" exact="treatment" post="of HIV that is associated with reduced mortality and"/>
   <result pre="the Drug Enforcement Agency in the case of buprenorphine or" exact="treatment" post="in a federally certified opioid treatment program in the"/>
   <result pre="case of buprenorphine or treatment in a federally certified opioid" exact="treatment" post="program in the case of methadone. Unfortunately, many clinical"/>
   <result pre="physicians have waivers to prescribe buprenorphine and most substance use" exact="treatment" post="programs do not have opioid treatment programs, which makes"/>
   <result pre="and most substance use treatment programs do not have opioid" exact="treatment" post="programs, which makes methadone treatment challenging to obtain [18]."/>
   <result pre="programs do not have opioid treatment programs, which makes methadone" exact="treatment" post="challenging to obtain [18]. Therefore, the prevailing care for"/>
   <result pre="relapse to opioid use after failure to connect with OUD" exact="treatment" post="referrals. Such inadequate care results in prolonged hospitalizations due"/>
   <result pre="leave the hospital, readmissions after OUD relapse, and, if concomitant" exact="infection" post="is present, lack of antibiotic adherence and reinfection. Ultimately,"/>
   <result pre="predict and respond to emerging epidemics. 11. Integrate MOUD and" exact="counseling" post="services during incarceration. 12. Integrate screening for OUD and treatment"/>
   <result pre="epidemics. 11. Integrate MOUD and counseling services during incarceration. 12. Integrate" exact="screening" post="for OUD and treatment with MOUD into jails and"/>
   <result pre="and counseling services during incarceration. 12. Integrate screening for OUD and" exact="treatment" post="with MOUD into jails and prisons. 13. Expand access to"/>
   <result pre="human immunodeficiency virus; IDU, injection drug use; MOUD, medication for" exact="treatment" post="of opioid use disorder; OUD, opioid use disorder; SSPs,"/>
   <result pre="including provisions that improved Medicaid and Medicare coverage of SUD" exact="treatment" post="and services, and that increased the patient cap for"/>
   <result pre="repayment over 6 years for providers working in substance use" exact="treatment" post="facilities [20]. Both programs depend on Congress to appropriate"/>
   <result pre="provide funding to states to support comprehensive prevention, care, and" exact="treatment" post="programs [23]; and the Mainstreaming Addiction Treatment Act that"/>
   <result pre="harm reduction services, including access to MOUD and infectious diseases" exact="treatment" post="services in order to decrease HCV, HIV, IDU-related infections,"/>
   <result pre="space without stigma for individuals with SUDs to also receive" exact="counseling" post="regarding safe sexual practice, safe injection practice, and provision"/>
   <result pre="HIV preexposure prophylaxis (PrEP) and contraception. SSPs that also provide" exact="treatment" post="for OUD can facilitate linkage to care for effective"/>
   <result pre="outcomes for people with HIV [43]. As a next step," exact="treatment" post="programs that integrate substance use care and treatment for"/>
   <result pre="next step, treatment programs that integrate substance use care and" exact="treatment" post="for infectious complications in order to improve outcomes are"/>
   <result pre="HIV, HCV) can be cost-effective and is associated with improved" exact="infection" post="and SUD outcomes [44]. Previous studies have shown that"/>
   <result pre="However, significant gaps remain in understanding the role substance use" exact="treatment" post="plays in caring for people with other IDU-related infections,"/>
   <result pre="One innovative care model combined outpatient parenteral therapy with buprenorphine" exact="treatment" post="and showed similar clinical and drug use outcomes to"/>
   <result pre="[48]. Studies are needed to evaluate novel approaches to antimicrobial" exact="treatment" post="for IDU-associated infections such as the role of long-acting"/>
   <result pre="some physicians from integrating buprenorphine into their practice for the" exact="treatment" post="of OUD [49]. Warmlines, such as the one run"/>
   <result pre="locator https://www.samhsa.gov/medication-assisted-treatment/practitioner-program-data/treatment-practitioner-locator Buprenorphine waiver and training resources https://www.samhsa.gov/medication-assisted-treatment/training-materials-resources/apply-for-practitioner-waiver Behavioral health" exact="treatment" post="services locator https://findtreatment.samhsa.gov/ Clinical consultation center—substance use management warmline"/>
   <result pre="technical assistance consortium https://opioidresponsenetwork.org/ Support for hospital opioid use disorder" exact="treatment" post="https://www.projectshout.org In addition, a reorganization of the buprenorphine prescribing"/>
   <result pre="increase medication uptake and improve outcomes by increasing access to" exact="treatment" post="where people reside. In addition, multidisciplinary team meetings, including"/>
   <result pre="women [52] and has been successfully integrated into most prenatal" exact="screening" post="paradigms, allowing for perinatal management that decreases the risk"/>
   <result pre="risk of infant infection. In September 2006, the CDC recommended" exact="screening" post="all sexually active persons 13–65 years old for HIV"/>
   <result pre="Services Task Force issued a draft recommendation for universal HCV" exact="screening" post="[53]. Given that overall incidence of HCV is increasing"/>
   <result pre="education and increased resources are needed to ensure universal HCV" exact="testing" post="is performed, particularly among women of child-bearing age and"/>
   <result pre="of child-bearing age and in prenatal care to prevent infant" exact="infection" post="[55–57]. Persons experiencing homelessness and unstable housing are similarly"/>
   <result pre="with SUD. This is, in part, due to the high" exact="prevalence" post="of concomitant untreated mental illness and SUD among these"/>
   <result pre="population. In addition to ensuring persons who experience homelessness receive" exact="treatment" post="of their infectious diseases and SUD through low-barrier and"/>
   <result pre="majority of federal funding has been directed towards opioid overdose" exact="treatment" post="and HIV resultant from IDU, but not toward the"/>
   <result pre="resultant from IDU, but not toward the bacterial and fungal" exact="infection" post="complications, partly due to lack of integrated surveillance systems"/>
   <result pre="population (CJIP) have OUD or SUD, with a 10-fold higher" exact="prevalence" post="than found in the general adult population [62]. As"/>
   <result pre="general adult population [62]. As such, employing and enforcing evidence-based" exact="treatment" post="guidelines that address the overlap of SUD and infectious"/>
   <result pre="new entrants for SUD and IDU-related infections, integrating MOUD and" exact="counseling" post="services during incarceration, providing both appropriate medical care during"/>
   <result pre="HIV, and HBV/HCV-induced liver disease [66–68]. Additionally, overall infectious disease" exact="testing" post="rates and rates of vaccination against HAV and HBV"/>
   <result pre="are low [69, 70]. Integration of infectious disease management with" exact="treatment" post="for OUD in CJIP is an endorsed strategy for"/>
   <result pre="Despite the evidence, however, few incarcerated settings offer MOUD. SUD" exact="screening" post="in jails and prisons with linkage to substance use"/>
   <result pre="screening in jails and prisons with linkage to substance use" exact="treatment" post="also decreases postrelease mortality [72, 73] and increases postrelease"/>
   <result pre="increases postrelease HIV viral suppression [16, 17]. Clearly, prevention and" exact="treatment" post="for OUD and associated infections in this population can"/>
   <result pre="opportunity to engage a vulnerable population. Screening for OUD and" exact="treatment" post="with MOUD need to be integrated into jails and"/>
   <result pre="improve substance use and infectious diseases outcomes. In addition to" exact="testing" post="and treatment, access to harm reduction tools to prevent"/>
   <result pre="testing and treatment, access to harm reduction tools to prevent" exact="infection" post="needs to be prioritized in the CJIP. Harm reduction"/>
   <result pre="be implemented in jails, effectively containing outbreaks [77]. Substance use" exact="treatment" post="coupled with uninterrupted health insurance is needed to improve"/>
   <result pre="jail and prison. As a case study, expansion of HCV" exact="treatment" post="during incarceration is feasible, cost-effective, and the best option"/>
   <result pre="to move closer to national HCV elimination [78, 79]. HCV" exact="diagnosis" post="in jails with linkage postrelease is a feasible alternative"/>
   <result pre="jails with linkage postrelease is a feasible alternative if HCV" exact="treatment" post="costs are deemed prohibitive [80]. A major barrier in"/>
   <result pre="Centers for Disease Control and Prevention (CDC)Community outbreak of HIV" exact="infection" post="linked to injection drug use of oxymorphone–Indiana, 2015. MMWR"/>
   <result pre="5.ZibbellJE, AsherAK, PatelRC, et al.Increases in acute hepatitis C virus" exact="infection" post="related to a growing opioid epidemic and associated injection"/>
   <result pre="68:253–4.30870405 11.GoldenMR, LechtenbergR, GlickSN, et al.Outbreak of human immunodeficiency virus" exact="infection" post="among heterosexual persons who are living homeless and inject"/>
   <result pre="68:344–9.30998671 12.EvansME, LabudaSM, HoganV, et al.Notes from the field: HIV" exact="infection" post="investigation in a rural area—West Virginia, 2017. MMWR Morb"/>
   <result pre="and Human Services, 2018. 15.GowingL, FarrellMF, BornemannR, SullivanLE, AliROral substitution" exact="treatment" post="of injecting opioid users for prevention of HIV infection."/>
   <result pre="Acquir Immune Defic Syndr2018; 78:43–53.29373393 18.collab: Congressional Research Service. Opioid" exact="treatment" post="programs and related federal regulations. Washington, DC: United States"/>
   <result pre="of Sciences, Engineering, and Medicine, 2018. 27.SpringerSA, KorthuisPT, Del RioCintegrating" exact="treatment" post="at the intersection of opioid use disorder and infectious"/>
   <result pre="Drug Policy2019; 67:9–18.30802842 41.MeinhoferA, WitmanAEThe role of health insurance on" exact="treatment" post="for opioid use disorders: evidence from the Affordable Care"/>
   <result pre="Prev Med2018; 54:S208–S14.29779544 50.TalalAH, AndrewsP, McleodA, et al.Integrated, co-located, telemedicine-based" exact="treatment" post="approaches for hepatitis C virus management in opioid use"/>
   <result pre="Preventive Services Task Force. Draft recommendation statement hepatitis C virus" exact="infection" post="in adolescents and adults: screening. Rockville, MD: USPSTF, 2019."/>
   <result pre="54.ZibbellJE, AsherAK, PatelRC, et al.Increases in acute hepatitis C virus" exact="infection" post="related to a growing opioid epidemic and associated injection"/>
   <result pre="Health2018; 108:175–81.29267061 55.LyKN, JilesRB, TeshaleEH, FosterMA, PesanoRL, HolmbergSDHepatitis C virus" exact="infection" post="among reproductive-aged women and children in the United States,"/>
   <result pre="Intern Med2013; 158:109–13.23437438 57.BellR, WolfeI, CoxD, ThakaraK, LucasL, CraigAHepatitis C" exact="screening" post="in mothers and infants exposed to opioids. Hosp Pediatr2019;"/>
   <result pre="BeiserM, LeónC, GaetaJM, O’ConnellJJ, LinasBPExperience and outcomes of hepatitis C" exact="treatment" post="in a cohort of homeless and marginally housed adults."/>
   <result pre="JAMA Intern Med2017; 177:880–2.28395004 60.BeiserME, SmithK, IngemiM, MulliganE, BaggettTPHepatitis C" exact="treatment" post="outcomes among homeless-experienced individuals at a community health centre"/>
   <result pre="of Justice, 2017. 63.HennesseyKA, KimAA, GriffinV, CollinsNT, WeinbaumCM, SabinKPrevalence of" exact="infection" post="with hepatitis B and C viruses and co-infection with"/>
   <result pre="Brinkley-RubinsteinL, et al.Postincarceration fatal overdoses after implementing medications for addiction" exact="treatment" post="in a statewide correctional system. JAMA Psychiatry2018; 75:405–7.29450443 73.DegenhardtL,"/>
   <result pre="TasilloA, VellozziC, et al.Cost-effectiveness and budgetary impact of HCV testing," exact="treatment" post="and linkage to care in U.S. prisons [published online"/>
   <result pre="10.1093/cid/ciz383. 79.HeT, LiK, RobertsMS, et al.Prevention of hepatitis C by" exact="screening" post="and treatment in U.S. prisons. Ann Intern Med2016; 164:84–92.26595252"/>
   <result pre="LiK, RobertsMS, et al.Prevention of hepatitis C by screening and" exact="treatment" post="in U.S. prisons. Ann Intern Med2016; 164:84–92.26595252 80.NguyenJT, RichJD,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="dict8/PMC7467512/results/search/testTrace/results.xml">
   <result pre="The current COVID-19 pandemic has resulted in high rates of" exact="infection" post="and death, as well as widespread social disruption and"/>
   <result pre="health crisis and prevent deaths. Examples of such measures include" exact="social distancing," post="quarantine, lockdown, mass-media campaigns, non-essential workplace and school closures,"/>
   <result pre="mental health outcomes in non-clinical populations.9 In a recent review," exact="quarantine" post="was found to be associated with traumatic stress symptoms,"/>
   <result pre="associated with traumatic stress symptoms, depressive symptoms and loneliness.10 Social" exact="isolation" post="and loneliness are strong risk factors for depressive symptomatology,"/>
   <result pre="facing job insecurity are more likely to experience anxiety during" exact="quarantine" post="measures.20 Evidence suggests that people with pre-existing mental disorders"/>
   <result pre="disorders. Stakeholders were most often concerned about the effects of" exact="social distancing," post="such as the impact of loneliness on people with"/>
   <result pre="curb pandemics/epidemics (eg, quarantine): We hypothesise that measures grounded in" exact="social distancing" post="(eg, quarantine, legally mandated isolation) will show the strongest"/>
   <result pre="be scant, data from the general population suggest that longer" exact="quarantine" post="duration and isolation measures that impede access to resources"/>
   <result pre="from the general population suggest that longer quarantine duration and" exact="isolation" post="measures that impede access to resources can worsen psychological"/>
   <result pre="also apply to this specific population.10 As mentioned previously, social" exact="isolation" post="is also a strong predictor of a number of"/>
   <result pre="that can be used during the current pandemic while maintaining" exact="physical distancing." post="Our three objectives meet a number of the recommendations"/>
   <result pre="Our population of interest is people with mental disorders whose" exact="diagnosis" post="predated the onset of a pandemic or epidemic. Studies"/>
   <result pre="include studies reporting on the following exposures: all forms of" exact="social distancing," post="physical distancing, travel suspensions, mass-media campaigns, as well as"/>
   <result pre="reporting on the following exposures: all forms of social distancing," exact="physical distancing," post="travel suspensions, mass-media campaigns, as well as closures of"/>
   <result pre="scale covers six domains of bias: selection bias, performance bias," exact="detection" post="bias, attrition bias, reporting bias, and other bias, and"/>
   <result pre="project to summarise the neuropsychiatric manifestations of COVID-19. Through rigorous" exact="screening" post="and synthesising of the literature, we hope that our"/>
   <result pre="around the world have been left without access to crucial" exact="treatment" post="services. While innovation of evidenced-based interventions is important, it"/>
   <result pre="Psychiatry2020;7:547–60. 10.1016/S2215-0366(20)30168-132304649 10BrooksSK, WebsterRK, SmithLE, et al.The psychological impact of" exact="quarantine" post="and how to reduce it: rapid review of the"/>
   <result pre="OCD: effects of contamination symptoms and remission state before the" exact="quarantine" post="in a preliminary naturalistic study. Psychiatry Res2020;291:113213. 10.1016/j.psychres.2020.11321332535508 32FischerM,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="dict8/PMC7469891/results/search/testTrace/results.xml">
   <result pre="Revolution and artificial intelligence, centuries-old interventions, such as face coverings," exact="social distancing" post="and isolation (quarantine) of infected cases, as well as"/>
   <result pre="intelligence, centuries-old interventions, such as face coverings, social distancing and" exact="isolation" post="(quarantine) of infected cases, as well as shutdown of"/>
   <result pre="people is considered to be low. Under experimental conditions, while" exact="testing" post="for suitable animal models of COVID-19, the virus has"/>
   <result pre="closures that are commonly suggested for mitigating epidemics of respiratory" exact="infection" post="were among the first social distancing measures implemented during"/>
   <result pre="for mitigating epidemics of respiratory infection were among the first" exact="social distancing" post="measures implemented during this pandemic. Decreases in COVID-19 cases"/>
   <result pre="would prevent only 2–4% of deaths, much less than other" exact="social distancing" post="interventions, according to a review from the UK led"/>
   <result pre="generally experience less severe disease and have better prognosis after" exact="infection" post="with SARS-CoV-2 [27], although a multisystem inflammatory syndrome (MIS-C)"/>
   <result pre="and South Korea, Davies et al. estimated that susceptibility to" exact="infection" post="in individuals under 20 years of age was approximately"/>
   <result pre="the dynamics of COVID-19 transmission within families showed significantly lower" exact="infection" post="rates in children compared with adults residing in the"/>
   <result pre="a study of young children from northern France [36], SARS-CoV-2" exact="infection" post="was found to be largely mild or asymptomatic and"/>
   <result pre="[43]. Sampling bias due to the increased possibility of asymptomatic" exact="infection" post="in children that reduces the chances of being tested"/>
   <result pre="children that reduces the chances of being tested early in" exact="infection" post="when virus levels in the nasopharynx are high, could"/>
   <result pre="to SARS-CoV-2, will help determine the incidence of novel coronavirus" exact="infection" post="in children in the USA and whether rates differ"/>
   <result pre="infected than adults (at least based on nasopharyngeal viral RNA" exact="detection" post="as discussed in the previous subsection), and when they"/>
   <result pre="with continuous monitoring of possible resurgence in infections through frequent" exact="testing" post="and isolation of infected – and perhaps more importantly"/>
   <result pre="monitoring of possible resurgence in infections through frequent testing and" exact="isolation" post="of infected – and perhaps more importantly of infectious"/>
   <result pre="be implemented as at other essential workplaces, including hand hygiene," exact="physical distancing" post="considering the recent advances in the biophysics of host-to-host"/>
   <result pre="hamsters. Nature583, 834–838 (2020).32408338 14.OreshkovaN , MolenaarRJ , VremanSet al.SARS-CoV-2" exact="infection" post="in farmed minks, The Netherlands, April and May 2020."/>
   <result pre="J. Med. Virol. (2020). 36.FontanetA , GrantR , TondeurLet al.SARS-CoV-2" exact="infection" post="in primary schools in northern France: a retrospective cohort"/>
   <result pre="in NSW (2020). http://ncirs.org.au/sites/default/files/2020-04/NCIRS%20NSW%20Schools%20COVID_Summary_FINAL%20public_26%20April%202020.pdf 40.ParkYJ , ChoeYJ , ParkOet al.Contact" exact="tracing" post="during coronavirus disease outbreak, South Korea, 2020. Emerg. Infect."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="dict8/PMC7470771/results/search/testTrace/results.xml">
   <result pre="#stayhome to contain Covid-19: Neuro-SIR – Neurodynamical epidemic modeling of" exact="infection" post="patterns in social networks LymperopoulosIlias N.[], pmc-release: 2020-9-9ppub: 2021-3-3epub:"/>
   <result pre="to the activity propagation in neuronal populations. The workings of" exact="infection" post="transmission from individual to individual through a network of"/>
   <result pre="equipment (PPE) (Chu et al., 2020, Leclerc et al., 2020);" exact="infection" post="transmission through asymptomatic individuals (Huang et al., 2020, Nishiura"/>
   <result pre="transmission of action potentials through synaptic connections among neurons. The" exact="infection" post="mechanism is represented by the activation dynamics of leaky"/>
   <result pre="represented by the transmission delays of action potentials. Viral loads," exact="social distancing," post="contact network, and usage of personal protective equipment, can"/>
   <result pre="the transmission dynamics of pathogens, and the description of the" exact="infection" post="mechanism. Also, they cannot support a high level of"/>
   <result pre="for a medical examination that could lead to quarantine, and" exact="contact tracing." post="The only way to detect asymptomatic individuals and determine"/>
   <result pre="and determine their proportion in a population is trough massive" exact="testing" post="of a population for Covid-19. As a result, asymptomatic"/>
   <result pre="by Neuro-SIR are described below: •Investigation of the impact of" exact="social distancing," post="usage of personal protective equipment, transmission of viral load"/>
   <result pre="contagious disease, through the configuration of the distribution of the" exact="infection" post="thresholds of a simulated population of individuals, susceptible to"/>
   <result pre="epidemic spreading pattern, through the configuration of an additional asymptomatic" exact="infection" post="propagation layer interacting with the layer of the symptomatic"/>
   <result pre="outbreak of Covid-19, since there are no medicines and vaccines," exact="social distancing" post="is a major strategy for enduring this unprecedented storm."/>
   <result pre="the ability of a health system to respond to the" exact="treatment" post="needs of the infected individuals (Böttcher, Woolley-Meza, Araújo, Herrmann,"/>
   <result pre="t ( t ) ∕ τ , which represents the" exact="infection" post="force increasing i’s susceptibility to the disease D. As"/>
   <result pre="individuals, leads to the development of a critical level of" exact="infection" post="signifying the onset of the disease D in the"/>
   <result pre="infectious disease. In particular, case studies have shown that the" exact="infection" post="risk of tuberculosis increases with multiple exposures to infected"/>
   <result pre="a sigmoidal pattern, whereby a sudden transition to a high" exact="infection" post="risk occurs after a certain number of contacts with"/>
   <result pre="the epidemiological empirical evidence of the phase transition in the" exact="infection" post="risk, as the number of contacts with infected individuals"/>
   <result pre="a hospital to receive medical care (quarantine). Subsequently, if the" exact="treatment" post="is successful, an infected individual recovers from the disease,"/>
   <result pre="transmits pathogens to his/her connection only once, since after the" exact="infection" post="the individual j moves permanently to the Removed (R)"/>
   <result pre="is indeed a highly effective strategy for slowing down the" exact="infection" post="rate, and preventing the spreading of the disease. In"/>
   <result pre="the epidemic spreading, the variability in the sensitivity to an" exact="infection" post="in a population due to factors, such as age,"/>
   <result pre="which a susceptible individual gets infected. Furthermore, we record the" exact="infection" post="rate per 2 ms, that is, the number of"/>
   <result pre="are connected in a random network. The experiment examines the" exact="infection" post="rate, the speed of epidemic spreading, and the evolution"/>
   <result pre="model simulates an Susceptible–Infected–Removed epidemic process. Fig. 1 illustrates the" exact="infection" post="rate per 2 ms in the population of 1000"/>
   <result pre="population. It can be seen in Fig. 1 that the" exact="infection" post="rate exhibits a sharp increase, and the duration of"/>
   <result pre="of the duration of the experiment. Fig. 2 shows the" exact="infection" post="rate with the network density of the interconnected individuals"/>
   <result pre="individuals’ degree distribution is approximately 15. In comparison with the" exact="infection" post="rate of the previous case ( d G ="/>
   <result pre="a significant decrease is noticed. The maximum value of the" exact="infection" post="rate is substantially lower and the epidemic lasts longer."/>
   <result pre="we visualize two additional epidemic spreading patterns along with the" exact="infection" post="rate. In particular, Fig. 3 shows the evolution of"/>
   <result pre="infected individuals during an epidemic. The effective control of the" exact="infection" post="rate through the reduction of the network density, is"/>
   <result pre="distribution is approximately 10. It can be observed, that the" exact="infection" post="rate is substantially smoother and the epidemic lasts significantly"/>
   <result pre="Covid-19. By decreasing the density of a social network, the" exact="infection" post="rate becomes less bursty and the epidemic progresses at"/>
   <result pre="infectious and dangerous disease like Covid-19. Fig. 5 illustrates the" exact="infection" post="rate in a random network with density d G"/>
   <result pre="( d G = 0 . 01 ) , the" exact="infection" post="rate is substantially lower and smoother in comparison with"/>
   <result pre="individuals. For network densities equal to 0.03 and 0.015, the" exact="infection" post="spreads to the entire population. However, in the case"/>
   <result pre="outbreak is sharper, when we compare the penetration of the" exact="infection" post="in the population in random networks with densities 0.01"/>
   <result pre="values separating the containment of a disease from the widespread" exact="infection" post="of a population. Fig. 7 Comparison of infection rates"/>
   <result pre="the widespread infection of a population. Fig. 7 Comparison of" exact="infection" post="rates for various interaction network densities. Fig. 8 Visualization"/>
   <result pre="density 0.00825. Fig. 7 illustrates a comparative chart of the" exact="infection" post="rates in relation to the network density. This diagram"/>
   <result pre="networks. The denser a contact network is, the higher the" exact="infection" post="rate will be. As a result, &quot;lockdown&quot; policies constitute"/>
   <result pre="2020, Zheng et al., 2020). Fig. 10 The evolution of" exact="infection" post="events in the symptomatic layer, with (middle) and without"/>
   <result pre="in the lower part of the figure. Fig. 11 The" exact="infection" post="rate in the layer of susceptibles who can develop"/>
   <result pre="of the figure. Fig. 10, in the middle, shows the" exact="infection" post="events in the layer of susceptible individuals, who become"/>
   <result pre="upper part of Fig. 10 shows the evolution of the" exact="infection" post="events without asymptomatic transmission. It can be seen that"/>
   <result pre="can be seen that when asymptomatic transmission takes place, the" exact="infection" post="events increase and occur in a shorter time interval."/>
   <result pre="after a time point do not give rise to new" exact="infection" post="events, as the remaining susceptibles have a higher infection"/>
   <result pre="new infection events, as the remaining susceptibles have a higher" exact="infection" post="threshold, which cannot be crossed through the accumulation of"/>
   <result pre="by asymptomatic individuals. Fig. 11, in the middle, illustrates the" exact="infection" post="rate in the layer of susceptibles who can develop"/>
   <result pre="layers. As expected, the existence of asymptomatic transmission increases the" exact="infection" post="rate in the layer of susceptible-symptomatic individuals, and shortens"/>
   <result pre="other infected individuals do not drive his/her susceptibility towards the" exact="infection" post="threshold. After the expiration of the immunity period, an"/>
   <result pre="the dynamically evolving susceptibilities from the reset value to the" exact="infection" post="threshold, for all the interconnected individuals of the simulation"/>
   <result pre="occur in waves, whereby vulnerable individuals contract the disease through" exact="infection" post="cascades transmitting significant pathogenic load from the infected to"/>
   <result pre="in the contact network lead to stronger and more solid" exact="infection" post="bursts. Neuro-SIR models these bursts through the dynamics of"/>
   <result pre="transmission risk of a contagious disease. ii.Social distancing: Complying with" exact="social distancing" post="rules has a significant impact on the containment of"/>
   <result pre="provided into the design of the proper strategy for the" exact="testing" post="of large portions of a population. The identification of"/>
   <result pre="on the calibration and adaptation of Neuro-SIR to more realistic" exact="infection" post="transmission scenarios. The implementation of such simulation experiments entails"/>
   <result pre="the Covid-19 transmission risk, in relation to the location, activity," exact="social distancing," post="and the individuals’ contact network. Configuring the Neuro-SIR model"/>
   <result pre="2020, Zou, Ruan et al., 2020). (b) The impact of" exact="social distancing" post="and personal protective equipment on the propagation of Covid-19"/>
   <result pre="individuals. In this regard, we initiated the modeling of the" exact="infection" post="transmission process, through an isomorphism between disease spreading in"/>
   <result pre="accelerate and intensify the epidemics of contagious diseases, and therefore" exact="social distancing" post="is crucial to inhibiting the progression of infections in"/>
   <result pre="2020). (b) The containment of the propagation of Covid-19 through" exact="social distancing" post="and use of personal protective equipment (Chu et al.,"/>
   <result pre="also expanded on the ability of Neuro-SIR to capture the" exact="infection" post="mechanism through multiple exposures to infected individuals. Recent epidemiological"/>
   <result pre="transmitted (Ackley et al., 2019, Lee et al., 2016). The" exact="infection" post="threshold featured in Neuro-SIR, which is reached through contacts"/>
   <result pre="time-varying external signals driving one’s susceptibility either closer to the" exact="infection" post="threshold, or away from it. When the individuals’ susceptibility"/>
   <result pre="the individuals’ susceptibility has increased due to external conditions, then" exact="infection" post="cascades of large size can easily occur, as the"/>
   <result pre="can easily occur, as the individuals’ are closer to the" exact="infection" post="threshold and few contacts with infected persons suffice to"/>
   <result pre="in posterior oropharyngeal saliva samples and serum antibody responses during" exact="infection" post="by SARS-CoV-2: an observational cohort studyThe Lancet Infectious Diseases2020"/>
   <result pre="transmission dynamics in Wuhan, ChinaNature Medicine2642020506510 YuP.ZhuJ.ZhangZ.HanY.A familial cluster of" exact="infection" post="associated with the 2019 novel coronavirus indicating possible person-to-person"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="dict8/PMC7472381/results/search/testTrace/results.xml">
   <result pre="their assumptions and parameter estimates, the CHIKV-R combination had higher" exact="prevalence" post="and faster epidemics than did the CHIKV-A combination. Their"/>
   <result pre="In addition, recent work suggests variability between people and PCR" exact="detection" post="of virus for 4–16 days [42]). To focus attention"/>
   <result pre="of going extinct. To address this, if the combined virus" exact="prevalence" post="went below 0.5 (i.e., H i n + ∑"/>
   <result pre="was assumed to die out and all state variables including" exact="infection" post="reset to 0. (8) d H s d t"/>
   <result pre="There is less information available on the rate of human" exact="infection" post="following infectious bites (βj), so the range and most"/>
   <result pre="43.XiaoF.-Z.ZhangY.DengY.-Q.HeS.XieH.-G.ZhouX.-N.YanY.-S.The effect of temperature on the extrinsic incubation period and" exact="infection" post="rate of dengue virus serotype 2 infection in Aedes"/>
   <result pre="incubation period and infection rate of dengue virus serotype 2" exact="infection" post="in Aedes albopictusArch. Virol.20141593053305710.1007/s00705-014-2051-124990415 44.ChanM.JohanssonM.A.The incubation periods of Dengue"/>
   <result pre="(Diptera: Culicidae)J. Med. Entomol.20135083884610.1603/ME1214623926783 62.McMenimanC.J.LaneR.V.CassB.N.FongA.W.C.SidhuM.WangY.F.O’NeillS.L.Stable introduction of a life-shortening Wolbachia" exact="infection" post="into the mosquito Aedes aegyptiScience200932314114410.1126/science.116532619119237 63.DongY.MortonJ.C.RamirezJ.L.Souza-NetoJ.A.DimopoulosG.The entomopathogenic fungus Beauveria"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="dict8/PMC7482569/results/search/testTrace/results.xml">
   <result pre="a skilled nursing facility in USA infected with SARS-CoV-2, extensive" exact="testing" post="was carried out and 23 days later it was"/>
   <result pre="in addition to its accelerated efforts to develop an effective" exact="treatment" post="and a vaccination, is also playing an important role"/>
   <result pre="data until around the time when the maximum rate of" exact="infection" post="occurs, which will be denoted by T (the corresponding"/>
   <result pre="model is the time T when the maximum rate of" exact="infection" post="is achieved: computing the second derivative of the right-hand"/>
   <result pre="is used in [26] to estimate the associated per day" exact="infection" post="mortality and recovery rates. (iv) In [27], by combining"/>
   <result pre="In [27], by combining a stochastic model for the SARS-CoV-2" exact="infection" post="with the knowledge of data from China during January"/>
   <result pre="China, Italy and France. (vi) In [29], the effect of" exact="social distancing" post="was studied by using a model where the population"/>
   <result pre="has the following consequences: (i) for the case that an" exact="infection" post="that has been stabilized, any of the three analytical"/>
   <result pre="5. Figure 5. Plot of α(t) for the SARS-CoV-2 virus" exact="infection" post="for Italy, Spain, France, Germany, USA and Sweden as"/>
   <result pre="40BrooksSK, WebsterRK, SmithLE, WoodlandL, WesselyS, GreenbergN, RubinGJ2020The psychological impact of" exact="quarantine" post="and how to reduce it: rapid review of the"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="dict8/PMC7494453/results/search/testTrace/results.xml">
   <result pre="Government bodies make plans using other countries’ data to project" exact="infection" post="rates. The high degree of uncertainty associated to novel"/>
   <result pre="included relevant data and were included in this review. The" exact="screening" post="process is depicted in Fig. 1 . Fig. 1"/>
   <result pre="medical staff and 257 administrative staff, with 213 working in" exact="isolation" post="wards 2 days, February 2020 NRS, HAMA and HAMD"/>
   <result pre="stress symptoms which were strongly associated with exposure to SARS," exact="quarantine" post="and a relative or friend acquiring SARS (Wu et"/>
   <result pre="of depression, while having a colleague hospitalised or placed in" exact="quarantine" post="was associated with PTSS, whereas, a colleague dying was"/>
   <result pre="HCWs with high anxiety was being suspected of having COVID-19" exact="infection" post="when compared to those who were not suspected of"/>
   <result pre="et al., 2020). A lack of family support and social" exact="isolation" post="had a negative psychological impact on nurses who chose"/>
   <result pre="of 1,557 nurses identified three attitudinal factors (health fear, social" exact="isolation" post="and job stress) mediated the association between contact with"/>
   <result pre="and therefore little evidence on the long-term psychological sequelae and" exact="treatment" post="needs. There is a lack of in-depth research considering"/>
   <result pre="During the COVID-19 pandemic, HCWs have been exposed to high" exact="infection" post="risks, death and dying, moral dilemmas in deciding who"/>
   <result pre="COVID-19 on health care providers in ChinaAm. J. Psychiatr.1777202063563632605443 LiuC.-Y.The" exact="prevalence" post="and influencing factors in anxiety in medical workers fighting"/>
  </snippets>
 </snippetsTree>
</projectSnippetsTree>
